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General introduction
General Introduction
Anxiety is a common emotion in reaction to a threatening stressor. Anxiety can range 
on a scale from normal to pathological. Normally, when a person detects danger, 
he or she responds by feeling anxious, which in turn activates the body and enables 
him or her to react physically to the perceived threat: either fight or flight. In this 
way, anxiety is adaptive. However, when anxiety is disproportionate, in type, extent 
and/or duration, and limits a person to function adequately in daily life, it becomes 
maladaptive or pathological.
At the pathological end of the anxiety spectrum are the anxiety disorders, which 
are among the most prevalent psychiatric disorders 1 and are defined by anxiety and 
distress, anxiety-related avoidance behavior and functional impairment. Almost one-
third of all people experience an anxiety disorder during their life 2. An example of 
an anxiety disorder is panic disorder, which is characterized by sudden and repeated 
attacks of intense fear. During these panic attacks, patients experience symptoms of 
physical arousal (like a racing heart or hyperventilation) and have fearful thoughts 
(e.g. being out of control or having a fear of dying). In between panic attacks patients 
fear new attacks. 
Pathological anxiety often coincides with depression: a state of low  mood  and/
or anhedonia (loss of interest in activities formerly found amusing) that influences 
wellbeing and interferes with daily life. In the majority of the patients with a diagnosed 
anxiety disorder a comorbid (current or lifetime) depression is present 3. Additionally, 
in patients with a somatic disorder (pathological) anxiety is highly prevalent 4 and 
often concomitant with depression, and vice versa: e.g. in 90% of the depressed 
patients with a myocardial infarction mixed anxiety-depression is present one month 
post-MI 5.
Anxiety results from a perceived threat. This threat can be caused by internal triggers 
(like physical symptoms or worrying thoughts) or external triggers (like threatening 
behavior of other people or dangerous events), both real or imagined. An example of 
a serious threat is a heart disorder. When the heart is (thought to be) in danger, this 
can be (experienced as) life-threatening and as such provoke fear. The present thesis 
focuses on this subtype of anxiety related to the heart: cardiac anxiety.
This general introduction starts by putting cardiac anxiety in context by given 
background information about coronary artery disease (CAD), its associations with 
depression and anxiety and the hypothesized postulated mechanisms underlying 
these associations. Within this context, I will point to the importance of investigating 
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Chapter 1
subtypes of anxiety and will introduce the concept of cardiac anxiety. Next, current 
research findings of cardiac anxiety in patients with a myocardial infarction (MI) are 
outlied, after which the focus is switched to non-cardiac chest pain (NCCP) patients. 
These patients experience symptoms of cardiac disease (chest pain) in the absence of 
a diagnosed cardiac origin. Research findings of (cardiac) anxiety in this population 
are discussed. Moreover, possible treatment options regarding cardiac anxiety are 
described. Finally, the aims and outline of the current thesis are presented.
Coronary Artery Disease and Myocardial infarction
Coronary artery disease (CAD), also called ischaemic heart disease, is the most 
common type of heart disease. It is a condition in which the coronary arteries which 
supply the heart of oxygen are completely or partially blocked, causing damage to the 
heart muscle. A wellknown type of CAD is a myocardial infarction (a heart attack).
As CAD is a potentially disabling and lethal disorder, it represents a major health 
problem with a large burden. CAD is the leading cause of death worldwide 6. Although 
age-specific death rates for CAD are projected to decline, ageing of the population 
will result in significantly increasing total deaths over the coming years with global 
cardiovascular deaths expected to increase from 16.7 million in 2002 to 23.3 million in 
2030 7. At present, approximately 3.8 million men and 3.4 million women worldwide 
die each year from CAD according to WHO data 8. In the Netherlands, CAD is the 
second cause of death after cancer responsible for 9 720 deaths per year (CBS). A 
myocardial infarction (MI) was in 2012 responsible for 64% of the deaths caused by 
CAD, and for 35% of the hospital admissions caused by CAD in the Netherlands 
(CBS).
In addition to mortality rates, disease burden can be expressed by disability adjusted 
life years (DALYs), which are the total years of life lost due to premature mortality 
and years of health lost due to disability. The global burden of CAD increased by 29 
million DALYs between 1990 and 2010, predominantly due to population growth 
and aging 9. Although non-fatal CAD has increased more than the CAD deaths since 
1990, CAD mortality remains the greatest contributor to disease burden 9. Regarding 
DALYs, CAD is together with diabetes mellitus in the Netherlands third in the order 
of rank, after cancer and neuropsychiatric diseases.
As can be expected in review of the previous numbers, the economic impact of CAD 
is also high and even exceeds that of other diseases 10. In the Netherlands, CAD is 
second in the order of rank regarding health care costs 11.
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Pathophysiology and symptomatology
CAD is a late stage of atherosclerosis and characterized by the forming of atherosclerotic 
plaques in the coronary arteries. These plaques consist of substances found in the blood 
like fat, cholesterol, and calcium. Atherosclerosis narrows the arteries and impairs 
the blood flow. Plaque rupture may occur, exposing the underlying tissue, initiating 
platelet adherence, aggregation and further narrowing of the arteries (thrombosis), 
potentially leading to damage of the heart muscle. When the myocardium is injured, 
cardiac enzymes (e.g. troponin or creatinkinase) of dying heart cells are released in 
the blood, and as such may serve as a biological marker for heart damage. Depending 
on the severity of the impairment, CAD can be asymptomatic or symptomatic. 
Symptomatic CAD –also called Acute Coronary Syndrome- presents its-self as 
unstable angina (chest pain or discomfort in rest) or a myocardial infarction (a heart 
attack). 
Diagnosis:
According to the World Health Organization 12 criteria a diagnosis of MI can be 
established when at least two out of the three following criteria are met: 1) chest 
pain for at least 20 minutes, 2) typical changes in electrocardiogram (ECG): the 
development of pathological Q-waves and/or new significant ST-segment-T-wave 
changes or a new left bundle branch block, 3) a typical rise and fall of cardiac enzyme 
levels creatin kinase MB fraction and troponin (T and I).
Treatment:
Treatment consists of reperfusion (restoring blood flow), which includes anti 
thrombotic treatment (pharmacological reperfusion), as well as coronary angiography 
followed by revascularisation if appropriate (mechanical reperfusion by percutaneous 
coronary intervention). The remaining heart function is determined by assessing 
the left ventricular ejection function (LVEF) by echo-cardiogram and patients are 
assigned for cardiac rehabilitation. Secondary prevention measures consist of 
management of cardiovascular risk factors (like hypertension, dyslipidemia, diabetes 
mellitus, tobacco use, and physical inactivity) with lifestyle changes and drug therapy 
as indicated.
In regard to cardiac rehabilitation, several aspects should be considered. In addition 
to setting physical aims (like optimizing the physical condition and coping with 
physical limitations), psychological aspects (like coping) as well as social aspects (like 
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social support) deserve attention. An illustration of this is the presence of anxiety and 
depressive symptoms, which may interfere with the physical recovery aims: patients 
can become physically inactive due to anxiety-related avoidance or due to energy loss 
and anhedonia in depression 13,14. Overcoming fear of exercise, regaining emotional 
balance, and adequately coping with the heart disease could therefore be important 
psychological aims in cardiac rehabilitation. Regretfully, research findings suggest 
that depressive and anxiety symptoms are in fact associated with non-attendance to 
these cardiac rehabilitation programs 15.
Psychological impact
As a potential life-threatening event, a myocardial infarction (MI) also has 
psychological impact. During the event, patients may experience anxiety as a natural 
response to the pain and the circumstances surrounding a heart attack 16. Afterwards, 
when the acute stress of the event itself and its treatment is expected to be settled 
down, patients have to deal with insecurities and with the feeling that the body is 
unreliable: they need to find a new balance in life 17. Whereas some patients will 
manage to cope, the majority of the patients may experience significant symptoms 
of depression and/or (pathological) anxiety post-MI and a quarter to a third of the 
MI patients may continue to experience these symptoms one year after the MI 14,18-20. 
In recent years, there has been increasing interest on the relationship between physical 
and mental health in CAD and MI, with the specific focus on depression and -more 
recently- anxiety. These concomitant affective symptoms are not only associated 
with a higher medical consumption 21 and a lower quality of life 22,23, but they also 
are associated negatively with cardiac prognosis (see below). If this prognostic 
association in fact turns out to be causal, it is clinically very relevant, especially since 
both depression and anxiety are potentially modifiable.
Depressive symptoms and cardiac prognosis in ischaemic heart disease/ after a 
myocardial infarction
For depression, a bidirectional association with CAD has been described. In 
community based populations, meta-analyses showed an association between 
depressive symptoms and incident CAD with higher depression levels leading to 
more incident CAD 24-26. In MI patients, recent meta-analyses demonstrated that 
depressive symptoms increase the risk of new cardiac events 27 and mortality 27,28. 
Unfortunately randomized controlled trials examining the efficacy of interventions 
for depressive symptoms (respectively Cognitive Behavioral Therapy (CBT), and 
antidepressants mirtazepine/citalopram, sertralin) did not find improving effects on 
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cardiac outcome 29-31. These findings challenge the idea that these associations are 
causal. Some explanations can be put forward. 
Firstly, one of these meta-analyses found that only eight of the 34 studies adjusted 
for left ventricular ejection function as marker for cardiac disease severity, which 
attenuated the estimated risk of depression with almost 50% from 2.18 to 1.53 28. This 
suggests that the prognostic effect of depression on cardiac outcome may be partly 
dependent on cardiac disease severity. 
Secondly, most studies evaluating the prognostic effect of depression, assessed 
depressive symptoms with self-report questionnaires like the Beck Depression 
Inventory (BDI). This self-report questionnaire consists of a cognitive-affective 
dimension (assessing e.g. “sadness”) and of a somatic-affective dimension (inquiring 
e.g. about “energy loss”). Previous studies reported a prognostic impact of the 
somatic-affective items with cardiac outcome, whereas no association was seen for 
the cognitive-affective items 32-35. This suggests that the somatic-affective symptom 
dimension of the BDI picks up symptoms from the underlying medical condition. 
A recent study indeed found that at lower severity levels the BDI predominantly 
assessed somatic symptoms in MI patients 36.
Another explanation might be that measurements of depression and/or psychological 
stressors are not specific enough. As most psychological constructs related to 
mood- and anxiety disorders partly overlap, it may explain that different constructs 
are prospectively associated with cardiac prognosis, but also why some studies are 
negative. In this thesis, therefore, we specifically focus on cardiac anxiety (see below). 
The impact of (general) anxiety on cardiac prognosis after a myocardial infarction
Like all diseases, a myocardial infarction by its very nature poses some level of threat 
37. Among patients with cardiac disease, anxiety can be functionally appropriate when 
it motivates them to immediately seek treatment for acute cardiac symptoms 14 or 
to adhere well to medical risk-reducing recommendations 38. Some studies indeed 
found a protective effect of anxiety in patients with CAD on cardiac outcome 39-40. 
However, anxiety may have negative consequences (including difficulty in making 
recommended lifestyle changes or in decreasing risky behaviors) when it is persistent 
or severe 14 and develops to pathological anxiety: a disproportionate and inappropriate 
reaction as to type, intensity or duration of the eliciting stimulus 41,12. 
Findings of three recent meta-analyses of prospective community-based studies 
examining the prognostic association of anxiety on incident CAD 42-44 have 
demonstrated that anxiety is associated with an increased incidence of CAD. The first 
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meta-analysis 42 of 20 studies published up to 2009 showed a prognostic association 
for anxiety symptoms: these were associated with a 26% increased risk for CAD and 
a 48% increased risk of cardiac mortality, after adjustment for demographics, cardiac 
risk factors and health behaviors. The second meta-analysis 43 included 37 studies 
published up to 2013 of which 9 studies assessed anxiety disorders. This meta-analysis 
found that -after adjustment for publication-bias- the presence of anxiety increased 
the risk of CAD (combined with stroke and peripheral vascular disease) with 41%. 
These findings were consistent for studies examining anxiety disorders as well as for 
those evaluating anxiety symptoms. Results were also consistent between studies that 
took comorbid depression into account and those who did not. A third meta-analysis 
44 focused on 12 studies reporting on panic disorder specifically and showed a 47% 
increased risk of CAD in the presence of a panic disorder. 
The latter three meta-analyses of community based prospective studies were all in 
persons initially free of CAD. In addition to these findings, a meta-analysis in 1649 
MI patients  (i.e. in patients with established CAD) -including 12 studies published 
up to 2009 - showed in anxious versus non-anxious MI patients a pooled odds risk 
of 1.36 and 1.47 for adverse cardiac outcomes and all-cause mortality respectively 45. 
Thus, although there are controversial findings, the presence of anxiety seems to be 
associated with the development of new CAD, both in patients originally free of CAD 
and in MI patients with established CAD.  
Although in the meta-analysis in MI patients after multivariate analysis only three 
studies remained significant in showing an inverse association for anxiety with 
cardiac prognosis, effect estimates of the included positive studies 18,46-48 that did 
adjust for Left Ventricular Ejection Fraction were only slightly or not attenuated. 
Furthermore, in a prospective study generalized anxiety disorder was associated 
with a higher risk of cardiovascular events and mortality in MI patients, and this 
prognostic association was independent from cardiac disease severity parameters 49. 
This suggests that the relationship between anxiety and cardiac prognosis post-MI 
might be less confounded by cardiac disease severity than that between depressive 
symptoms and cardiac prognosis. 
As stated previously, recent research findings trying to disentangle the unique 
contribution of depression on cardiac prognosis, indicate the importance of looking 
into subtypes of depression. Likewise, as it remains unclear which specific aspects 
of anxiety are associated with cardiac prognosis, the need to examine the unique 
contribution of types of anxiety on cardiovascular risk has been recommended 
42,50. Recently, a community-based study indeed found that worry predicted non-
fatal cardiac outcome over a three-year follow-up, whereas panic and phobia did 
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not 51. Furthermore, a recent study in CAD patients undergoing coronary artery 
bypass graft surgery showed different associations of different types of anxiety with 
cardiac prognosis: no association of the fear and panic disorders and their symptom 
dimensions, but an adverse association with generalized anxiety disorder 52. 
These findings suggest that different types of anxiety may be differently related with 
cardiac prognosis. With regard to cardiac prognosis, this thesis therefore specially 
focuses on a relatively unexplored subtype of anxiety: cardiac anxiety (see below).
Potential mechanisms
The association between anxiety and ischemic heart disease might be explained by both 
behavioral and biological mechanisms, which in turn may be associated with specific 
subtypes of anxiety. Anxiety appears to be associated with unhealthy behavior, which 
includes both more cardiac-risk-increasing behavior (like smoking) and less adherence 
to risk reducing advises (like medication, cardiac rehabilitation and physical activity). 
General anxiety (assessed with Hospital Anxiety and Depression Scale) in outpatients 
at risk of CAD is reported to be associated with poor diet (including higher cholesterol 
and alcohol intake) and more physical inactivity and smoking 53. General anxiety 
symptoms (assessed with the State-Trait Anxiety Inventory (STAI) in MI patients 
are associated with non-attendance of cardiac rehabilitation programs, although this 
association lost significance in multivariate analysis 15. Another study suggested less 
adherence of anxious MI patients (assessed with the Beck Anxiety Inventory) to risk 
reducing recommendations like reducing stress, cessation of smoking and increasing 
socialization, but better adherence to carrying medical supplies 54. 
After a MI, patients have been demonstrated to develop symptoms of post-traumatic 
stress disorder (PTSD) 55,56. PTSD is an anxiety like disorder provoked by a safety-
threatening event (among which a MI) and includes arousal, re-experiences of 
the event (by e.g. intrusions and/or nightmares) and avoidance. PTSD symptoms 
secondary to MI are associated with lower levels of adherence to medical treatment 
among those MI patients diagnosed with PTSD compared to those without PTSD 
57,58. An explanation may be the avoidance symptoms of PTSD: the patient is unable 
to face the MI and avoids reminders of its traumatic nature 59. In addition to the 
onset of PTSD symptoms, also the onset of panic attacks and agoraphobia have 
been described post-MI 60. In respect to mechanisms of non-adherence and physical 
inactivity, catastrophic misinterpretation of cardiac symptoms is likely to be a factor 
in this anxiety subtype 59. 
Also, various potential biological mechanisms explaining the negative prognostic 
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association between anxiety and CAD have been suggested. These mechanisms include 
rhythm disturbances due to increased sympathetic or decreased parasympathetic 
nervous activity as well as atherosclerosis promoting abnormalities like increased 
platelet activity or inflammation. A recent study showed anxiety disorder to be an 
independent predictor of reduced vagal control of the heart in post-MI patients, 
whereas no association was found between self-reported general  anxiety (assessed 
with the State Trate Anxiety Inventory (STAI)) symptoms and heart rate variability 
61. In another study, general anxiety post MI (assessed with STAI) was significantly 
related to reduced baroflex control in multivariate analysis 62. Furthermore, in patients 
without established CAD, anxiety appeared to be associated with increased platelet 
activity 63 or inflammation 64, arrhythmic mechanisms 65 and metabolic abnormalities 
as hypertension 66 and increased cholesterol levels 67.  
Cardiac Anxiety in MI
Current anxiety questionnaires predominantly assess general anxiety, avoidance 
behavior, worrying and fear of bodily sensations. However, after a MI, cardiac-
related stimuli and sensations may trigger specific anxiety symptoms, based upon 
their assumed negative consequences 68. Heart-related fear is frequently associated 
with attention to and avoidance of cardiac-related stimuli and sensations 69,70. When 
patients have more heart-focused attention, it is likely that they, regardless of their 
specific condition, will become concerned about cardiac-related sensations (e.g. chest-
pain or heart palpitations). They may be afraid to experience a (new) heart attack 
especially during chest discomfort or changes in heart activity. Consequently, in order 
to diminish anxiety, patients may tend to anxiously check their pulse, avoid activities 
believed to induce symptoms, and may tend to time and again seek reassurance from 
health care practitioners and/or family members 68. This specific fear and anxiety-
related behavior can be conceptualized as cardiac anxiety. 
Although some extent of cardiac anxiety may in fact be normal after a MI, at some 
point cardiac anxiety can shift toward the pathological side of the anxiety spectrum. 
In respect to this, not only the degree of cardiac anxiety but also its course should be 
considered. Unfortunately, only few studies have evaluated cardiac anxiety in cardiac 
patients (mainly heterogeneous populations of both CAD and non-CAD patients) 
and all but one 37 had a cross-sectional design 68,71,72. The only longitudinal study 
showed that one fifth of cardiac patients (n=90) continued to experience clinically 
elevated levels of cardiac anxiety after elective bypass surgery for six months after the 
surgery, while levels of global anxiety and depression decreased 37. However, due to 
lack of information on cardiac outcome, it is difficult to interpret the clinical relevance 
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of this increased and persistent cardiac anxiety. To date, no studies in a homogeneous 
sample of MI patients have focused on cardiac anxiety. Therefore, the present thesis 
studies cardiac anxiety in MI patients specifically, by evaluating both cross-sectional 
associations and the longitudinal course of cardiac anxiety after a MI.
Assessment of Cardiac Anxiety in MI patients
Eifert et al. has developed the Cardiac Anxiety Questionnaire (CAQ) within a 
heterogeneous population of both hospitalized and outpatients with and without 
CAD 68 . Eifert et al. evaluated the relevance of 63 items potentially assessing cardiac 
anxiety. These items originated from semi-structured interviews in cardiac outpatients 
and a literature review. Finally, 18 items were selected as potentially relevant (and 
unique and not overlapping) for a self-report questionnaire, assessing different aspects 
of cardiac anxiety by questions like “When I have chest discomfort, or when my heart 
is beating fast: I get frightened”, “I avoid activities that make my heart beat faster” or “I 
pay attention to my heart beat”. Each item was rated on a 5-point Likert scale ranging 
from 0 (never) tot 4 (always). An exploratory factor analysis was performed on these 
18 items, yielding a factor structure of three factors, assessing fear, avoidance and 
attention. Internal consistency was checked showing a good internal consistency of 
the total and subscale scores.
Convergent and divergent validity of the CAQ was assessed in 30 post-angiography 
patients and 12 outpatients suffering from either panic disorder, generalized anxiety 
disorder or hypochondriasis. Correlation coefficients indicated high to moderate 
correlations between CAQ and convergent anxiety measures (the body sensations 
questionnaire, anxiety sensitivity index and illness attitude scales), and with one 
exception (fear scale of fear of negative evaluation scores), no association was found 
between CAQ and divergent validity measures (activities of daily living, brief fear of 
negative evaluation scale), indicating good divergent validity. The CAQ subscale fear 
was in general more related to convergent anxiety measures than the other two CAQ 
subscales. In short, the CAQ appeared to be suitable to measure cardiac anxiety, had 
good psychometric properties and  successfully differentiated cardiac anxiety from 
general anxiety in psychiatric patients 68. 
Good psychometric properties of the CAQ were confirmed in a cross-validation 
study in CAD outpatients 72. However, in this study a fourth subscale assessing safety-
seeking behavior was detected. The relevance of exploring different aspects of cardiac 
anxiety as assessed with the CAQ subscales is made clear in two studies. A cross-
sectional study in post-angiography patients (of which one third had no or minimal 
CAD) demonstrated greater cardiac attention, but no greater avoidance nor fear of 
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cardiac sensations in patients with CAD who smoked compared those without CAD 
or those who were nonsmokers 71. A longitudinal study in patients undergoing elective 
cardiac surgery 37 described a varying course of different aspects of cardiac anxiety 
after surgery: fear declined significantly 6 weeks after surgery and remained stable, 
whereas no change was found in heart-focused attention and in contrast, avoidance 
was stable 6 weeks after surgery, but then declined to a level that was lower than that 
before surgery. These findings show that different indicators of cardiac anxiety need 
to be considered separately. Due to the inconsistencies found in the number of CAQ 
subscales in the previously mentioned validation studies (revealing either a three or 
four factor structure), there is a need to validate the CAQ in an independent sample. 
Another reason for a cross-validation is that previous validation studies evaluated the 
CAQ in a heterogeneous population instead of in MI patients specifically. Therefore, 
the present thesis validates the CAQ in a population of MI patients.
Obviously, when aiming to explore cardiac anxiety, the preferred method is to assess 
it directly, e.g. with an instrument like the CAQ. However, as the research field of 
cardiac anxiety in cardiac patients is relatively unexplored, it would be interesting to 
see if cardiac anxiety can be addressed when it is not explicitly measured, as is the 
case in some existing datasets on MI patients like in the Depression after Myocardial 
Infarction (DepreMI) study 73,74. In the previously mentioned longitudinal study in 
cardiac patients undergoing planned surgery 37, the CAQ scales were - as can be 
expected - generally more strongly associated with anxiety than with depression, but 
- more importantly - (negative) correlations of cardiac anxiety were stronger with 
physical quality of life than with psychological quality of life. Therefore, the present 
thesis explicitly assessed cardiac anxiety with the CAQ but also tried to capture cardiac 
anxiety by using self-reported physical health as measured in the DepreMI study.
Cardiac anxiety and Non-Cardiac Chest pain
Cardiac anxiety may not be limited to those with a myocardial infarction or ischaemic 
heart disease. Higher cardiac anxiety is also reported in patients at increased risk 
for arrhythmias and sudden cardiac death because of a personal or a family history of 
an inherited cardiac disorder 75. Furthermore, a recent study evaluated the presence 
of cardiac anxiety in the general population showing higher cardiac anxiety to be 
associated with increasing age, a lower education level, unemployment, and not being 
in a stable relationship 76.  
A subgroup particularly at risk for developing high cardiac anxiety are persons who 
experience cardiac sensations (like chest pain) in the absence of a diagnosed organic 
substrate, as happens in patients with non-cardiac chest pain (NCCP). These patients 
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report significantly higher levels of both general and cardiac anxiety compared to 
the general population 77 and similar to higher levels of cardiac anxiety compared to 
patients with established CAD 78. This is in line with other studies showing a prevalence 
of up to 50% of psychiatric symptoms in patients with NCCP 78,79, reporting high 
levels of general anxiety, depression, catastrophic thinking, and physical disability 81,82. 
Additionally, the prevalence of psychiatric diagnoses in NCCP is high, with reported 
percentages of 44% for a current psychiatric disorder, 41% for a current anxiety 
disorder and 13% for a mood disorder 83. With respect to the diagnosis of panic 
disorder, some studies reported even higher percentages in NCCP patients of almost 
40% 81,82. Although cardiac anxiety and a diagnosis of panic disorder are essentially 
two different phenomena, which can co-occur independently, due to the experienced 
chest pain it is likely that the main anxiety theme of panic attacks in NCCP patients 
diagnosed with a panic disorder is characterized by cardiac anxiety.
When NCCP patients present themselves to a hospital with chest pain, common 
practice is to reassure them and refer them back to primary care. Unfortunately, the 
prognosis of NCCP is poor: despite reassurance by medical professionals, more than 
half of patients continue to report chest pain and remain concerned about having 
a serious heart disease 84,85. In other words, they are assumed to experience high 
and persistent levels of cardiac anxiety. This is a pity, since psychiatric disorders like 
panic disorder and depressive disorder can be treated effectively, e.g. with cognitive 
behavioral therapy 86,87. Therefore, the present thesis investigates the effect of a short 
CBT intervention in NCCP patients diagnosed with panic and/or depressive disorder. 
Aim of the present thesis
In the present thesis three main questions concerning the concept of cardiac anxiety 
will be raised and addressed. 
First of all, can cardiac anxiety be assessed validly and reliably with the Cardiac 
Anxiety Questionnaire (CAQ) in a (Dutch) population hospitalized for myocardial 
infarction, and if so, what is the prevalence and what are correlates of cardiac anxiety 
in patients hospitalized for MI? 
Subsequently, what is the course of cardiac anxiety in the year after a MI and what is the 
impact of cardiac anxiety post MI on both quality of life and cardiac prognosis? Can a 
possible prognostic impact of cardiac anxiety be explored in independent populations 
of MI patients and by assessing cardiac anxiety on different ways: explicitly (with the 
CAQ) and indirectly (by using self-reported cardiac health complaints)? 
Finally, can anxiety and depressive symptoms and disease severity be targeted with 
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cognitive behavioral therapy (CBT) in patients with non-cardiac-chest-pain who 
present themselves at the cardiac emergency unit and are diagnosed with a comorbid 
panic disorder and/or depressive disorder?
Outline of the present thesis:
This thesis focuses on aspects of cardiac anxiety in two cohorts of MI patients (chapters 
2-5 and chapter 6 respectively) and in patients with NCCP (chapter 7). Validity 
(chapter 2), cross-sectional associations (chapter 3), longitudinal course (chapter 4) 
and prognostic impact of cardiac anxiety on cardiac prognosis are studied (chapters 
5-6), and the effect of brief cognitive-behavioral therapy is compared with treatment 
as usual in a randomized controlled trial (chapter 7).
In chapter 2 we cross-validated the CAQ in a sample of 237 patients admitted for an 
acute coronary syndrome (ACS) and a control group of 49 patients admitted for an 
exacerbation of rheumatoid arthritis (RA). We evaluated the validity of cardiac anxiety 
as opposed to general anxiety measured with established questionnaires (Beck Anxiety 
Inventory, Spielberger State-Trait Anxiety Inventory and Agoraphobic Cognitions 
Questionnaire) and we compared the levels of cardiac anxiety in the ACS patients 
with the non-cardiac hospital inpatients, thereby controlling for general distress level 
(anxiety and depression) associated with acute hospitalization. Furthermore we tested 
the internal consistency and test-retest-reliability of the CAQ.
In chapter 3 we studied the cross-sectional associations between cardiac anxiety 
and several socio-demographic, psychological (depressive symptoms, agoraphobic 
cognitions and avoidance behavior respectively) and cardiac disease characteristics in 
for the same cohort of MI patients.
In chapter 4 we described the course of cardiac anxiety during the year after a MI 
in a subsample of 194 MI patients of the previously mentioned cohort. We assessed 
cardiac anxiety in the days after admission, and one, three, six and twelve months after 
discharge. Latent class growth analysis (LCGA) was performed to identify groups 
based on cardiac anxiety course. Between group differences were checked on several 
relevant socio-demographic, cardiac and psychiatric variables. 
In chapter 5 we evaluated the prognostic association of cardiac anxiety on cardiac 
prognosis in a subsample of 193 MI patients of the previously mentioned cohort. 
Within one week of hospitalization and approximately three months after discharge 
the CAQ was administered. Study endpoint was a major adverse cardiac event 
(MACE) defined as a readmission for ischemic cardiac disease or all-cause mortality 
within 4.3 (2.0) years after the index-MI. The prognostic impact of CAQ on MACE 
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was evaluated with Cox regression analysis, adjusted for age, cardiac disease severity 
(i.e. Left Ventricular Ejection Fraction, cardiac history as defined by a history of a 
previous MI), and depressive symptoms (Beck Depression Inventory).
In chapter 6 we investigated the prognostic association of health complaints (as a 
proxy for cardiac anxiety although this was not explicitly assessed in this study) on 
MACE in another cohort of MI patients recruited consecutively from four hospitals 
in the north of the Netherlands: the DepreMI study. The somatic subscale of the self-
report Health Complaints Scale (HCS) was administered to 424 MI-patients at 3 and 
12 months post-MI. The prognostic impact of the HCS on MACE was evaluated with 
Cox regression analysis, adjusted for all socio-demographic, cardiac and psychiatric 
variables that were associated with MACE univariately (p<0.10), among which sex, age, 
education-level, left ventricular ejection fraction, history of MI, depressive symptoms 
(Beck Depression Inventory) and a diagnosis of a generalized anxiety disorder. In 
addition, the type of physical health complaints as well as their trajectories over time 
were explored. 
In chapter 7 we diagnosed 103 patients visiting the cardiac emergency unit of a 
university medical center for non-cardiac chest pain with a comorbid depression and/
or panic disorder and randomized them over a CBT intervention (n=60) or treatment 
as usual (n=53).  After 24 weeks we evaluated the effects on disease severity as assessed 
by a blinded independent rater, and on several self-reported depressive and anxiety 
symptoms.
In chapter 8 we summarized the main results of chapter 2 to 7.
In chapter 9 we reflected in the discussion on the concept of cardiac anxiety and our 
research findings, on strengths and limitations of the studies described in the previous 
chapters, and on implications for clinical practice and future research.
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Abstract
Objective – General anxiety symptoms are common in patients with cardiac disease 
and considered to have an adverse effect on cardiac prognosis. The role of specific 
cardiac anxiety, however, is still unknown. The aim of this study is to examine the 
factor structure, reliability and validity of the Dutch version of the Cardiac Anxiety 
Questionnaire (CAQ), which was specifically designed to assess heart focused anxiety.
Methods – 237 patients admitted for an acute coronary syndrome (ACS) and a control 
group of 49 patients admitted for an exacerbation of rheumatoid arthritis (RA) 
completed the CAQ, the Agoraphobic Cognitions Questionnaire, Mobility Inventory, 
Beck Depression Inventory, Beck Anxiety Inventory and the State-Trait Anxiety 
Inventory. 
Results – Although the original three-factor solution (fear, avoidance and attention) 
was acceptable (model fit parameters: CFI=0.89 and TLI=0.87), our data were 
best explained by a four factor model including safety seeking behaviors. Internal 
consistency and test-retest reliability were good. The CAQ had moderate correlations 
with the other anxiety and depression questionnaires. Recently admitted ACS patients 
had significantly higher scores than RA patients, even after controlling for general 
anxiety and depressive symptoms (p<0.001). 
Conclusion – The CAQ is a reliable and valid instrument to assess cardiac anxiety in 
patients hospitalized with ACS. These results enable longitudinal studies to examine 
the relationship of heart-focused anxiety with cardiac prognosis and to evaluate 
interventions specifically targeted at anxiety in cardiac patients.
Keywords  – anxiety, cardiac, heart, psychometrics, questionnaires.
Chapter 2
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Introduction
Coronary heart disease is the leading cause of death in the United States of America, 
with 1,200,000 cases of coronary events per year. Psychiatric co-morbidity in this 
population is common. Up to 50% of patients with myocardial infarction (MI) suffer 
from clinically relevant anxiety or depressive symptoms 1. Numerous studies have 
shown 2,3 that depressive symptoms or general distress have a negative impact on 
duration of admission, prognosis and quality of life in cardiac patients 4,5.
Fewer studies, however, have focused on the role of anxiety in cardiac patients. Some 
studies suggest that anxiety may be an independent risk factor for MI in patients with 
and without a cardiac history 6,7. A recent meta-analysis of 12 prospective studies with 
5750 MI patients demonstrated that anxious patients had a 36% increased risk for 
mortality and cardiac events compared to non anxious patients 8. Anxiety was assessed 
by self-report questionnaires like the State-Trait Anxiety Inventory (STAI) or Hospital 
Anxiety and Depression Scale (HADS). Since the STAI does not clearly differentiate 
anxiety from depression 9 and several emotional disturbances have been related to 
cardiac outcome 10, the authors state the need for new instruments to examine which 
particular aspects of anxiety are related to vascular events8.  
Current anxiety questionnaires predominantly assess general anxiety or fear of bodily 
sensations. However, as a life-threatening event, MI might evoke anxiety symptoms 
specific for cardiac related sensations and situations. Eifert and colleagues have 
developed the Cardiac Anxiety Questionnaire (CAQ) to specifically assess cardiac 
anxiety, heart-focused attention and related avoidance behaviors 11. They demonstrated 
the CAQ to have adequate psychometric properties. It also successfully differentiated 
cardiac from general anxiety in psychiatric outpatients 11.
The aim of this study is to examine the factor structure, internal consistency, test-
retest reliability, convergent and divergent validity of the Dutch version of the CAQ in 
patients hospitalized with an Acute Coronary Syndrome (ACS).
Methods
Setting and design
The study population consisted of patients admitted to the Department of Cardiology 
of the Radboud University Medical Center, the Netherlands, between November 
2006 till March 2008. Patients were assessed for eligibility by a cardiologist within two 
days of admission. Patients with a diagnosis of ACS, both ST Elevated Myocardial 
Infarction (STEMI) and Non ST Elevated Myocardial Infarction (NSTEMI) were 
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eligible. The diagnosis was confirmed by the rise and fall of troponin I (> 0.20 μ/l) 12-14. 
Exclusion criteria were: age above 85 years, discharge within two days of admission, 
and inability to fill in questionnaires.
Between day 2 and day 7 after admission, patients completed four questionnaires: 
the Cardiac Anxiety Questionnaire 11, Agoraphobic Cognitions Questionnaire 15, 
Mobility Inventory 16, and Beck Depression Inventory 17,18. Socio-demographic data 
and information about cardiovascular risk factors, cardiac history and co-morbidity 
were extracted from the medical records. Furthermore, a subgroup, consisting of 
those patients admitted between December 2008 and March 2008 and who were 
still hospitalized, completed the CAQ again one week later to evaluate the test-retest 
reliability.
In December 2007,  a comparison group of patients admitted to the Department of 
Rheumatology of the same hospital was recruited, using the same exclusion criteria. 
In this subsample, two more questionnaires were administered: the Beck Anxiety 
Inventory 19 and the STAI 20. 
Measures
Cardiac Anxiety Questionnaire (CAQ) - The CAQ is an 18-item, self-report 
questionnaire, designed to measure heart-focused anxiety, rated on a 5-point Likert 
scale ranging from 0 (never) tot 4 (always). Heart- focused anxiety was defined as 
“the fear of cardiac-related stimuli and sensations because of their perceived negative 
consequences” 11. It may be relevant to medical syndromes characterized by chest 
pain and psychological distress, among which cardiac and non-cardiac chest pain and 
panic disorder. The original factor analysis identified three subscales: heart-related 
fear (8 items); avoidance (5 items); and attention (5 items) 11. The CAQ had good 
internal consistency of both total (Cronbach α =0.83) and subscale scores (Cronbach 
α of 0.83, 0.82 and 0.69 respectively).
Agoraphobic Cognitions Questionnaire (ACQ) - The ACQ is a 14-item scale assessing 
catastrophic thoughts while experiencing anxiety 15, rated on a 5-point Likert scale 
from (1) ‘thought never occurs’ to (5) ‘thought always occurs’. It consists of two 
subscales: social-behavioral and physical concerns. It has high internal consistency 
(Cronbach α= 0.87), moderate test-retest reliability (r= 0.67 for 1 month) and 
sensitivity to changes due to treatment 15. It also differentiates between persons with 
and without anxiety disorders 21.
Mobility Inventory (MI) - The MI is a self-report questionnaire assessing avoidance 
behavior. The level of avoidance is rated (from 0 “never avoid” through 4 “always 
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avoid”) in 26 situations. The questionnaire has good internal consistency (Cronbach 
α= 0.94), convergent and divergent validity, and high test-retest reliability (r=0.90) 16. 
Beck Depression Inventory (BDI) - The BDI is a 21-item self-report questionnaire 
measuring depressive symptoms on a 4 point scale. The total sum score (range 
0-63) represents the  severity of depressive symptoms, with a score of 10 or higher 
representing mild to severe symptoms 17,18. It has good internal consistency (Cronbach 
α= 0.93) 17 and is an acceptable instrument of screening for depression in patients 
post-MI 22.
Beck Anxiety Inventory (BAI) - The BAI is a 21-item self-report questionnaire 
measuring symptoms of clinical anxiety, rated on a 4-point scale ranging from 0 (not 
at all) to 3 (severely). It has good internal consistency, with reported Cronbach alphas 
of 0.93 and 0.94 23,24, and discriminates well between patients with and without anxiety 
disorder 25. 
Spielberger State-Trait Anxiety Inventory (STAI) – The STAI is a self-report 
questionnaire with two subscales; one measuring state anxiety (STAI-S) and one 
measuring trait anxiety (STAI-T). Each consists of 20 items on a 4-point scale (0-3). 
The STAI-S measures the transitional emotional states evoked by a stressful situation, 
like a MI. The STAI-T reflects individual differences in anxiety proneness. Both scales 
have been found to be reliable (Cronbach α> 0.89) and valid 20.
Statistical analysis
First, a confirmatory factor analysis (CFA) for continuous data was conducted to test 
the model of Eifert et al. 11 in our ACS population (n=237). Model fit was evaluated 
by calculating the Tucker–Lewis Index (TLI) and the Comparative Fit Index (CFI) 
26,27. The TLI and CFI range from 0 (indicating no fit) to 1 (perfect fit) and apply a 
penalty function for estimating more parameters. Values of 0.90 or above indicate an 
acceptable fit.
As our CFA did not strictly confirm the original solution of Eifert et al. 11, we performed 
an exploratory factor analysis (EFA), using oblique (Oblimin) rotation, similar to 
Eifert et al. 11. Since both analyses were conducted in the same sample, we controlled 
for possible optimism bias by checking our findings in multiple independent samples. 
Using bootstrapped samples, confidence intervals of the model results were calculated 
for both the 3- and 4-factor solution.
How the items of a questionnaire are related to each other is measured with the 
internal consistency. It is preferably high, but not too high, ensuring that each item 
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contributes some unique information. Internal consistency was determined for total 
and subscale scores. Test-retest reliability was measured by conducting the bivariate 
correlation test of Spearman. 
Construct validity is the extent to which the questionnaire really measures the 
psychological construct of cardiac anxiety we assume it measures. Construct validity 
was determined by an EFA using Oblique rotation on the subscales of the used 
questionnaires. 
Two further aspects of construct validity are convergent and divergent validity. 
Convergent validity is the extent to which the questionnaire is similar to other 
questionnaires assessing similar pathology. To measure convergent validity, a 
Pearson correlation coefficient was employed to assess the correlation between the 
different questionnaires. Divergent validity is the extent to which the questionnaire 
differentiates between populations. This was measured by comparing CAQ scores of 
ACS with RA patients. Differences in CAQ sum and subscale scores between both 
populations were tested by ANOVA controlling for possible confounders. 
The CFA and bootstrapping procedures were conducted using Mplus 28, all other 
analyses using SPSS for Windows, version 15.0. All tests were two-tailed, with P ≤ 
0.05 considered statistically significant. 
Results
Study population 
Of the 254 eligible ACS patients, 237 patients (93.3%) gave informed consent and 
were included. The study sample consisted of 158 males (66.7%; mean age = 59.7, SD = 
11.0) and 79 females (33.3%; mean age = 65.0, SD = 11.5). Further socio-demographic 
characteristics are presented in table 1. Of the patients, 128 (54%) suffered from 
STEMI and 109 (46%) from NSTEMI. Non-participants had a significantly higher 
prevalence of STEMI and higher troponin-level (81.2% vs. 54.4%, p=0.04 and mean 
difference 22.1 u/l, p=0.04, respectively) than participants.  
Of the 54 eligible RA patients, 49 (90.7%) gave informed consent and formed the 
comparison group. In table 1, the RA patients are compared to the 56 patients with 
ACS recruited after December 2007. RA patients differed significantly from ACS 
patients regarding gender, marital status, work, cardiac risk factors (hypertension and 
hypercholesterolemia) and arthritis (see Table 1). 
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Table 1: Characteristics of the subjects
Whole sam-
ple
Sample needed for divergent 
validity
Statistics
ACS (n=237)* ACS (n=56) RA (n=49) P value
Sociodemographics:
     Age (mean) 61.5 (SD 11.4) 58.9 (11.2) 57.7  (10.2) .56
     Male gender (%) 66.7 71.4 40.8 .002
     Married (% yes) 82.3 91.1 71.4 .09**
     Higher education (% yes) 25.3 21.4 20.4 .90
     Working (% yes) 43.9 44.6 22.4 <.001**
Cardiac risk factors (%):
     Hypertension 44.7 41.1 8.2 <.001**
     Diabetes Mellitus 17.3 16.1 8.2 .29
     Hypercholesterolemia 27.4 25.0 4.1 .007**
Co-morbid somatic disorders (%):
     History of cardiac disease 32.1 28.6 18.4 .28
     Peripheral Atherosclerosis 13.1 8.9 18.4 .25
     Stroke 3.4 1.8 2.0 .65
     Lung disease 16.0 12.5 18.4 .47
     Cancer 10.5 5.4 2.0 .43
     Arthritis 6.3 3.6 100.0 <.001**
* All patients including those recruited after December 2007
Factor structure
The CFA for the 3-factor-solution described by Eifert et al. 11 yielded a CFI of 0.89 and 
TLI of 0.87. As both parameters were (slightly) below 0.90, we subsequently conducted 
an exploratory factor analysis. According to both Kaiser’s criterion (eigenvalues > 1) 
and scree plot analysis, this solution included five factors. However, two factors were 
difficult to interpret. Based on interpretability of the factor solution, a 4-factor-solution 
was subsequently extracted and appeared the most suitable for our data (explaining a 
total variance of 56.8%). The first three factors were identical to the original model 11, 
except for item 4 (“Chest pain/discomfort wakes me up at night.”) loading on factor 
fear instead of attention, and items 11 (“I feel safe being around a hospital.”) and 18 
(“I tell my family and friends.”) loading on factor attention instead of fear. The fourth 
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factor consisted of three items and could be labeled as “safety seeking behaviors” (see 
table 2).  Using 1000 bootstrapped samples, confidence intervals of the model results 
were calculated for both the 3- and 4-factor solution. Within the 3-factor solution, a 
95% confidence interval about the correct assignment of an item to a specific factor 
could not be found for 5 items (6, 11, 13, 17, and 18). For the 4-factor solution, such 
confidence could not be found for only 2 items (6 and 17). This indicates that the 
4-factor solution is more robust, but that the items 6 (“I check my pulse”) and 17 (“I 
like to be checked out by a doctor”) remain difficult to fit for both models.
Internal consistency 
Cronbach’s alpha for the overall scale was 0.84, indicating a good internal consistency. 
In our 4-factor-model, good internal consistency was found for the subscales “fear” 
and “avoidance” (α = 0.77, α  = 0.90, respectively). Moreover, the internal consistency 
was substantially higher for subscale “physical attention” ( α = 0.60) and for additional 
factor “safety seeking behavior”(α =0.57) compared to the original subscale “attention”. 
Test-retest reliability
A subsample of 34 ACS patients were asked to complete the questionnaires one week 
later and all agreed. This subgroup did not differ from all ACS patients on any of 
the characteristics presented in table 1. Spearman rank correlations between CAQ at 
admission and after one week were high for the total score (r=0.88, p<0.001). The test-
retest reliability for the four subscales was also high (fear, r=0.88; attention, r=0.94; 
avoidance, r=0.80; safety seeking behavior, r=0.84, all p-values < 0.001). 
Similar results were found for the individual items. Test-retest reliability was moderate 
for item 11 (r=0.63), moderately high for items 5, 8, 9, 10, 13, 15 (r=0.70-0.79), and 
high for the majority of items (r>0.80). 
Construct validity
Entering the subscales of the CAQ, BDI, ACQ and MI, the EFA identified three factors 
with eigenvalues greater than one. This solution had a cumulative variance of 65.4%. 
Factor 1 contained all CAQ subscales, indicating cardiac anxiety as separate construct 
distinct from depressive and general anxiety symptoms (see table 3).
Thesis Marleen.indd   38 15-9-2016   10:48:27
Processed on: 15-9-2016
505364-L-bw-vanBeek
39
The cardiac anxiety questionnaire: a cross-validation study
2
Table 2: Factor loadings of factor analyses (n=237 patients)
Model 1 (Eifert) Model 2 (based on own PCA)
Original subscales, item numbers 
and text
Fear
Avoid-
ance
Atten-
tion
Fear
Avoi-
dance
Atten-
tion
Safety
Subscale 1: Fear
10. If tests come out normal, I still 
worry about my heart
0.54 0.29 0.05 0.54 0.30 0.08 0.04
11.I feel safe being around a hospi-
tal, physician or medical facility
0.20 0.18 0.61 0.03 0.12 0.21 0.65
13. I worry that doctors do not 
believe my chest pain is real
0.56 0.19 0.21 0.63 0.13 0.06 0.19
14. I worry that I may have a heart 
attack
0.68 0.05 0.09 0.64 0.06 0.01 0.17
15. I have difficulty concentrating on 
anything else
0.68 0.01 0.08 0.68 0.04 0.05 0.10
16. I get frightened 0.76 0.01 0.07 0.83 0.06 0.14 0.03
17. I like to be checked out by a 
doctor
0.63 0.01 0.33 0.38 0.07 0.13 0.60
18. I tell my family or friends      0.28      0.12      0.45 0.09 0.03 0.21 0.82
Subscale 2: Avoidance
2. I avoid physical exertion 0.06 0.87 0.02 0.05 0.85 0.05 0.00
5. I take it easy as much as possible 0.08 0.83 0.05 0.07 0.80 0.08 0.17
7. I avoid exercise or other physical 
work
0.03 0.88 0.03 0.01 0.87 0.01 0.02
9. I avoid activities that make my 
heart beat faster
0.00 0.86 0.05 0.03 0.84 0.06 0.03
12. I avoid activities that make me 
sweat
0.03 0.78 0.11 0.08 0.79 0.11 0.03
Subscale 3: Attention
1. I pay attention to my heart beat 0.24 0.30 0.38 0.06 0.20 0.59 0.26
3. My racing heart wakes me up at 
night
0.28 0.17 0.45 0.24 0.14 0.43 0.20
4.Chest  pain/discomfortwakes me 
up at night
0.55 0.06 0.18 0.48 0.05 0.26 0.03
6. I check my pulse 0.07 0.10 0.43 0.22 0.05 0.66 0.01
8. I can feel my heart in my chest 0.42 0.09 0.47 0.23 0.01 0.66 0.01
Explained variance 11.7% 29.0% 8.4% 29.0% 11.7% 7.7% 8.4%
Bold factors: score > 0.50 and  a difference with the other factors >0.20.
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Table 3 Factor analysis of scale scores (n=237 patients)
Factor loadings
1 2 3
Component 1: Cardiac anxiety
   CAQ attention 0.82
   CAQ avoidance 0.72
   CAQ fear 0.71
Component 2: Avoidance
   MI avoidance activities when alone 0.96
   MI avoidance activities when together with others 0.96
Component 3: General anxiety and mood
   ACQ social/behavioural 0.71
   ACQ physical 0.89
   BDI sum score 0.64
Bold factors: score > 0.50 and a difference with the other factors >0.20 
Convergent validity
CAQ total score was moderately correlated to all anxiety questionnaires (ACQ, 
r=0.31; BAI, r=0.32; STAI-S, r=0.39, STAI-T, r=0.36) and weakly to the BDI (r=0.27) 
and Mobility Inventory (alone, r=0.21; together, r=0.22). A similar pattern for all 
CAQ subscales of the 3- and 4-factor-solutions was shown, except for the subscale 
“avoidance” that correlated less with all other questionnaires (range r=0.09 - 0.19, 
with exception of the STAI-T, r=0.37).
Divergent validity
Divergent validity was assessed by comparing CAQ scores of ACS and RA patients. 
Univariate ANOVA revealed a significantly higher mean (SD) CAQ score in ACS 
compared to RA patients (1.36 (0.64) versus 0.73 (0.49), p<0.001) and the four 
subscales: “fear” (2.09 (0.76) versus. 1.36 (0.59), F=29.3, p<0.001), “avoidance” (2.58 
(1.05) versus 10.87 (0.74), F=15.6, p<0.001), “physical attention”(1.98 (0.59) versus. 
1.56(0.70), F=11.5, p=0.001) and “safety seeking behaviors”(3.38(0.93) versus. 
2.65(0.81), F=18.1, P<0.001). Correcting for gender, work status, marital status, level 
of depressive symptoms (BDI score) and general anxiety (BAI, STAI) using ANOVA 
did not change these results (mean (SE) corrected CAQ total score of 1.33 (0.08) 
versus 0.77 (0.08), F=19.4, 94, p<0.001). 
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Discussion
Cross-validation of the CAQ in patients hospitalized for an acute coronary syndrome 
(ACS) yielded good psychometric properties. Importantly, our study contributes 
to the validity of cardiac anxiety as opposed to general anxiety measured with 
established questionnaires (BAI, STAI, and ACQ). Its validity is further supported 
by a significantly higher level of cardiac anxiety in cardiac compared to non-cardiac 
hospital inpatients, even after controlling for general distress level (depression and 
anxiety) associated with acute hospitalization. 
In contrast to the original study, our data were best explained by a 4-factor-model. 
This solution resembled the original 3-factor-model 11, with exception of an additional 
subscale of “safety seeking behaviors”. Interestingly, this subscale was also identified in 
a study of 658 persons referred for screening on coronary heart disease 29. In this study, 
the stability of the CAQ was further supported by the fact that the same 4-factor-
solution applied to patients with and without coronary heart disease. 
Our 4-factor-solution yielded a further differentiation between internal cues triggering 
anxiety (physical attention) and behaviors aimed at preventing possible catastrophes 
(safety seeking behaviors). This is in accordance with modern cognitive behavioral 
models of anxiety that increasingly differentiate between selective attention and 
safety seeking behaviors 30. A minor difference was item 4 (“chest pain/discomfort 
wakes me up at night”) which in our study did not load on factor attention but on the 
factor fear. A possible explanation is that our subjects were all inpatients, and sleeping 
disturbances in cardiac inpatients are linked with several factors including anxiety 31. 
Reliability of the CAQ  
Although the 4-factor-solution was most suitable to explain our data and appeared 
to be clinically meaningful, the original 3-factor-solution 11 was still satisfactory. 
In addition, we found good internal consistency for the total CAQ score and for 
subscales “fear” and |”avoidance” in both solutions. The internal consistency for 
subscale “attention” of the 3-factor-solution substantially improved by dividing it into 
two subscales, “physical attention” and “safety seeking behaviors”. Finally, high test-
retest reliabilities for both total score and subscales were found. 
Validity of the concept of cardiac anxiety 
The moderate correlations between CAQ and the other questionnaires confirm that 
cardiac anxiety is a different concept from panic attacks (ACQ), somatic anxiety 
(BAI), worry or generalized anxiety (STAI) and depression (BDI). This correlation is 
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consistent with previous research in ACS indicating an association between anxiety 
and depression 6,32,33. High general anxiety has been identified as an independent 
predictor for cardiac events and increased health care consumption 34. As our data 
support the presence of specific heart-focused anxiety in cardiac patients, one 
might hypothesize that this might have an even more specific (negative) effect on 
cardiac prognosis and might need more targeted interventions. This hypothesis is 
in accordance with research in patients after cardiac surgery showing that cardiac 
anxiety might remain high despite significantly decreased general anxiety 35.
Strengths and weaknesses of the study 
This cross-validation shows good psychometric properties of the CAQ in cardiac 
inpatients and therefore justifies further prospective studies on the predictive validity. 
Some methodological issues, however, should be discussed. 
First of all, a high number of eligible patients was willing to take part in the study. 
Nevertheless, non-participants had a significantly higher troponin level and were 
more often diagnosed with a STEMI. Therefore, we cannot exclude the possibility of 
a selection bias excluding the most severe cases who might have experienced more 
cardiac anxiety. 
Secondly, we used only self-report questionnaires. The use of continuous scales has 
the advantage of measuring a broader continuum of symptoms. This is relevant 
since previous research has demonstrated a linear association between depressive 
symptoms and coronary artery diseases 36,37. Moreover cardiac anxiety, as a concept, 
is not included in the DSM-IV-classification system. It might be interesting for future 
research though, to assess the relationship of cardiac anxiety with formal psychiatric 
diagnoses such as anxiety disorders or major depression. 
Finally, it might be important to consider the nature of the comparison group. The 
choice of RA patients was made for several reasons. First of all, both groups were 
admitted for an acute event: exacerbation of RA and ACS, respectively. Secondly, 
both diseases share overlapping pathophysiological processes with regard to 
inflammation 38. Thirdly, the prevalence of general anxiety and depressive symptoms 
in RA and cardiac patients is similar 39,40. In our study, however, RA patients reported 
significantly less general anxiety. This might be explained by a longer duration of 
the underlying illness and a less urgent nature of the admission. However, even after 
controlling for general anxiety, the level of cardiac anxiety remained significantly 
higher in ACS patients. This is in line with the findings of Hoyer et al. 35, in patients 
undergoing cardiac surgery who found that 6 months after surgery, scores on all CAQ 
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subscales had declined compared to pre-surgery, but were still elevated compared to a 
comparison group of orthopedic inpatients without known cardiac disease.
Conclusion
We conclude that the CAQ is a valid and reliable instrument to assess cardiac anxiety 
in patients hospitalized for ACS. The high anxiety level in cardiac patients, its negative 
effect on the cardiac prognosis 41 and the availability of suitable treatment options for 
both general 42 and cardiac anxiety 29, make a convincing case for further research 
6. In addition to further prospective cohort studies of cardiac patients examining 
prognostic significance of cardiac anxiety, general anxiety and depressive symptoms, 
randomized controlled trials are necessary to evaluate the effectiveness of targeted 
interventions to reduce cardiac anxiety. 
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Abstract
Objective – General anxiety in cardiac patients is associated with worsened cardiac 
course. An Acute Coronary Syndrome (ACS) might evoke specific cardiac anxiety. 
We explored characteristics associated with cardiac anxiety in ACS patients.
Methods – In 237 patients admitted with ACS we assessed cardiac anxiety using the 
Cardiac Anxiety Questionnaire and gathered information on socio-demographic, 
psychological and cardiac disease characteristics. Univariate, multivariate logistic 
and linear regression analyses were used to determine which characteristics were 
associated with cardiac anxiety. 
Results – Cardiac anxiety was not associated with socio-demographic variables. More 
severe cardiac injury - as indicated by ST-Elevated Myocardial Infarction (STEMI) 
and troponin level - was associated with less cardiac anxiety. Psychological variables 
(depressive symptoms, agoraphobic cognitions, avoidance behavior) were associated 
with more cardiac anxiety. 
Discussion – Cardiac anxiety in ACS patients is associated with more psychological 
distress, but lower severity of cardiac injury as indicated by STEMI and troponin level. 
Two explanations seem likely for this latter finding. Anxious persons might seek help 
earlier, thus being diagnosed more often with minor cardiac pathology. Secondly, 
cardiac anxiety might partly be caused by diagnostic uncertainty. Future research 
should focus on communication strategies to reassure patients more efficiently. 
Keywords – anxiety, myocardial infarction, cardiac injury, heart, questionnaires.
Chapter 3
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Introduction
General anxiety and depression symptoms are common after an acute coronary 
syndrome 1-3. Most research has been conducted on depression, whereas in recent 
years more attention has been paid to anxiety. These more recent studies show that 
about 30-40% of hospitalized patients experience significant anxiety after a myocardial 
infarction 1-3. As the co-occurrence of cardiac disease and significant anxiety levels are 
higher than can be expected by chance, a causal relationship between cardiac disease 
and anxiety has been postulated. To date, several studies examined the bidirectional 
relationship between psychiatric disease and cardiovascular disease. Interestingly, 
meta-analyses of these studies have found that anxiety disorders are independent risk 
factors for myocardial infarction in otherwise healthy people 4, and that high anxiety 
after a myocardial infarction significantly worsens the prognosis of the cardiac disease 
5. A recent meta-analysis which included 12 studies in patients with a myocardial 
infarction (MI) showed that higher anxiety levels increase the risk of adverse cardiac 
outcomes after a MI with 36%, with reported hazard ratios (HR) of 1.23 (95% CI 
1.03-1.47) for cardiac death, 1.47 (95% CI 1.02-2.13), for overall death and 1.71 (95% 
CI 1.31-2.23) for cardiac events 4. In patients with a MI, generalized anxiety disorder 
is associated with an almost twofold increased risk of adverse outcomes in ten years 
follow-up independent of demographic and clinical variables and depression 6. 
Although the potential mechanisms linking anxiety and depression with impaired 
cardiovascular prognosis are still poorly understood, there are some theories 
concerning effects on the HPA-axis, inflammation (e.g. C-reactive protein), platelet 
aggregation as well as several behavioral mechanisms 7-11. 
The studies described above, however, include general measures of anxiety, whereas it 
is likely that an Acute Coronary Syndrome (ACS) evokes anxiety specifically related to 
cardiac disease such as fear of recurrence. Such specific cardiac fears may be different 
than general anxiety in associations with other variables, for example in being more 
strongly associated with avoidance behaviors than general fears, thus having a greater 
and more negative impact on the prognosis 5. To assess cardiac anxiety, the Cardiac 
Anxiety Questionnaire has been developed 12, with good psychometric properties 
in a recent cross-validation in the Netherlands 13. To guide future studies on the 
value of cardiac anxiety with respect to cardiac prognosis as well as to guide the 
development of (nursing) interventions to lower cardiac anxiety, more knowledge is 
needed on the determinants of cardiac anxiety. The objective of the present study was 
to explore characteristics associated with cardiac anxiety. The hypothesis was that a 
higher severity of cardiac anxiety is associated with both psychological characteristics 
(increased levels of depressive symptoms and general anxiety symptoms), as well as a 
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higher extent of cardiac injury. 
Methods
Participants
Eligible patients received oral and written information about the study and were asked 
informed consent. Included were patients admitted to the department of cardiology 
of a university medical center who were diagnosed with an acute coronary syndrome 
(ACS) confirmed by the presence of a rise and fall of troponin I ( Troponin I > 0.20 
μ/l) 14-16. Patients with both ST Elevated Myocardial Infarction (STEMI) and Non 
ST Elevated Myocardial Infarction (Non-STEMI) were included. Exclusion criteria 
were: age above 85 years, discharge out of hospital within two days of admission, 
and inability to fill in questionnaires (due to insufficient knowledge of the Dutch 
language, cognitive impairments or being too ill to participate). The study protocol 
was approved by the local Medical Ethics Committee.
Psychosocial assessment
Within one week of admission, all participants completed a set of four self-report 
questionnaires. The primary outcome parameter was cardiac anxiety as measured with 
the Cardiac Anxiety Questionnaire (CAQ). This self-report questionnaire consists of 
18 items rated on a 5-point Likert scale ranging from 0 (never) tot 4 (always) and is 
designed to measure heart-focused anxiety. The questionnaire assesses heart-related 
fear (e.g. “I worry that I may have an heart attack”), avoidance (e.g. “I take it easy 
as much as possible”), attention (e.g. “I can feel my heart in my chest” ) and safety 
seeking behavior (e.g. “I like to be checked out by a doctor”. It is well-validated in both 
psychiatric and cardiac populations 12,13. A recent cross validation in the Netherlands 
13 reported good internal consistency of both total (Cronbach α 0.84) and subscale 
scores (Cronbach α between 0.6-0.9) and a high test-retest-reliability (0.88, p<.001). 
In another independent cross validation study in 658 persons referred for screening 
for coronary artery disease comparable results were shown 17. 
Furthermore, three well-validated self-report questionnaires were administered, 
being the Agoraphobic Cognitions Questionnaire (ACQ) 18, the Mobility Inventory 19, 
and the Beck Depression Inventory (BDI) 20,21. 
The ACQ is a self-report-questionnaire which is designed to assess the frequency of 
catastrophic thoughts during the experience of fear. It contains 14 items which are 
rated on a 5-point Likert scale from (1) ‘thought never occurs’ to (5) ‘thought always 
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occurs’. The ACQ consists of two subscales, i.e. 1) social or behavioral concerns (e.g. 
act foolish), and 2) physical concerns (e.g. heart attack). The ACQ has high internal 
consistency (Cronbach α=0.87) and moderate test-retest reliability (r=0.67 for 1 
month), as well as sensitivity to changes due to treatment 18. 
The Mobility Inventory is a self-report questionnaire, which scores the level of 
avoidance behavior (from 0 “never avoid” through 4 “always avoid”) in 26 situations 
(e.g. being home alone). Avoiding these situations is assessed in two conditions; when 
accompanied and when alone. The MI has good internal consistency (Cronbach 
α=0.94), high test-retest reliability (r=0.90), and good convergent and discriminant 
validity 19,22. 
The BDI is a widely used well-validated 21-item-self-report-questionnaire assessing 
depressive symptoms. The total sum score ranges from 0 to 63, a score of 10 or 
higher is indicative of mild to severe depressive symptomatology 20,21. It is proven to 
be an acceptable screening instrument (Cronbach α=0.81) in somatic populations 23 
including patients with MI 24.
Cardiovascular assessment
In addition, socio-demographic data and information about cardiovascular risk 
factors, cardiac history and co-morbidity and in-hospital clinical course were 
extracted from the medical records. All cardiovascular variables were collected by a 
cardiologist in training  and independently checked by a consultant cardiologist. This 
double check did not reveal any disagreement between the two.
Cardiovascular variables – The diagnosis of a MI was based on clinical history and 
a rise and fall of troponin I (>0.20 μ/l). Creatinin Kinase (CK) was determined 
with an enzymatic assay (ArchitectC16000 analyzer Abbott Diagnostics Hoofddorp 
(Netherlands). Based on the electro cardiogram (ECG), patients were classified as 
having a ST-Elevated MI (STEMI: ≥0.2 mV in men or ≥ 0.15 mV in women in leads 
V2–V3 and/or ≥0.1 mV in other leads) or Non ST-Elevated MI (NSTEMI). C-reactive 
Protein level (CRP) on the first day of hospitalization was extracted from the medical 
records (available for only 74.7% (n=177) of  our patients). In routine clinical care 
CRP is assessed with turbidimetric assay (CRP antigen plus antiCRP antibody-> 
antigenantibodycomplex, type reaction; end-up).
Statistical analyses
The association of the CAQ with four categories of potential determinants was explored, 
namely socio-demographic variables, cardiovascular risk factors, psychosocial 
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variables, and finally, the severity of the ACS as defined by electrocardiography 
(STEMI versus Non-STEMI) and by the blood levels of troponin and maximum 
Creatinin Kinase (CK). First univariate associations were explored (using Pearsons 
correlation or Spearman rank correlation based upon the distribution of the variables), 
and subsequently a block-wise, linear regression analysis with a stepwise procedure 
per block in order to examine possible independent determinants of cardiac anxiety.
Finally, post-hoc analyses were conducted to examine whether the hypothesized 
explanation between cardiac injury and psychosocial variables were mediated by 
CRP levels, as there is evidence for an association between CRP level and affective 
pathology in cardiac patients  10,11.
Results
A total of 237 patients were included (mean age of 61.5 (SD=11.4), 66.7% (n=158) 
males). The mean CAQ item score was 1.33 (SD=0.65). Table 1 presents the correlation 
coefficients with all variables of interest. 
In contrast to the hypotheses, more severe ACS as indicated by three severity markers 
of the ACS (STEMI/Non-STEMI, troponin level, maximum CK) appeared to be 
associated with a lower level of cardiac anxiety (see table 1); the association with 
STEMI/Non-STEMI was significant (p<0.05), whereas the negative correlation with 
maximum CK and troponin was not (p=0.055 for both). 
The block-wise, linear regression analysis yielded five independent determinants of 
a higher level of cardiac anxiety, i.e. having no cardiac history (β=0.12, p=.045), a 
higher level of depressive symptoms (β=0.21, p=.003), a higher degree of avoidance 
behavior (β=0.19, p=.003), more agoraphobic cognitions (β=0.17, p=.011) and having 
had a Non-STEMI injury (β=0.16, p=.008) (model statistics: F=14.2, 5,213, p<.001). 
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Table 1 Socio-demographic, cardiovascular and psychosocial variables and their 
correlation scores with cardiac anxiety
Determinants Mean (SD) / n (%) Correlation-
with CAQ
p-value
Socio-demographic
Age 61.5 (SD=11.4) 0.08 0.23
Sex (% male) (0=female, 1=male) 158 (66.7%) 0.55 0.40
Marital status, n (%) stable relationship 195 (82.3%) -0.04 0.66
Higher education, n (%) (0=no, 1=yes)  60 (25.3%) 0.04 0.50
Employed, n (%) (0=no, 1=yes) 104 (43.9%) <.001 1.00
Cardiovascular risk factors
Hypertension, n (%)(0=no, 1=yes) 106 (44.7%) 0.00 0.96
Hypercholesterolemia, n (%) (0=no, 1=yes)  65 (27.4%) 0.03 0.71
Diabetes mellitus, n (%)(0=no, 1=yes) 41 (17.3%) 0.05 0.45
History of ACS, n (%)(0=no, 1=yes) 76 (32.1%) 0.21 0.002*
PTCA/CABG intervention, n (%)          
(0=no, 1=yes)
182 (76.8%) -0.13 0.043*
Psychosocial
Depressive symptoms (BDI) 7.2 (SD=5.8) 0.34 <0.001*
Agoraphobic cognitions (ACQ) 1.3 (SD=0.3)/236 0.32 (S) <0.001*
Avoidance behavior 
      (MI together)
      (MI alone)
0.32 (SD=0.46)
0.39 (SD=0.54)
0.23 (S)
0.25 (S)
<0.001*
<0.001*
Severity of Myocardial Infarction
STEMI, n (%)(0=no, 1=yes) 128 (54.0%) -0.18   0.004*
Troponin (ng/L), mean (SD) 42.1 (40.1) -0.13 (S) 0.055
CK max (U/L), mean (SD) 1179 (1571) -0.13 (S) 0.055
* significant correlation of p<0.05 of variable with total CAQ score in Pearson (P)/Spearman ranking (S) 
test
Abbreviations: CAQ, Cardiac Anxiety Questionnaire, total score; BDI, Beck Depression inventory; ACQ 
Agoraphobic cognitions questionnaire; MI, Mobility Inventory; ACS, acute coronary syndrome; STEMI 
ST-elevated Myocardial Infarction; CK max, maximum Creatinin Kinase level; PTCA, Percutaneous 
transluminal coronary angioplasty; CABG, Coronary artery bypass grafting.
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Interestingly, no collinearity was found between the three different psychological 
variables, each independently contributing in explaining the variance in the level of 
cardiac anxiety. However, as collinearity with a STEMI/Non-STEMI injury might have 
caused non-significance for the troponin-level and the CKmax level, both markers 
were tested using linear regression with again cardiac anxiety as the dependent 
variable and corrected for all independent determinants as found previously, but not 
including a STEMI/Non-STEMI injury. This analysis revealed that having a troponin 
level at the lowest quartile was also associated with a higher level of cardiac anxiety 
(β=-0.13, p=.042), whereas having higher CKmax levels did not reach significance 
(β=-0.06, p=.31).
CRP levels were known for only 74.7% (n=177) of  our patients. However, as CRP 
is known to be associated with affective psychopathology 15,16, all regression models 
were repeated with additional adjustment for the CRP level. The additional analyses 
showed that CRP was not a determinant of cardiac anxiety, whereas the association 
between cardiac anxiety and the previously identified determinants did not change 
substantially (data not shown).
Discussion
Our results show that in patients hospitalized for a troponin-positive acute coronary 
syndrome both, the severity of the cardiac injury as well as general measures of 
psychopathology are determinants of the level of cardiac anxiety. As expected, cardiac 
anxiety was positively associated with other measures of psychological distress like 
depressive symptoms, agoraphobic cognitions and avoidance behavior. In contrast to 
the hypothesis, patients with a more severe myocardial infarction, as defined by the 
level of cardiac injury (STEMI versus Non-STEMI and troponin level), had lower 
severity of cardiac anxiety. This association was independent of their cardiac history, 
treatment received and inflammatory markers known to be associated with affective 
psychopathology 10,11. 
The direction of the association between cardiac anxiety and severity of cardiac injury 
was puzzling at first instance, as a meta-analysis (12 studies, 5750 patients) on the 
effect of anxiety on cardiac prognosis showed that high anxiety levels predict cardiac 
events (4). Nevertheless, only one study 25 corrected for cardiac injury (as measured 
by left ventricular ejection fraction LVEF<30%) alone. They reported an increase of 
the odds ratio for general anxiety levels when corrected for severity of cardiac injury. 
This is consistent with the direction of the association we found. In the other studies 
26-28, the independent effect of severity of cardiac injury on anxiety was difficult to 
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assess since correction was done for numerous confounders simultaneously.
Two, not mutually exclusive explanations may account for the present findings. A first 
explanation could be that in case of less severe cardiac injury, patients are confronted 
with more uncertainty. In case the ECG does not show an ST elevation (non-ST 
elevated ACS), patients have to wait for the confirmation of the blood tests and thus 
the definitive diagnosis. In this particular group, patients themselves experience 
that something is wrong (as they experience the signs for which they visited the 
emergency department), whereas the first message they receive is “nothing is wrong, 
but we have to wait for the blood results”. Such uncertainties may account for higher 
levels of cardiac anxiety, as these patients feel bodily distressed, but remain unsure 
as to whether this distress is based on a medical condition; they experience a lack 
of control. This uncertainty may lead to increased awareness for cardiac symptoms, 
resulting in cardiac anxiety. In line with this hypothesis are the findings of a cross 
sectional study in 184 patients with acute coronary syndrome that showed that if 
persons attributed their symptoms to a heart attack this was related to experienced 
fear of dying 29. 
A second explanation could be selection bias as the chance to visit (by themselves) or 
the chance to be referred by their general practitioner to the emergency department 
may be affected by the patients’ anxiety level. One may argue that persons who 
experience higher cardiac anxiety levels are more likely to seek medical help for their 
symptoms, with more chance to be diagnosed with “minor” cardiac pathology, as 
opposed to non-anxious patients who may not seek help for mild symptoms. Selection 
bias may occur especially in the group of patients with only mild cardiac injury. In this 
subgroup, the diagnosis of an acute coronary syndrome is not always easy to made. 
This contrasts with patients with an ST elevation. These patients directly know that 
they have heart problems (and thus that nurses and physicians will take good care of 
them).
The clinical implications of our results lie in the high prevalence of anxiety in 
cardiac patients and the negative effect of anxiety on the cardiac prognosis 4-6. A 
first step in improving health care, is thus the detection of anxiety. As nurses are 
closest to providing care to cardiac patients, they have a good chance of signaling 
and targeting anxiety. A first step in reducing anxiety levels after detection, is taking 
anxiety symptoms as seriously as somatic signs and symptoms as well as providing 
appropriate information and reassurance. This requires specialized communication 
skills. A recent study showed that a patient’s comprehension about what is going 
on with them on an emergency ward, is closely related to level of comprehension 
of the nurses 30. Therefore efficient communication between doctors and nurses is 
Thesis Marleen.indd   57 15-9-2016   10:48:31
Processed on: 15-9-2016
505364-L-bw-vanBeek
58
Chapter 3
important as well as highly trained nurses with sufficient knowledge of cardiology and 
psychiatry. Furthermore, several studies point to the importance of communication 
skills  of nurses and possibility of training for nurses 31-34. Although most of these 
studies are conducted in cancer patients (assumed to have a higher stress level), two 
recent studies suggest that communication skills  may be equally important in cardiac 
patients with high anxiety levels 33,34. Firstly, a randomized controlled trial showed 
that a nursing intervention targeted at communication skills significantly increased 
enrollment in cardiac rehabilitation programs 33. Secondly, a randomized controlled 
pilot study suggested that nurse-initiated preoperational education and counseling is 
associated with a reduced level of anxiety following coronary artery bypass graft 34. 
Therefore specialized communication strategies to reassure patients efficiently should 
be developed as these might be relevant for both, the subgroup of patients placed in 
a situation of uncertainty due to minor cardiac injury (see above, explanation 1) as 
well as the subgroup of patients with higher levels of cardiac anxiety in general (see 
above, explanation 2). 
Although the results are strengthened by a large sample size, well-validated measure 
of cardiac anxiety and well-defined study population, it has to be acknowledged 
that the size of the correlations seems rather small. This may partly be due to the 
relatively low CAQ mean item score of 1.33 (SD 0.65) in our population. Although the 
CAQ has not yet an established cut-off score to identify cases with clinically relevant 
cardiac anxiety, data of a recent study, consisting of one-year-follow up data of the 
majority of the here described ACS patients, suggest that a clinically relevant cut-off 
lies somewhere in between 1.45 and 1.90 35. 
As the study has been conducted in the Netherlands, one should be careful to 
generalize these results to other (Western) countries. Nevertheless, guidelines for 
diagnosing ACS at the emergency department are comparable between countries 36,37. 
Future research should be conducted on the clinical relevance of our findings as 
well as the possibility to reduce cardiac anxiety by specific communication strategies 
applied directly by nurses at the emergency department.  
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Abstract
Introduction – Longitudinal elevated depressive symptom scores are associated with 
a less favorable cardiac outcome. Although anxiety has received less attention, meta-
analysis suggests that high baseline levels of general anxiety might worsen cardiac 
outcome. The objective of this study was to explore the longitudinal course of cardiac 
anxiety after a myocardial infarction (MI).
Methods – The Cardiac Anxiety Questionnaire (CAQ) was administered to 194 
patients hospitalized for MI after admission, and one, three, six and twelve months 
after discharge. Latent class growth analysis (LCGA) was performed to identify groups 
based on cardiac anxiety course. Between group differences were checked on relevant 
socio-demographic, cardiac and psychiatric variables. 
Results – LCGA identified three groups with stable CAQ levels over time, indicative 
of high (7.7%), intermediate (45.4%) and low (30.4%) levels of cardiac anxiety, 
respectively. A fourth group (16.5%) reported high levels of cardiac anxiety that 
decreased over time. Between group differences were of particular interest for the two 
subgroups that started high in cardiac anxiety, since these may differentiate patients 
with spontaneous remission from those who might be in need of treatment. Patients in 
whom cardiac anxiety persisted were less often employed, had more diabetes mellitus, 
a history of acute coronary syndrome, depressive symptoms, anxiety and avoidance at 
baseline and a lower quality of life at follow-up.
Conclusion – This first study addressing cardiac anxiety after an MI identified four 
trajectories. Future studies should focus on cardiac outcome and treatment strategies 
for cardiac anxiety in the subgroup with persistent high anxiety levels.
Keywords – anxiety, cardiac, heart, myocardial ischemia, myocardial infarction, acute 
coronary syndrome.
Chapter 4 
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Introduction
While depression and its association with cardiac disease have been thoroughly 
studied 1, anxiety in cardiac patients has received far less attention. Recently, it has been 
suggested that anxiety disorders are independent risk factors for myocardial infarction 
(MI) 2. In a large cohort of young men (n=49321), early-onset anxiety predicted acute 
MI (hazard-ratio (HR) = 2.51 (95% Confidence Interval (CI) 1.38-4.55) 3. In two 
meta-analyses similar conclusions were drawn 4,5. The first included 20 studies and 
confirmed that anxiety might be an independent risk factor for incident coronary 
heart disease (HR= 1.26 (95% CI 1.15-1.38) and cardiac mortality (HR=1.48 (95% 
CI 1.14-1.9) . The second meta-analysis included 12 studies and showed that higher 
anxiety levels increased the risk of adverse cardiac outcomes after a MI with 36%, 
with reported HRs of 1.23 (95% CI 1.03-1.47) for cardiac death, 1.47 (95% CI 1.02-
2.13), for overall death and 1.71 (95% CI 1.31-2.23) for cardiac events 5. Nevertheless, 
the actual number of studies remains small in comparison to studies examining 
depression in heart disease and, more importantly, confounding by cardiovascular 
risk factors cannot be fully excluded 4,5. Furthermore, heterogeneity of individual study 
results included in the meta-analyses was substantial and hypothesized to be due to 
the diversity in anxiety measures. Therefore, which aspects of anxiety are related to 
cardiac outcome remains unknown and confounding by depression as overlapping 
construct cannot be excluded. Finally, most studies focus on the impact of anxiety 
measures at one time-point, whereas for depressive symptoms, it has been shown that 
longitudinally elevated symptom scores have the highest risk of a negative outcome 
6. The objective of the present paper is to identify patients with different courses of 
cardiac anxiety after a myocardial infarction.
Only two studies have explored the course of anxiety in cardiac patients 7,8 and yielded 
widely different results. The first study was conducted among female cardiac patients 
and identified two trajectories. The majority of patients had low anxiety levels, 
which improved during the one year follow-up. A small group started with relatively 
higher levels of anxiety and/or depression that worsened over the year 7. The second 
study, conducted among exhausted cardiac patients after a Percutaneous Coronary 
Intervention, yielded five different trajectories. Four trajectories showed stable anxiety 
scores over time and were defined by their baseline levels of anxiety symptoms (no, 
mild, moderate, severe). A fifth trajectory was found including patients with severe 
anxiety that decreased over time 8. 
These varying results might be explained by a different population, but also by the 
instruments used to measure anxiety. After a MI specific anxiety symptoms related 
to cardiac stimuli and sensations may develop. This is known as cardiac anxiety, 
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which can be reliably assessed by the Cardiac Anxiety Questionnaire (CAQ) 9-11. Both 
previous studies, however, included only general measures of anxiety, respectively the 
Hospital Anxiety Depression Scale (HADS) 7 and the Spielberger State-Trait Anxiety 
Inventory (STAI) 8. Moreover, the STAI does not clearly differentiate anxiety and 
depression 12. 
The CAQ has been developed based on the assumption that specific fears about heart 
disease might be more important with regard to prognosis and need for interventions 
in cardiac patients than more general fears. Available studies indeed show that the 
CAQ is more sensitive than a general anxiety measure like the HADS in patients 
who are focused on chest pain 13,14. In 90 cardiac patients, Hoyer et al. 13 assessed 
both general anxiety (HADS) and cardiac anxiety (CAQ) before and after cardiac 
surgery. While general anxiety decreased in all patients to levels similar to the general 
population, cardiac anxiety remained elevated in a subgroup of patients. This might 
help to identify cases in need for additional support in adjusting to their cardiac 
problems. This was further supported by a randomized controlled trial comparing 
cognitive behavioral therapy, antidepressant medication and placebo in patients with 
non-cardiac chest pain. Effectiveness of treatment was found to be mediated by the 
subscale “heart-focused anxiety” of the CAQ but not the HADS 14.
We conducted an exploratory prospective cohort study in cardiac patients hospitalized 
with  myocardial infarction with follow up after discharge at one, three, six and 
twelve months. Aims of the current study were 1) to identify the different trajectories 
of cardiac anxiety over a 12-month period in patients hospitalized for a MI and 2) 
to compare the different trajectories in terms of socio-demographic, cardiac and 
psychiatric variables at baseline and quality of life at end of follow-up.
Methods
Study population
The study population consisted of all patients admitted between November 2006 and 
December 2007 to the department of cardiology of Radboud University Nijmegen 
Medical Centre, the Netherlands. All were screened for eligibility by a senior 
cardiologist within two days after admission. Inclusion criteria were a final diagnosis 
of Myocardial Infarction, both ST-Elevated MI (STEMI) and Non ST-Elevated MI 
(NSTEMI). The diagnosis was confirmed by the presence of a rise and fall of troponin 
I (>0.20 μg/l). Exclusion criteria were: age above 85 years, discharge out of hospital 
within two days of admission, and inability to fill in questionnaires (due to insufficient 
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knowledge of the Dutch language, cognitive impairment or being too ill to participate). 
Procedure
Eligible patients received oral and written information about the study and were 
asked informed consent. Between day 2 and 7 after admission, patients completed 
a set of five self-report-questionnaires: the Cardiac Anxiety Questionnaire 9-11, the 
Agoraphobic Cognitions Questionnaire 15,16, the Mobility Inventory 17,18, the Beck 
Depression Inventory 19-21 and the EuroQol-5D 22,23. In addition, socio-demographic 
data and information about the presence of cardiovascular risk factors hypertension, 
diabetes mellitus, hypercholesterolemia, and peripheral atherosclerotic disease, as 
well as a history of coronary artery disease and stroke and other somatic co-morbidity 
were extracted from the medical file. 
At one, three, six and twelve months after discharge patients were sent the same 
questionnaires by post. If necessary, patients were contacted by phone two weeks 
later as a reminder. The study protocol was approved by the local Medical Ethics 
Committee.
Measures
Cardiac Anxiety Questionnaire (CAQ) - The CAQ is an 18-item self-report-
questionnaire, designed to assess heart-focused anxiety, rated on a 5-point Likert 
scale ranging from 0 (never) tot 4 (always). In line with previous publications on the 
CAQ, the overall score as well as subscale scores are expressed as an average item 
score 10. The original factor analysis identified three subscales: 1) heart-related fear 
(8 items e.g. “I worry that I may have a heart attack” and “If test come out normal, 
I still worry about my heart”); 2) avoidance (5 items e.g. “I take it easy as much as 
possible”); and 3) attention (5 items e.g. “I check my pulse”) 10. In a sample of 188 
patients referred for angiography the CAQ had a good internal consistency of both 
total (Cronbach α =0.83) and subscale scores (Cronbach α of 0.83, 0.82 and 0.69 
respectively). It also showed good convergent validity, with moderate correlations 
with established anxiety measures like the Anxiety Sensitivity Index (0.69) and the 
Body Sensations Questionnaire (0.66). The CAQ also successfully differentiated 
cardiac anxiety from general anxiety in psychiatric outpatients 10. A recent cross 
validation in the Netherlands 9 identified four subscales (fear, avoidance, physical 
attention and safety seeking behavior) with a good internal consistency of both total 
(Cronbach α 0.84) and subscale scores (Cronbach α between 0.6-0.9) In this study the 
CAQ had a high test-retest-reliability (0.88, p<.001) and low to moderate correlations 
with questionnaires such as the ACQ (0.31), STAI-State (0.39) and the BDI (0.27). 
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Comparable results, including the four subscales, have been previously reported in an 
independent cross validation study in 658 persons referred for screening for coronary 
artery disease 11. 
Agoraphobic Cognitions Questionnaire (ACQ) - The ACQ is a widely used 14-item 
scale assessing the frequency of catastrophic thoughts during the experience of 
anxiety and fear 15, rated on a 5-point Likert scale from (1) ‘thought never occurs’ to 
(5) ‘thought always occurs’. The ACQ consists of two subscales: 1) social/ behavioral 
concerns (e.g. act foolish, hurt someone); and 2) physical concerns (e.g. heart attack, 
stroke). The ACQ has high internal consistency (Cronbach α=0.87), moderate test-
retest reliability (r=0.67 for 1 month) and sensitivity to changes due to treatment 15,16. 
The ACQ also differentiates between persons with and without anxiety disorders 24.
Mobility Inventory (MI) - The MI is a self-report-questionnaire to measure avoidance 
behavior. Patients are instructed to rate their level of avoidance (from 0 “never 
avoid” through 4 “always avoid”) in 26 familiar situations (e.g. driving a car, going 
to supermarkets, being home alone). Patients score avoiding these situations in 
two conditions; when accompanied and when alone. The questionnaire has good 
internal consistency (Cronbach α=0.94), high test-retest reliability (r=0.90), and good 
convergent and discriminant validity 17,18.
Beck Depression Inventory (BDI) - Depression symptoms were measured on a 4 
point scale with the BDI, a 21-item self-report-questionnaire. The total sum score 
(range 0-63) is indicative of the severity of depressive symptoms, a score of 10 or 
higher is indicative of mild to severe symptomatology 19,20. The BDI has good internal 
consistency (Cronbach α=0.93) 17. It is proven to be an acceptable screening instrument 
(Cronbach α=0.81) in somatic populations 21 including patients with MI 25.
Cardiovascular variables – The diagnosis of a MI was based on clinical history and 
a rise and fall of troponin I (>0.20 μ/l). Creatinin Kinase (CK) was determined with 
an enzymatic assay (ArchitectC16000 analyzer). Based on the electro cardiogram 
(ECG), patients were classified as having a ST-Elevated MI (STEMI: ≥0.2 mV in men 
or ≥ 0.15 mV in women in leads V2–V3 and/or ≥0.1 mV in other leads) or Non ST-
Elevated MI (NSTEMI). 
Medical history was retrieved from the medical dossier of either the general 
practitioner and/or hospital consultant. Hypertension was defined as repeatedly 
elevated blood pressure exceeding 140/90mmHg or the use of anti-hypertensive 
medication. Hypercholesterolemia was defined as a total cholesterol level higher 
than 240mg/dL or the use of cholesterol lowering medication. We prospectively 
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collected data whether patients were referred to a heart rehabilitation program after 
discharge. All cardiovascular variables were collected by a cardiologist in training  and 
independently checked by a consultant cardiologist. This double check did not reveal 
any disagreement between the two. 
Quality of life - Quality of life was measured using the EuroQol EQ-5D 22. The EQ-
5D measures quality of life in five dimensions, including mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression. The dimensions are divided into 
three response levels: no problems, some/moderate problems, and extreme problems/
unable to. The combination of scores is weighted to arrive at a single index score 
between -0.33 (worst imaginable health state) and 1.00 (best imaginable health state). 
Dutch norm scores were used to calculate the mean EQ-5D index values 23.
Statistical analysis:
Conventional growth models assume that individuals come from a single population 
and that a single growth trajectory can approximate the entire population. This 
assumption, however, does not automatically apply for all research domains, and 
currently new methods are available to model such heterogeneity of growth trajectories 
26. Latent class growth analysis (LCGA) tries to identify different homogeneous groups 
within the larger heterogeneous population, each with its own growth trajectory. The 
total CAQ score was taken as the primary outcome and we performed a LCGA in 
Mplus 6.11, using maximum likelihood parameter estimator with robust standard 
errors, starting with a one class model (which in fact reflects the homogeneous 
model), and expanding the number of classes (introducing heterogeneity), until the 
best model fit was found. LCGA tries to fit the data on a model in which each class 
represents a group of patients which have more or less the same severity and course of 
cardiac anxiety. The course over time is modeled using polynomials with a maximum 
order of three, and it was assumed that the total scores follow a Poisson distribution, 
meaning that in the Mplus-model these had to be defined as count variables. The best 
model fit is determined by the lowest BIC value and still a significant difference in the 
Vong-Lo-Mendell-Rubin likelihood ratio test (VLMR) 27. Subsequently, the procedure 
was repeated using the different subscales of the CAQ 9,10, in order to check whether 
the different symptom cluster results in similar trajectories or whether trajectories are 
subscale specific. 
Finally, classes were compared with regard to relevant socio-demographic, cardiac 
and psychiatric variables at baseline and quality of life endpoint, by performing 
ANOVA for continuous variables or X2-tests for categorical variables using SPSS17.0. 
Normal distribution was checked for continuous variables, and if needed variable was 
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transposed to log or tested non parametrically by KrussKal Wallis or Mann-WhitneyU 
tests. Due to the large number of tests, the level for statistical significance should 
be adapted to less than .05. However, as correction for multiple comparisons may 
increase the risk of type II errors, we have chosen to present all individual statistics 
and p-values 28. 
Results
Sample
During the study period, 398 patients with a MI had been admitted, of which 135 
patients after primary PTCA were relocated to a hospital in their home area within 
two days of admission. Of the 263 patients who were still present at the time we asked 
informed consent, 203 patients (77%) agreed to participate. Nine persons had to be 
excluded from the analysis because more than 3 items of the CAQ were missing (n=3) 
or because the CAQ was only available for one assessment (n=6). 
The average age of the study sample (n=194) was 61.8 years (SD=11.5; range 24-85) 
and the male-female-ratio 2:1 (130/64). A total of 65/194 (32%) had a history of 
coronary artery disease.
The overall average item score of the CAQ was 1.35 (SD=0.60). Correlation of scores 
of the CAQ with cardiac disease severity was low. Spearman rank correlation of CAQ 
with STEMI/NSTEMI was r=-0.18, p=.004, with troponin levels r= -0.13, p=.06 and 
with CKmax level r=-0.13, p=.06. 
Latent class growth analyses
The CAQ data of the 194 patients were imported in Mplus and analyzed. Using 
quadratic polynomials with the LCGA, showed better results compared to a linear 
model. A cubic model did not obtain better results when compared to the quadratic 
model. Therefore, having less free parameters, we chose the quadratic model. 
Its decision parameters (BIC, VLMR, P-value, Entropy) are shown in table 1. The 
decision parameters show that a solution with 4 classes was the most optimal, i.e. it 
had the lowest BIC value and the VLMR test showed a significant improvement of the 
model when compared to 3 classes. Although the entropy of 4 classes was just above 
0.70, it was significantly better than the entropy of 5 classes.
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Table 1: CAQ latent class growth analysis decision parameters.
Classes BIC VLMR P-value Entropy
1 5143 - -
2 4619 0,0000 0,763
3 4554 0,0035 0,760
4 4516 0,0004 0,716
5 4519 0,4088 0,627
Figure 1: The total CAQ score of the four groups based on the Latent Class Analy-
sis at baseline, and 1, 3, 6, and 12 months after discharge.
Best fit model in Mplus showing the four classes with their course on CAQ score 
during one year (admission, one month after discharge, three months, six and 
twelve months after discharge). On y-axis CAQ-total score on Cardiac Anxiety 
Questionnaire.
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In our model we thus identified four classes of different courses of cardiac anxiety 
(average CAQ item scores) during one year. These different courses of cardiac anxiety 
were already apparent after three months (retention rate 65%, 127/194). Overall 
retention rates for CAQ were 72% (149/194) after one month, 65% (127/194) after 
three months, 49% (95/194) after six months, and 24% (46/194) after one year. 
The first group “A”(n=15, 7.7%) started with a high average CAQ item score 
(and stayed high on cardiac anxiety level). The second “B”(n=88, 45.4%) had a 
continuously intermediate CAQ level (labeled as “continuously medium”), the third 
group “C” a continuously low CAQ level (n=59, 30.4%), and a fourth group “D” 
(n=32, 16.5%) with patients who started with high anxiety levels at hospitalization, 
that diminished in the course of a year to a low score at one year follow up 
(see figure 1). 
The CAQ can be divided in three 10 or four 9,11 clinically relevant subscales, targeting 
fear, avoidance, attention and the fourth safety seeking behavior. When doing a 
LCGA on a model using the average item score of these subscales, the individual 
trajectories of each subscale followed the same latent class growth pattern as the 4 
groups described above, based on the total average CAQ item score. Assignment 
to a class was checked for stability; each class showed the same number of persons 
and no person switched into another class. Thus, even with a model with more free 
parameters, we obtained the exact division of persons into classes and the sub-scale-
trajectories resembled very close.
Baseline characteristics per Cardiac Anxiety Class
Differences between patients with the four trajectories on demographic characteristics, 
cardiac measures and risk factors, and psychiatric parameters at baseline are shown 
in Table 2. Significant differences between the four classes were age, employment, 
diabetes mellitus, coronary heart disease, and all psychiatric symptom scales (see 
table 2).
For clinical practice, the differences between subjects in trajectories A and D are 
interesting, as these may differentiate patients with spontaneous remission of high 
anxiety scores from those who might benefit from treatment. Post hoc comparison 
of these two groups on those overall significant variables, showed that patients in 
whom cardiac anxiety persisted over time had significantly less employment (χ2=5.8, 
p=0.016,), more diabetes mellitus (χ2=6.2, p=0.013) and more often a history of acute 
coronary syndrome (χ2=8.9, p=0.003) (see Table 1). They also reported significantly 
more depressive (t=2.3, p= 0.029) and anxiety symptoms (t=2.3, p=0.026), and more 
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avoidance (t=2.2, p=0.032). As the number of persons in the subgroups was too small, 
no multivariate analyses were conducted. 
Quality of life at end of follow-up
Due to low retention rates at the end of follow-up (see above), last-observation carried 
forward (LOCF) was applied to the EQ-5Dscores obtained at follow-up (baseline 
values were not carried forward as these values are supposed to be confounded by 
being hospitalized). LOCF was deemed reliably as all pairs of follow-up measures 
did not differ significantly in patients with complete data (mean difference between 
follow-up measures ranged from 0.002 through 0.030 points (all p-values>.22). One-
way-ANOVA showed significant differences between the four groups (F=3.5; 3,149; 
p=.017). Post-hoc comparisons showing that group A (high) had significantly lower 
EQ-5Dscores compared to group B (intermediate, p=.047), group C (low, p=.004) and 
group D (high-low, p=.006) (see figure 2). Group D (high-low) did neither differ from 
group B (intermediate, p=.16), nor from group C (low, p=.88).
Thesis Marleen.indd   73 15-9-2016   10:48:32
Processed on: 15-9-2016
505364-L-bw-vanBeek
74
Chapter 4 
Table 2  Baseline characteristics of the four subclasses based on CAQ course
Variable Total  
Sample
Low (C) Medi-
um (B)
High 
(A)
High-
Low (D)
Statistics
(n=194) (n=59) (n=88) (n=15) (n=32)
Demographics
Age (years), mean 
(SD)
61.8 
(11.5)
60.0 
(11.8)
61.0 
(11.5)
69.3 
(10.8)
63.6 
(10.3)
F=3.0; 3;p=.030
Male sex, n (%) 130 
(67%)
38 (36%) 58 
(66%)
12 
(80%)
22 (69%) X2=1.4; 3;p=.70
Stable relationship, 
n (%)
155 
(80%)
46 (78%) 70 
(80%)
14 
(93%)
25 (78%) X2=1.9; 3;p=.60
Higher education, 
n (%)
50 (26%) 16 (27%) 21 
(24%)
2 (13%) 11 (36%) X2=3.0; 3;p=.40
Employment, n (%) 86 (46%) 24 (43%) 44 
(51%)
2 (13%) 16 (50%) X2=7.8;3;p=.051
Somatic history of
Hypertension, n (%) 85 (44%) 23 (39%) 44 
(50%)
7 (47%) 11 (34%) X2=3.1; 3;p=.37
Hypercholestero- 
laemia, n (%)
55 (28%) 15 (26%) 32 
(36%)
3 (20%) 5 (16%) X2=6.1; 3;p=.11
Diabetes mellitus, 
n (%)
33 (17%) 5 (9%) 19 
(22%)
6 (40%) 3 (9%) X2=11.3; 
3;p=.010
Peripheral atheroscel-
erosic disease, n (%)
28 (14%) 8 (14%) 14 
(16%)
1 (7%) 5 (16%) X2=1.0; 3;p=.81
Stroke, n (%) 7 (4%) 2 (3%) 4 (5%) 1 (7%) 0 (0%) X2=1.8; 3;p=.61
(history) Coronary 
artery disease, n (%)
62 (32%) 13 (22%) 32 
(37%)
10 
(67%)
7 (22%) X2=13.3;3;p=.004
Assigned for heart 
rehabilitation, n (%)
84 (43%) 22 
(37.3%)
44 
(50.0%)
3 
(20.0%)
15 
(46.9%)
X2=6.0, 3;p=0.11
Cardiac disease 
status
Troponin, n (%) 
above median
96 31 (53%) 41 
(47%)
9 (60%) 15 (47%) X2=1.3; 3;p=.74
CKmax, median (P25 
– P75) *
571 (158-
1594)
752 (180 
- 1577)
531 
(161 - 
1388)
546 (117 
- 1644)
579 (188 - 
2188) 
F=0.3;190,3; 
p=.83
Non-ST elevated MI, 
n (%)
92 (47%) 25 (42%) 41 
(47%)
8 (53%) 18 (56%) X2=1.3; 3;p=.74
Duration of hospita- 
lization (days), medi-
an (P25 – P75) *
6 (4-8) 5 (4 - 8) 6 (5 - 8) 5 (4 -10) 6 (4 - 8) F=0.6l; df=190; 
p=.64
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Variable Total  
Sample
Low (C) Medi-
um (B)
High 
(A)
High-
Low (D)
Statistics
Psychological symp-
toms
BDI sum score, me- 
dian (P25 – P75)
6 (3-10) 4 (2 - 7) 6 (4 - 
10)
12 (7 - 
16)
7 (4 - 12) X2= 21.7;3; 
p<.001
BDI  >=10, n (%) 54 (28%) 10 (17%) 23 
(26%)
11 
(73%)
10 (32%)
ACQ sum score, 
median (P25 – P75)
1.21 
(1.00-
1.50)
1.14 ( 
1.00 – 
1.36)
1.21 
(1.07 – 
1.50)
1.43 
(1.29 - 
1.71)
1.14 (1.00 
- 1.43)
X2=18.6;3; 
p<.001
ACQ social/behavior-
al, median (P25 – P75)
1.29 
(1.00-
1.71)
1.14 ( 
1.00 – 
1.41)
1.43 ( 
1.00 - 
1.71)
1.71 
(1.29 – 
2.00)
1.29 ( 
1.00 – 
1.57)
X2=17.9;3; 
p<.001
ACQ physical, me- 
dian (P25 – P75)
1.00 
(1.00-
1.29)
1.00 (1.00 
– 1.14)
1.00 
(1.00 – 
1.14)
1.29 
(1.14 – 
1.57)
1.00 (1.00 
– 1.14)
X2=18.7;3; 
p<.001
MI together, median 
(P25 – P75)
0.17 
(0.0-0.7)
0.03 (0.00 
-0.31)
0.21 
(0.00 – 
0.69)
0.72 
(0.37 – 
1.69)
0.21 (0.00 
– 0.90)
X2=16.6; 3; 
p=.001
MI alone, median 
(P25 – P75)
0.14 (0.0-
0.48)
0.03 (0.00 
– 0.31)
0.14 
(0.00 – 
0.41)
0.72 
(0.29 – 
1.39)
0.14 (0.00 
– 0.72)
X2=1.63; 3; 
p=.001
Statistics based on Log-transformed CKmax values analyzed with ANOVA
Variables low-medium-high-high low are the classes based on course of total Cardiac Anxiety  
Questionnaire (CAQ) score; 
  
n=number; SD=standard deviation; CKmax= maximum level of Creatinin Kinase; P25;=value at the 25th 
percentile; P75=value at the 75th percentile; MI=myocardial infarction; BDI-=Beck Depression Inventory: 
ACQ=Agoraphobic Cognitions Questionnaire; MI Mobility Inventory; MI together=subscale of MI mea-
suring avoidance behavior with others; MI alone=subscale of MI measuring avoidance behavior alone
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Figure 2 Quality of life as assessed with the EuroQol-5D at end of follow-up for 
the four groups with a different trajectory of cardiac anxiety
Legend:
Group A: Stable levels of high cardiac anxiety during follow-up
Group B: Stable levels of intermediate levels of cardiac anxiety during follow-up
Group C: Stable levels of low levels of cardiac anxiety during follow-up
Group D: High initial levels of cardiac anxiety which decrease during follow-up
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Discussion
Main finding
In addition to the few studies of trajectories of anxiety in cardiac patients, the present 
study is the first to examine the trajectories of specific cardiac anxiety in patients 
hospitalized for myocardial infarction, including both ST-elevated and non-ST-
elevated MI. We identified four latent classes with distinctive courses of cardiac 
anxiety; during the one-year follow up  three groups stayed at about the same level of 
cardiac anxiety as they started (with respectively a low, intermediate and high level 
of cardiac anxiety), and the fourth group had a high but decreasing level of cardiac 
anxiety. Although we acknowledge that the retention rate decreased over time, the 
differences in CAQ course are already determined at time 2 and 3, when the retention 
was still substantial. The finding of multiple trajectories instead of one anxiety 
trajectory is consistent with previous researches reporting multiple trajectories on 
anxiety, depression and quality of life in cardiac patients 6-8,29, although none of these 
studies specifically addressed cardiac anxiety. 
Remarkable was the distinct course of group D with high but diminishing cardiac 
anxiety symptoms over the one year follow-up period. A similar subgroup that 
started high but showed declining general anxiety levels in the follow up period, was 
seen in women followed up to 12 months after a MI or coronary artery bypass graft 
surgery 7 and in a study of exhausted cardiac patients after a percutaneous coronary 
intervention during an 18-months follow up period 8. The relevance of our findings of 
different trajectories of specific cardiac anxiety is indicated by a study of Hoyer et al. 
12 who assessed both general anxiety (HADS) and cardiac anxiety (CAQ) before and 
after cardiac surgery in 90 cardiac patients. While general anxiety decreased to levels 
comparable with the general population, cardiac anxiety decreased but still remained 
elevated for a subsample, indicating that measures of specific heart anxiety, in contrast 
to global psychosocial indicators, may help to identify cases in need for additional 
help in adjusting to their cardiac problems. 
For clinical practice it is indeed relevant to get more information about the people in 
whom the anxiety persists,  particularly as their quality of life at one-year follow-up is 
significantly lower than that of the other groups. Unfortunately, the CAQ has not yet 
an established cut-off score to identify cases with clinically relevant cardiac anxiety. 
The average CAQ item score in our population (1.35 (SD=0.60) was lower than that in 
other populations demonstrating mean CAQ item scores of 1.67 (SD=0.81) in 30 post-
angiography and 12 outpatients 10 and 1.87 (SD=0.55) in 90 cardiology pre-surgery 
patients 13. The included patients in above mentioned studies may not be entirely 
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comparable with our population. In the first study the 12 outpatients were selected 
because of a diagnosis of anxiety disorder. Furthermore, in 47.6% of the patients 
referred for angiography coronary artery disease was not established, implying a 
higher level of psychiatric symptoms in this subgroup. In the latter study, the CAQ was 
assessed 2 weeks before scheduled cardiac surgery. The CAQ scores of groups A and D 
based on the LCGA in our sample (1.90 (SD=0.56) and 1.94 (SD=0.36), respectively) 
were higher than in the previously reported studies 10,13. Although preliminary, these 
data suggest that a clinically relevant cut-off lies somewhere in between the average 
item score in the group with intermediate CAQ item scores (i.e.1.45 (SD=0.40) and 
these higher average item scores of 1.90.
A closer look at the differences between the two subgroups with high baseline cardiac 
anxiety levels, is therefore of clinical importance. Previous studies, focusing on 
factors associated with a continuing high anxiety or depression level, reported mixed 
results. Reported determinants of persistent anxiety or depressive symptoms were 
psychosocial characteristics like educational level and perceived social support 7,8,30, 
as well as the presence of somatic diseases like a previous acute coronary syndrome 
(ACS) or cardiac risk factors like diabetes mellitus (DM) 31-33. Our study replicates 
the association with somatic diseases: the subgroup of patients which experienced 
high cardiac anxiety over time had a significantly higher frequency of DM and more 
often a history of ACS than the subgroup of patients who had a high but declining 
level of cardiac anxiety. Interestingly, baseline characteristics of the group with 
decreasing cardiac anxiety levels most closely resembled the group with stable low 
cardiac anxiety. One may hypothesize that a higher level of somatic co morbidity may 
trigger a negative attitude towards newly developed somatic symptoms as patients 
had negative experiences before.
Importantly, cardiac anxiety did not represent a more severe cardiac injury as it was 
hardly related to the actual severity of cardiac injury. The correlation coefficients 
between CAQ score and three indicators of cardiac injury were not clinically relevant 
(range r=-.13 through-.18) and only the association with STEMI/NSTEMI reached 
statistical significance.
Furthermore, our study replicates the association with psychological determinants; 
the subgroup of patients which experienced high cardiac anxiety over time also 
reported significantly higher depressive symptoms as well as avoidance behavior 
than the subgroup of patients who had a high but declining level of cardiac anxiety. 
One may hypothesize that inactivity, which can be associated with depression, as 
well as avoidance behavior may maintain cardiac anxiety. Targeting this avoidance, 
for example by exposure, may therefore be of importance in the treatment of these 
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patients. This is also supported by studies in chronic back pain patients, in which 
anxiety for physical activity and the associated avoidance are shown to be important 
determinants for the maintenance of symptoms. Treatment of chronic back pain, 
targeting this avoidance by exposure has been shown to be effective 34.
Methodological considerations
A strength of this study is the use of repeated CAQ assessments and the LCGA 
method toidentify different courses of cardiac anxiety symptoms after MI, which 
has not been applied previously in this context. The follow up period of 12 months 
provides clinically relevant information about the course of anxiety and depressive 
symptoms after the initial stressful cardiac event and hospitalization. 
In a LCGA analysis each person is assigned to the class with the best fit. It is 
recommended that the number of class members of each class is at least equal to 
the number of free parameters of the model. For our quadratic LCGA with 4 classes 
there are 15 free parameters, where the minimum class membership is also 15 (in one 
class). However, we must be aware that significant group differences are not the same 
as clinically relevant individual predictors. Nevertheless, the significant differences 
between the four classes, and especially the differences between the two classes with 
persons who scored high on cardiac anxiety levels at hospitalization, provide a first 
insight in possible relevant factors for clinical practice. 
Although the recruitment rate was relatively high, generalization of our results is 
compromised by the fact that we could not include patients who were transferred 
after intervention to other hospitals within two days and those with the greatest illness 
severity. As we did not include the most ill and those being healthy enough for early 
transportation to other hospitals, we cannot estimate whether this has biased our 
results and if so, in what direction. The mean CAQ score in our population was indeed 
slightly lower than that in other cardiac populations 10,13, suggesting that we might 
not have included  the most anxious patients. Nevertheless, the number of patients 
(n=194) and response rate (77%) was reasonably high, particularly given the practical 
difficulties conducting a study of psychological symptoms in a patient population 
with a severe somatic condition like MI. Unfortunately the number of persons in the 
two subgroups of interest were too small to control for possible confounders in a 
multivariate analysis. We consider the comparison as a first step in exploring possible 
confounders. It would be interesting to re-examine the somatic and psychological 
variables in a bigger independent sample of cardiac patients with high CAQ levels, 
in order to interpret and weigh the clinical relevance of the found predictors better.
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Final conclusion/implications
This study identified four different courses of cardiac anxiety in MI patients in a 12 
months follow up. Of those patients presenting with high level on cardiac anxiety, 
those with high levels of general psychological distress and a more complicated 
history of somatic diseases, had persistent levels of cardiac anxiety during follow-
up and a significantly lower quality of life at the end of follow-up. These findings 
may be a first step in providing tools for the clinician to decide which patients 
deserve attention for their anxiety levels and may benefit from early interventions. 
Furthermore, reassessment after one month may also identify patients with initially 
high cardiac anxiety levels, but a much more favorable course. In addition, as the class 
of patients with intermediate CAQ scores does not improve during follow-up either, 
we are not able to exclude the possibility that they might be in need of additional 
treatment for their symptoms as well. Interestingly, a recent RCT study in patients 
who were discharged for coronary heart disease showed that a cognitive behavioral 
therapy intervention focused on stress management on emotional factors as anxiety 
decreased the risk of recurrent myocardial infarction compared to traditional care 35. 
The potential determinants identified in the present study may guide the development 
of such interventions. For example coping strategies with and realistic expectancies 
about somatic co morbidity may be important. 
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Abstract
Background – General anxiety and depressive symptoms following a myocardial 
infarction are associated with a worse cardiac prognosis. However, the contribution 
of specific aspects of anxiety within this context remains unclear.
Aim – To evaluate the independent prognostic association of cardiac anxiety with 
cardiac outcome after myocardial infarction (MI).
Methods – We administered the Cardiac Anxiety Questionnaire (CAQ) during 
hospitalization (baseline, n=193) and four months (n=147/193) after discharge. 
CAQ-subscale-scores reflect fear, attention, avoidance and safety-seeking behavior. 
Study-endpoint was a major adverse cardiac event (MACE): readmission for ischemic 
cardiac disease or all-cause-mortality. In Cox regression analysis, we adjusted for age, 
cardiac disease severity, and depressive symptoms.
Results – The CAQ-sum-score at baseline and at 4 months significantly predicted 
MACE (HRbaseline= 1.59, 95% CI 1.04-2.43; HR4-months= 1.77, 95%CI 1.04-3.02) with 
a mean follow-up of 4.2 (sd=2.0) years and 4.3 (sd=1.7) years respectively. Analyses 
of subscale-scores revealed that this effect was particularly driven by avoidance 
(HRbaseline 1.23, 95% CI 0.99-1.53, HR4-months=1.77, 95% CI 1.04-3.02).
Conclusions – Cardiac anxiety, particularly anxiety-related avoidance of physical 
exercise, is an important prognostic factor for MACE in MI-patients, independent of 
cardiac disease severity and depressive symptoms. 
Keywords – anxiety, cardiac, myocardial infarction, cardiovascular prognosis, 
depression, heart. 
Chapter 5
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Introduction
Potential factors that determine cardiac prognosis after a myocardial infarction (MI) 
include demographic and clinical parameters, health behaviors, and psychiatric 
morbidities. Recently, the impact of anxiety symptoms on cardiac prognosis in heart 
disease patients has gained more attention. In a meta-analysis, post-MI anxiety was 
associated with a 36% increased risk of adverse cardiac outcomes 1. Although this 
meta-analysis could not adjust for measures of disease severity, effect estimates of 
included studies that did adjust for measures of disease severity were only slightly 
or not attenuated 1. Also, generalized anxiety disorder (GAD) was related to adverse 
outcomes in MI patients and this relationship was not explained by cardiac disease 
severity parameters 2. In contrast, other studies described no association 3-5 or even 
a beneficial association in MI patients 6,7 and stable coronary artery disease (CAD) 
patients 8 between anxiety and cardiac prognosis. Furthermore, a recent study in 
CAD patients undergoing coronary artery bypass graft surgery showed different 
associations of different types of anxiety with cardiac prognosis: no association of the 
fear and panic disorders and their symptom dimensions, but an adverse association 
with GAD 9. These controversy findings suggest that different types of anxiety may be 
differently related with cardiac prognosis.
As it remains unclear which specific aspects of anxiety are associated with cardiac 
prognosis, the need to examine the unique contribution of types of anxiety on 
cardiovascular risk has been advocated 1,10. Recently, a population-based study found 
that worry predicted non-fatal cardiac outcome over a three-year follow-up, whereas 
panic and phobia did not 11. Another population-based study suggested that in women 
phobic anxiety may predict fatal but not nonfatal cardiac events 12. 
After a MI, cardiac stimuli and sensations may trigger specific anxiety symptoms, 
conceptualized as cardiac anxiety. This can be assessed reliably by the Cardiac Anxiety 
Questionnaire (CAQ) 13,14. CAQ subscale scores in MI patients reflect fear, attention, 
avoidance of physical exercise, and safety-seeking behavior 14. Higher cardiac anxiety 
is shown to be associated with lower quality of life in MI patients 15. To our knowledge, 
the association between cardiac anxiety and cardiac outcome has not been examined 
previously.
Furthermore, in most studies anxiety symptoms are measured directly after 
hospitalization or surgery 1, which may inflate the rates of psychopathology due to 
the temporary distress of hospitalization. Long-term functional outcome may only 
be affected by psychopathological symptoms that persist, or develop during the first 
weeks as has been demonstrated for depressive symptoms 16. Previously, we showed 
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that trajectories of cardiac anxiety after a MI are largely determined within the first 
three to four months after the event 15.
The aim of the present study was to explore the impact of self-reported cardiac anxiety 
at both hospitalization and at four months after discharge on cardiac prognosis after 
a MI. We hypothesized that patients reporting elevated symptoms of cardiac anxiety 
had the worst cardiac prognosis independent from potential confounders like cardiac 
disease severity and depressive symptoms. 
Methods
Study population
For the present analysis we included MI-patients enrolled in an exploratory 
prospective cohort study described previously 15. Patients consecutively hospitalized 
with MI between November 2006 and December 2007 to the department of cardiology 
of Radboud University Medical Centre, the Netherlands, were recruited within two 
days after admission. Eligible patients had to be diagnosed with ST-Elevated (STEMI) 
or Non ST-Elevated MI (NSTEMI). The diagnosis was confirmed by the presence 
of a rise and fall of troponin I (>0.20 μg/l). Exclusion criteria were: age above 85 
years, discharge out of the hospital within two days of admission, and inability to fill 
out questionnaires (due to insufficient knowledge of the Dutch language, cognitive 
impairment or being too ill to participate). 
The study protocol was approved by the local Medical Ethics Committee, and all 
patients provided written informed consent. 
Procedure
Between days 2 and 7 after admission (baseline), patients completed a set of self-
report-questionnaires including the Cardiac Anxiety Questionnaire (CAQ) 13,14  and 
the Beck Depression Inventory (BDI) 17. At four months after discharge patients were 
sent the same questionnaires by post. If necessary, patients were contacted by phone 
as a reminder. 
Measures
Assessment of Cardiac Anxiety
Cardiac anxiety was assessed with the 18-item self-report-questionnaire CAQ, rating 
each item on a 5-point Likert scale ranging from 0 (never) tot 4 (always) 13. In line 
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with previous publications, the overall score as well as subscale scores are expressed 
as an average item score, which was computed by summing the score on the relevant 
items and dividing it by the number of items. The CAQ is well-validated in different 
populations, originally by Eifert et al. (2000) 13,14,18 . Recently we cross-validated the 
CAQ in MI patients and identified a factor structure of four subscales: assessing fear 
(e.g. “When I have chest discomfort, or when my heart is beating fast: I get frightened”), 
attention (e.g. “I pay attention to my heart beat”), avoidance of (physical) activity (e.g. 
“I avoid activities that make my heart beat faster”) and safety seeking behavior (e.g. 
“When I have chest discomfort or when my heart is beating fast, I like to be checked 
out by a doctor”) respectively 14. Our study showed a good internal consistency of 
both total and subscale scores (Cronbach α 0.84 and 0.6-0.9 respectively), a high test-
retest-reliability (0.88, p<.001) and low to moderate correlations with questionnaires 
such as the Agoraphobic Cognitions Questionnaire (0.31), the State-Trait-Anxiety 
Inventory (0.39) and the Beck Depression Inventory (0.27). Comparable results, 
including the four subscales, have been previously reported in an independent cross 
validation study in 658 persons referred for screening for coronary artery disease 
18.We confirmed the four subscales factor solution on the present data. In the present 
study, our main predictors were the continuous overall mean item score of the CAQ 
(i.e. total score divided by number of items),  as well as the mean item score of the 
subscales.
Assessment of covariates
Socio-demographic and cardiac-related variables
Socio-demographic and clinical data concerning the severity of the cardiac disease 
(left ventricular ejection fraction  (LVEF) and a history of MI), as well as relevant 
cardiac risk factors (including smoking, hypertension, hypercholesterolemia, diabetes 
mellitus, history of stroke, peripheral atherosclerotic disease, history of cardiac 
disease other than MI) were collected by the cardiologist during hospitalization 
for the MI. LVEF was determined by echocardiography according to the modified 
Simpson’s rule 19. Information on possible treatment with PCI and assignment for 
cardiac rehabilitation after admission was retrieved from the hospital files.
Psychiatric comorbidity
Anxiety often coincides with depression in MI patients 20. Two meta-analyses have 
identified depression in MI-patients as a risk factor for all-cause mortality, cardiac 
mortality, and cardiac events 21,22. In order to adjust for depression as a covariate, 
depressive symptoms were measured with the Beck Depression Inventory (BDI), a 
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21-item self-report-questionnaire rating each item on a 4-point Likert scale, which is 
well-validated in MI patients 17,23. 
Assessment of adverse outcomes
The primary outcome was a major cardiac adverse event (MACE), defined by all-
cause mortality or a re-admission for a major cardiac event, occurring after the CAQ 
assessment at baseline or four months after discharge respectively. 
Hospital re-admissions with discharge diagnoses with ICD-9 codes 410, 411, 413, 
414 (ischemic heart disease); 427.4 (Ventricular fibrillation and flutter), 427.5 
(cardiac arrest) and/or readmissions for an acute (unplanned) coronary intervention 
(coronary artery bypass graft/ percutaneous coronary intervention) were included as 
a major cardiac event 24. Data on all-cause mortality were obtained up until 01 January 
2013 from the Dutch Central Bureau of Statistics by linkage to the municipal personal 
records database. Data concerning hospital admissions came from the Dutch national 
registry of hospital discharges and were obtained up until 01 January 2012 from 
the Dutch Central Bureau of Statistics by linkage to the municipal personal records 
database. Furthermore, in order to obtain more complete data, we also examined 
the administration and patient records of the Radboud University Medical Centre 
on readmissions for MACE and/or mortality. These data were obtained up until 01 
January 2013.
Statistical analysis:
Multiple Imputation Model:
In order to use all available data for survival analysis, we performed multiple 
imputations in patients with data on MACE. Rubin’s rules were used to pool the data 
25. Linear and logistic regression for multiple imputations was performed with all 
variables to be included in the final analysis model, as well as other relevant variables 
that were not included in the analyses, including cardiac risk and disease variables, PCI 
treatment and assignment to cardiac rehabilitation. These variables were examined for 
normal distribution and if needed transposed before the imputation was run: BDI was 
Natural Log-transformed. In total, 7.0% of all values in the imputation model were 
missing. 67 datasets were created, because 67.0% of the cases had at least one missing 
value 26. For each imputed file, SPSS calculated in 100 iterations the best model fit.
Baseline:
Baseline demographic and clinical characteristics were compared with logistic 
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regression (for categorical variables), Student’s t-test, or when continuous variables 
were not normally distributed with the Mann Whitney U test.
Correlation and Survival analysis:
The correlation between sum scores of the CAQ and the BDI was evaluated with 
Spearman’s rho. 
Cox regression was used to evaluate risk of MACE associated with CAQ sum scores at 
baseline and at four months after discharge. Next, using Cox regression the association 
between each of the four CAQ subscales at baseline and at four months after discharge 
with MACE was evaluated. For analyses with CAQ at hospitalization as determinant, 
the follow-up period for the primary endpoint started at hospitalization for index-
MI. For analyses with CAQ at 4 months after index-MI as determinant, the follow-
up period for the primary endpoint started at the date of this CAQ assessment. In 
all analyses the follow-up period for primary endpoints ended at 01-01-2013, and 
patients who did not have the outcome of interest until 01-01-2013 were censored on 
01-01-2013.
In the basic model, adjustments were made for age and gender. A priori we decided to 
adjust for a history of MI and LVEF as objective parameters of cardiac disease severity, 
as both have been shown to be consistently related to worse cardiac prognosis. In 
addition, since cardiac related hospital readmissions between baseline and four 
months also reflect cardiac disease severity, we adjusted for this characteristic when 
examining the CAQ score at 4 months after discharge. In the final model, we also 
adjusted for BDI-scores.
Sensitivity analyses:
Post-hoc sensitivity analyses were performed in order to further adjust separately 
for possible confounders. In the basic model we tested those characteristics that at 
baseline differed between patients with and without a MACE. 
Furthermore, sex-effects were explored post-hoc as depression has a higher impact 
on mortality in males compared to females 27, although other studies with respect 
to cardiac prognosis did not find sex-specific effects 28,29. For the latter sensitivity 
analysis, we included this interaction variable in the regression model for multiple 
imputations.
For all analyses, SPSS 20 for Windows was used and significance level was set at 0.05, 
two-tailed.
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Results
Sample
Of 398 MI patients admitted at the cardiology ward, 135 patients were after primary 
PCI relocated to a hospital in their home area within two days of admission. Of the 263 
patients who were still present at the time we asked informed consent, 203 patients 
(77%) agreed to participate. Ten persons had to be excluded because of missing data 
on MACE, leaving 193 patients to be analyzed for the association between CAQ at 
baseline and MACE. Baseline characteristics, resulting from the imputational model, 
for the 193 patients stratified according to occurrence of MACE are shown in Table 1. 
Please note that four persons died before the assessment four months after discharge, 
leaving 189 persons to be analyzed for the association between CAQ at four months 
after discharge and MACE. 
The mean (SD) duration of assessment of CAQ and BDI was at baseline 3.7 (3.8) days 
from hospitalization (or index MI). The follow-up assessment took place 138.8 (59.4) 
days from hospitalization. A total of 77.8% (n=147/189) patients completed the CAQ 
at follow up. Sum scores of CAQ and BDI were moderately correlated at hospitalization 
(Spearman ρ=0.332, p<0.001)) and highly at four months after discharge (Spearman 
ρ=0.501, p<0.001).
Predictors of MACE 
During a mean (SD) follow-up period of 4.2 (2.0) years, 77 (39.9%) of 193 patients 
had a MACE after baseline (36 of them (46.8%) died). During a mean (SD) follow-up 
period of 4.3 (1.7) years, 67 (35.4%) of 189 patients had a MACE after four months 
(32 of them (47.8%)  died). Patients who had an event during the follow-up period 
were significantly older (p<0.001), had significantly higher CAQ scores at baseline 
(p=0.018) and were significantly more likely to have a comorbid cardiac disease 
(p<0.001), diabetes mellitus (p=0.002), lung cancer (p=0.029) and a positive cardiac 
history (p<0.001) (see Table 1).
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Table 1: Baseline characteristics of 193 MI patients divided according to incidence 
of MACE (yes/no) a
MACE No MACE Test statistic
(n=77) (n=116) OR b t-test U-test P
Age, mean (SD) 66.0 (11.6) 58.7 (11.0) 4.394 <0.001***
Male (%) 46 (59.7%) 83 (71.6%) 0.590, 0.089
Stable relation 57 (74.0%) 97 (83.6%) 1.791 0.107
High education1 (%)  20 (26.0)% 30 (25.9%) 0.981 0.953
Hypertension (%) 40 (51.9%)  45 (38.8%) 0.586 0.072
Diabetes Mellitus (%) 21 (27.3%)  12 (10.3%) 0.308 0.003**
Hypercholesterolemia (%) 22 (28.6%)  33 (28.4%) 0.994 0.985
History of MI (%) 41 (53.2%) 21 (18.1%) 0.194 <0.001***
History of cardiac disease 
other than MI c (%)
30 (39.0%) 11 (9.5%) 0.164 <0.001***
Peripheral atherosclerotic 
disease (%)
 14 (18.2%) 14 (12.1%) 0.618 0.241
History of stroke (%)  3 (3.9%) 4 (3.4%) 0.881 0.871
Smoker at inclusion (%) 38 (49.4%) 45 (38.8%) 1.58 0.157
Family history of cardiac 
disease (%)
 34 (44.2 %)  51 (44.0%) 0.993 0.982
LVEF%, mean(SD)  51.9 (12.7)  54.2 (10.3) 1.164 0.245
CAQ hospitalization, mean 
(SD)
 1.5 (0.6) 1.3 (0.6) 2.333 0.020*
CAQ 4 months post MI, 
mean (SD)
 1.3 (0.7)  1.0 (0.6) 2.908 0.004**
BDI hospitalization (IQR)  6.8  (4.0-12.0) 6.0 (3.9-9.5) 3484 0.2573
BDI 4 months post MI (IQR)  7.0 (4.8-11.0)  4.0 (2.0-8.0) 1758.5 0.0023**
PCI (%) 44 (57.1%) 73 (62.9%) 1.28 0.412
Assigned for cardiac reha-
bilitation (%)
35 (45.5%) 87 (75.0%) 3.56 0.001**
a. Rubin’s rules were used to pool the data of the imputed datasets25 
SD=Standard deviation; T=T test ; OR=Odds ratio; IQR=interquartile range; PCI=Percutaneous 
Coronary Intervention
b. We report OR (based on univariate analysis) for all categorical variables 
1The categorical variables high education, smoker at inclusion and family history of cardiac disease 
were (party) imputed. 
c. Including e.g. stable angina pectoris, endocarditis, heart failure and atrial fibrillation 
 
*p<0.05; **p<0.01; ***p<0.001
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CAQ sum score and risk of MACE
CAQ at baseline was significantly associated with a higher risk of MACE, independent 
of age and sex, LVEF and cardiac history, and BDI. CAQ at four months after discharge 
was also significantly associated with a higher risk of MACE, even when adjusted 
for age, sex, LVEF, cardiac history, cardiac related hospital readmissions between the 
index event and CAQ assessment and BDI (see Table 2 for Hazard Ratios (95% CI).
Subscales of CAQ at four months after discharge and risk of MACE 
Only the subscale “Avoidance” at four months after discharge was significantly 
associated with MACE independent from all previously mentioned covariates. The 
prognostic association of “Avoidance” at baseline lost significance after adjusting for 
severity of cardiac disease (see Table 3 for HR’s (95% CI)). 
Sensitivity analyses potential cardiac risk factors
In sensitivity analyses, we tested whether characteristics that differed at baseline 
between patients with and without MACE and were not included in our model, 
might have influenced our results. Adding these variables (see Table 1) to model 2 did 
virtually not affect the association between overall CAQ score and adverse prognosis. 
The only exception was the presence of a history of cardiac disease other than MI: 
in this model the HR for CAQ at baseline and MACE was attenuated to just non-
significant (HR: 1.43 (0.96-2.11); p=0.076). 
Sensitivity analyses sex differences in overall CAQ score and risk of MACE
We found an interaction effect between sex with overall CAQ score in the prognostic 
model (included variables: CAQ, sex, age, interaction sex-CAQ) at baseline (HRbaseline 
2.16, 95% CI 1.03-4.56, p=0.043; HRfourmonths  2.78, 95% CI 1.00-7.72, p=0.050). 
Stratified analyses showed larger HRs and more significant results in the females 
compared to the males. Only in females, the full model remained significant for the 
CAQ at baseline (HR 3.04 (1.47-6.28); p=0.003; n=64 of which n=31 had a MACE 
during follow-up), whereas the HR for the CAQ at four months lost significance after 
additional adjustment for BDI (HR 2.17 (0.78-6.07); p=0.139; n=62 of which n=27 
had a MACE during follow-up) (see supplemental Tables A-C).
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Table 2: Hazard ratio’s (95% CI) for MACE associated with scores on the CAQ 
during hospitalization and at 4 months after discharge
Hazard ratio (95% CI)
CAQ sum score at hospitalization
N=77/193
CAQ sum score at approximately 4 
months after discharge
N=67/189
p R2 (%) p R2(%)
Model 1 1.70 (1.16-2.46) 0.006** 4.1 2.09 (1.38-3.17) 0.001** 8.0
Model 2 1.64 (1.14-2.38) 0.008** 13.1 2.04 (1.30-3.19) 0.002** 12.9
Model 3 1.52 (1.03-2.23) 0.034* 22.6 2.00 (1.24-3.23) 0.005**  20.3
Model 4 1.59 (1.04-2.43) 0.033* 22.8 1.77 (1.04-3.02) 0.036*  21.1
*p<0.05; **p<0.01; ***p<0.001
Rubin’s rules were used to pool the data of the imputed datasets (Rubin 1987)
The explained variance (R2) for Cox regression was estimated according based on the log likelihood as 
proposed in Hosmer at al. 30..
Model 1: unadjusted; 
Model 2: adjusted for age and sex
Model 3: Model 2 + LVEF, history of MI, and hospital readmissions between the index event and CAQ 
assessment four months after discharge in the model evaluating HR at four months.
Model 4: Model 3 + transformed BDI-score at same time as cardiac anxiety assessment (i.e. at baseline or 
4 months after discharge, respectively)
BDI: Beck Depression Inventory; CAQ: Cardiac Anxiety Questionnaire; CI: confidence interval; LVEF: left 
ventricular ejection fraction; MACE: major adverse cardiac event; MI: myocardial infarction; baseline as-
sessment 3.7 (3.8) days from hospitalization; assessment 4 months after discharge 138.8 (59.4) days from 
hospitalization  
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Table 3: Hazard ratio’s (95% CI) for MACE associated with scores on the four CAQ 
subscales during hospitalization and at 4 months post-MI 
Baseline 
(77 persons out of a total of 193 had a MACE 
during follow- up)
4 months after discharge 
(67 persons out of a total of 189 had a MACE during 
follow- up)
Fear Avoid-
ance
Atten-
tion
Safety 
seeking
Fear Avoidance Attention Safety 
seeking
M
o
d
el
 1
1.29 
(0.95-
1.75); 
p=0.104; 
R2=1.3%
1.34  
(1.10-
1.64); 
p=0.003** 
R2=5.0%
1.02   
(0.73-
1.42); 
p=0.917 
R2=0.0%
1.29   
(1.01-
1.66); 
p=0.046* 
R2=2.1%
1.27  
(0.95-
1.70); 
p=0.114 
R2=2.7%
1.64  
(1.32-2.04); 
p<0.001** 
R2=10.3%
1.41  
(0.93-
2.12); 
p=0.106 
R2=1.9%
1.13  
(0.85-1.50); 
p=0.416 
R2=0.6%
M
ed
el
 2
1.33  
(0.98-
1.80); 
p=0.067 
R2=11.2%
1.31  
(1.08-
1.59); 
p=0.007** 
R2=13.5%
1.08  
(0.78-
1.50);  
p=0.625 
R2=9.9%
1.20  
(0.94-
1.54);  
p=0.137 
R2=10.8%
1.24  
(0.93-
1.66); 
p=0.138 
R2=8.6%
1.60 
 (1.26-2.02); 
p<0.001*** 
R2=14.2%
1.54  
(0.99-
2.39); 
p=0.054 
R2=9.0%
1.07  
(0.80-1.42); 
p=0.665 
R2=6.6%
M
o
d
el
 3
1.30  
(0.94-
1.81); 
p=0.119 
R2=21.7
1.23  
(1.00-
1.51); 
p=0.053 
R2=22.4%
1.05  
(0.76-
1.46); 
p=0.761 
R2=20.8%
1.25  
0.97-
1.61); 
p=0.084 
R2=22.0%
1.25  
(0.93-
1.68); 
p=0.146 
R2=17.1%
1.51  
(1.18-1.95); 
p=0.001** 
R2=20.4%
1.52  
(0.98-
2.36); 
p=0.062 
R2=17.3%
1.10  
(0.80-1.50); 
p=0.557 
R2=15.5%
M
o
d
el
 4
1.32  
(0.92-
1.90) 
p=0.1436 
R2=21.8%
1.23  
(0.99-
1.53); 
p=0.060 
R2=22.5%
1.04  
(0.74-
1.45); 
p=0.843 
R2=20.8%
1.25  
(0.96-
1.62); 
p=0.093 
R2=22.0%
1.09  
(0.78-
1.53); 
p=0.616 
R2=19.0%
1.41  
(1.07-1.86); 
p=0.014* 
R2=21.7%
1.45  
(0.92-
2.28); 
p=0.111 
R2=20.2%
1.07  
(0.78-1.46); 
p=0.690 
R2=18.8%
*p<0.05; **p<0.01; ***p<0.001 
The explained variance (R2) for Cox regression was estimated according based on the log likelihood as 
proposed in Hosmer et al. 30.
Model 1: unadjusted; 
Model 2: adjusted for age and sex
Model 3: Model 2 + LVEF and history of MI, and hospital readmissions between the index event and 
CAQ assessment four months after discharge in the model evaluating HR at four months.
Model 4: Model 3 + transformed BDI-score at same time as CAQ assessment (i.e. baseline or 4 months 
after discharge respectively).
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Supplemental Table A: Hazard ratio’s (95% CI) for MACE (and n with event/n) 
associated with scores on the CAQ during hospitalization and at 4 months after 
discharge in 193 MI patients
Male patients (n=129) Female Patients (n=64)
Hazard ratio (95% CI) Hazard ratio (95% CI)
Cardiac anxiety at 
hospitalization
Cardiac anxiety at 4 
months post-MI
Cardiac anxiety at 
hospitalization
Cardiac anxiety at 4 
months post-MI
M
o
d
el
 1
1.42 (0.88-2.29); 
p=0.156; 
n= 46/129 
R2=1.1%
1.94 (1.17-3.24;)
p=0.011*;  
n=40/127 
R2=4.1%
2.54 (1.41-4.57); 
p=0.002**; 
n=31/64 
R2=4.9%
2.63 (1.13-6.10); 
p=0.025*; 
n=27/62 
R2=4.8%
M
o
d
el
 2
1.24 (0.78-1.95); 
p=0.364; 
n=46/129 
R2=6.7%
1.90 (1.11-3.25); 
p=0.019*; 
n=40/127 
R2=7.1%
2.55(1.40-4.65); 
p=0.002** 
n=31/64 
R2=6.9%
2.41 (1.03-5.86); 
p=0.043*; 
n=27/62 
R2=5.4%
M
o
d
el
 3
0.09 (0.55-1.47); 
p=0.671; 
n=46/129 
R2=17.9%
1.65 (0.92-2.97); 
p=0.094; 
n=40/127 
R2=14.0%
2.75 (1.47-5.17); 
p=0.002**; 
n=31/64 
R2=8.9%
2.79 (1.09-7.11); 
p=0.032*; 
n=27/62 
R2=8.4%
M
o
d
el
 4
0.96 (0.55-1.68); 
p=0.880; 
n=46/129 
R2=18.0%
1.56 (0.80-3.04); 
p=0.194;  
n=40/127 
R2=14.4%
3.04 (1.47-6.28); 
p=0.003**; 
n=31/64 
R2=9.1%
2.17 (0.78-6.07); 
p=0.139; 
n=27/62 
9.7%
*p<0.05; **p<0.01; ***p<0.001
Model 1: unadjusted; 
Model 2: adjusted for age 
Model 3: Model 1 + LVEF and cardiac history, and hospital readmissions between the index event and 
CAQ assessment four months after discharge in the model evaluating HR at four months.
Model 4: Model 3 + transformed BDI-score at same time as cardiac anxiety assessment 
BDI: Beck Depression Inventory; CAQ: Cardiac Anxiety Questionnaire; CI: confidence interval; LVEF: left 
ventricular ejection fraction; MACE: major adverse cardiac event; MI: myocardial infarction
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Supplemental Table B: Hazard ratio’s (95% CI) for MACE (and n with event/n) 
associated with scores on the 4 CAQ subscales during hospitalization 
MALES FEMALES
Fear Avoidance Attention Safety 
seeking
Fear Avoidance Atten-
tion
Safety 
seeking
M
o
d
el
 1
1.12  
(0.77-
1.64); 
p=0.548; 
n=46/129 
R2=0.2%
1.30  
(1.00-
1.68); 
p=0.046*; 
n=46/129 
R2=2.3%
0.95  
(0.63-
1.45);  
p=0.819 
n=46/129 
R2=0.0%
1.12  
(0.80-
1.57);  
p=0.499; 
n=46/129 
R2=0.2%
2.06  
(1.16-
3.68); 
p=0.014*; 
n=31/64 
R2=3.0%
1.47 
(1.10-1.97); 
p=0.009**; 
n=31/64 
R2=3.7%
1.21  
(0.68-
2.18); 
p=0.518; 
n=31/64 
R2=0.2%
1.61  
(1.33-
1.94); 
p=0.012*; 
n=31/64 
R2=3.2%
M
o
d
el
 2
1.10 
(0.76-
1.58); 
p=0.621; 
n=46/129 
R2=6.4%
1.19  
(0.92-
1.54); 
p=0.192; 
n=46/129 
R2=7.3%
1.03  
(0.70-
1.54); 
p=0.868; 
n=46/129 
R2=6.3%
1.00  
(0.72-
1.37); 
p=0.975; 
n=46/129 
R2=6.3%
2.05 
(1.15-
3.69); 
p=0.016*; 
n=31/64 
R2=5.0%
1.49 
(1.11-1.99); 
p=0.008**;  
n= 31/64 
R2=5.9%
1.20  
(0.68-
2.13); 
p=0.526; 
n=31/64 
R2=2.4%
1.51  
(1.25-
1.83); 
p=0.030*; 
n=31/64 
R2=4.5%
M
o
d
el
 3
0.92  
(0.61-
1.39); 
p=0.698; 
n=46/129 
R2=17.9%
0.99  
(0.75-
1.32); 
p=0.963; 
n=46/129 
R2=17.9%
0.89 
(0.59-
1.35); 
p=0.584; 
n=46/129 
R2=18.0%
0.92  
(0.65-
1.31); 
p=0.655; 
n=46/129 
R2=17.9%
2.16  
(1.16-
3.99); 
p=0.015*; 
n=31/64 
R2=6.9%
1.49  
(1.10-2.01); 
p=0.010*; 
n=31/64 
R2=7.3%
1.30  
(0.73-
2.232); 
p=0.369; 
n=31/64 
R2=4.3%
1.59  
(1.08-
2.33); 
p=0.018* 
n=31/64 
R2=6.7%
M
o
d
el
 4
0.97  
(0.61-
1.54); 
p=0.904; 
n=46/129 
R2=18.0%
1.03  
(0.76-
1.39); 
p=0.864; 
n=46/129 
R2=18.1%
0.91  
(0.60-
1.39); 
p=0.657; 
n=46/129 
R2=18.1%
0.95  
(0.66-
1.37); 
p=0.780; 
n=46/129 
R2=18.0%
2.14  
(1.10-
4.16); 
p=0.026*; 
n=31/64 
R2=7.0%
1.50  
(1.06-2.11); 
p=0.022*; 
n=31/64 
R2=7.4%
1.19  
(0.64-
2.24); 
p=0.584; 
n=31/64 
R2=4.7%
1.58 
(1.06-
2.35); 
p=0.023*; 
n=31/64 
R2=7.0%
*p<0.05; **p<0.01; ***p<0.001
Model 1: unadjusted; 
Model 2: adjusted for age 
Model 3: Model 1 + LVEF and cardiac history
Model 4: Model 3 + transformed BDI-score at same time as cardiac anxiety assessment 
BDI: Beck Depression Inventory; CAQ: Cardiac Anxiety Questionnaire; CI: confidence interval; LVEF: left 
ventricular ejection fraction; MACE: major adverse cardiac event; MI: myocardial infarction
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Supplemental Table C: Hazard ratio’s (95% CI) for MACE (and n with event/n) 
associated with scores on the 4 CAQ subscales at 4 months after discharge 
MALES FEMALES
Fear Avoidance Attention Safety 
seeking
Fear Avoidance Attention Safety 
seeking
M
o
d
el
 1
1.26  
(0.80-
1.99); 
p=0.316; 
n=40/127 
R2=1.5%
1.60  
(1.22-2.10); 
p=0.001**; 
n=40/127 
R2=6.2%
1.03  
(0.60-
1.79); 
p=0.904 
n=40/127 
R2=0.1%
1.28  
(0.91-
1.79); 
p=0.158; 
n=40/127 
R2=1.3%
1.28  
(0.83-
1.97); 
p=0.264; 
n=26/62 
R2=1.6%
1.85  
(1.15-2.97); 
p=0.011**; 
n=26/62 
R2=4.8%
2.22  
(1.05-
4.71); 
p=0.038*; 
n=26/62 
R2=3.9%
0.93  
(0.57-
1.51); 
p=0.762; 
n=26/62 
R2=0.2%
M
o
d
el
 2
1.28  
(0.79-
2.08); 
p=0.311; 
n=40/127 
R2=5.2%
1.53  
(1.16-2.03); 
p=0.003**; 
n=40/127 
R2=8.3%
1.15  
(0.64-
2.07); 
p=0.631; 
40/127 
R2=3.9%
1.20  
(0.86-
1.68); 
p=0.286; 
n=40/127 
R2=4.3%
1.24  
(0.82-
1.86); 
p=0.307; 
n=26/62 
R2=2.9%
1.76  
(1.08-2.85); 
p=0.022**; 
n= 26/62 
R2=5.4%
2.13  
(1.01-
4.52); 
p=0.049*; 
n=26/62 
R2=5.2%
0.90  
(0.54-
1.47); 
p=0.663; 
n=26/62 
R2=1.9%
M
o
d
el
 3
1.23  
(0.75-
2.01); 
p=0.413; 
n=40/127 
R2=13.4%
1.34  
(0.98-1.84); 
p=0.065; 
n=40/127 
R2=14.1%
1.07  
(0.58-
1.97); 
p=0.832; 
n=40/127 
R2=12.5%
1.21  
(0.83-
1.75); 
p=0.322; 
n=40/127 
R2=12.9%
1.29  
(0.84-
1.98); 
p=0.249; 
n=26/62 
R2=5.3%
1.85  
(1.10-3.10); 
p=0.020*; 
n=26/62 
R2=7.9%
2.22  
(1.08-
4.55); 
p=0.030*; 
n=26/62 
R2=7.7%
0.99  
(0.58-
1.69); 
p=0.959 
n=26/62 
R2=4.0%
M
o
d
el
 4
1.14  
(0.66-
1.96); 
p=0.646; 
n=40/127 
R2=13.9%
1.30  
(0.92-1.84); 
p=0.140; 
n=40/127 
R2=14.6%
1.02  
(0.54-
1.91); 
p=0.961; 
n=40/127 
R2=13.4%
1.17  
(0.80-
1.71); 
p=0.419; 
n=40/127 
R2=13.7%
1.05 
(0.65-
1.70); 
p=0.837; 
n=26/62 
R2=8.1%
1.61  
(0.92-2.82); 
p=0.098; 
n=26/62 
R2=10.0%
2.15  
(1.08-
4.31); 
p=0.030*; 
n=26/62 
R2=11.1%
0.94  
(0.51-
1.74); 
p=0.850; 
n=26/62 
R2=8.1%
*p<0.05; **p<0.01; ***p<0.001
Model 1: unadjusted; 
Model 2: adjusted for age 
Model 3: Model 1 + LVEF and cardiac history + hospital readmissions between the index event and CAQ 
assessment four months after discharge
Model 4: Model 3 + transformed BDI-score at same time as cardiac anxiety assessment 
BDI: Beck Depression Inventory; CAQ: Cardiac Anxiety Questionnaire; CI: confidence interval; LVEF: left 
ventricular ejection fraction; MACE: major adverse cardiac event; MI: myocardial infarction 
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Discussion
Main finding
This study was the first to address the independent prognostic association of cardiac 
anxiety following myocardial infarction with adverse cardiac prognosis. Patients 
reporting higher cardiac anxiety were at increased risk of adverse prognosis after 
adjustment for age, gender, cardiac disease severity parameters and depressive 
symptoms; with each point increase on the CAQ, which has a possible range of 0 to 4, 
the risk of a new cardiac event increased from 56% (at baseline) to 71% (at 4 months 
after discharge). This effect seemed to be particularly driven by avoidance behavior. 
 Our findings are in line with previous research reporting the prognostic impact of 
anxiety 1 and anxiety disorders 2,29,31 in MI patients. These heterogeneous studies used 
different anxiety measures and the reported HRs in the meta-analysis (around 1.30) 1 
were based on dichotomous cut off points of anxiety (present or not) which makes it 
difficult to compare the reported HRs with ours. One study evaluated the prognostic 
association of separate dimensions of anxiety in MI patients. It also described an 
adverse prognostic association: significant associations for somatic anxiety (HR 1.29) 
and total anxiety (HR 1.38), with a trend for psychological anxiety 32. However, these 
anxiety dimensions were derived from a questionnaire assessing general anxiety 
(Hamilton Anxiety and Depression Rating Scales) and all dimensions are more or 
less associated with avoidance behavior. These general findings are extended by our 
findings showing the most specific results for avoidance behavior related to cardiac 
stimuli, especially at four months after discharge. 
For depression the reported HRs are even higher 33, especially when not adjusted 
for cardiac disease severity. In our study, after adjustment for parameters of cardiac 
disease severity, the association remained significant, and more importantly the HRs 
hardly attenuated, implying a prognostic effect of cardiac anxiety independent from 
cardiac disease severity. Adjustment for depressive symptoms did not affect the effect 
size of the cardiac anxiety on adverse cardiac prognosis. This is consistent with other 
studies assessing the association between general anxiety or anxiety disorder and 
cardiovascular events independent from depression 2,31,34. 
Potential mechanisms
The association between anxiety and ischemic heart disease might be explained by 
both behavioral and biological mechanisms. First, anxiety appears to be associated 
with unhealthy behavior (e.g. physical inactivity and smoking) in individuals at risk 
of coronary heart disease 35. Our finding that the main prognostic effect of cardiac 
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anxiety was driven by the subscale assessing avoidance of physical activity supports 
this. Surprisingly though, in our study patients reporting higher anxiety less often 
smoked. Although this is in contrast with a recent finding suggesting less adherence 
of anxious MI patients to risk reducing recommendations like cessation of smoking 
36, this difference might be caused by the type of anxiety (general versus cardiac) 
examined, or by differences in coping strategies of individual patients.
Unfortunately, our data do not provide any insight into potential biological 
mechanisms explaining the negative association between anxiety and cardiac disease, 
like reduced heart variability, cardiac arrhythmias, and increased platelet activity 
or inflammation 37-39. For example, increased anxiety levels may trigger ventricular 
tachycardia’s in a dose-dependent way and are among patients with implantable 
cardioverter defibrillators associated with a higher number of shocks 40.
Methodological considerations
A strength of the present study is that cardiac anxiety was assessed not only at 
hospitalization but also at four months post-MI, when the possible inflating impact 
of the stressful hospitalization and event itself on anxiety parameters is expected to be 
settled down 15. Importantly, although our sample size was relatively small, it was large 
enough to adjust for several important confounders simultaneously. Nonetheless, 
we were not able to address all indicators of cardiac disease severity. Therefore, we 
adjusted for the two most important indicators, LVEF and a history of a MI, in line 
with previous studies on this topic. However, since cardiac anxiety was inversely 
correlated with cardiac disease severity, as previously reported by our group 41, it 
seems unlikely that our results are driven by residual confounding due to cardiac 
disease severity.
In line with previous studies we chose as primary outcome a combination of all-cause 
mortality and cardiac readmissions. However, while previous studies included a rather 
broad range of cardiovascular events 1,2,21, we only evaluated readmissions for ischemic 
events. We consider this as an advantage. As patients with high cardiac anxiety might 
be more likely to consult their doctor and be admitted to the hospital with cardiac 
complaints, this might partly explain the association between cardiac anxiety and 
cardiovascular-related hospital readmissions. By only including readmissions due to 
acute ischemic events, this risk is minimized.
Although the prognostic association of cardiac anxiety with MACE was particularly 
driven by avoidance of physical activity, it is important to realize that physical activity 
was not assessed in the present study and some of the other dimensions of cardiac 
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anxiety (fear and attention respectively) showed even higher HRs than avoidance. 
The prognostic associations of these subscales were not significant in the final model, 
but this may be explained by a power problem (type two error). Studies in larger 
populations are needed to examine this more closely. Future studies should include 
physical activity as a mediating mechanism when studying the prognostic impact of 
cardiac anxiety.
Limitations of the present study are that we did not assess the presence (and/
or history) of a formal diagnosis of an anxiety and/or depressive disorder, nor did 
we have information on possible psychiatric treatment. Therefore we do not know 
how cardiac anxiety is related to psychiatric diagnosis. As (some) anxiety disorders 
have been associated with the development of coronary heart disease in the general 
population 12,42 and prognosis in patients with heart disease 2,28,29, this would have 
been interesting. Nevertheless, we did adjust for depressive symptoms, which is an 
important possible confounder 21,22. 
Our study had a high response rate of 77% 15, even though we had to exclude the most 
severely ill patients. As on the other hand, patients with milder symptoms who were 
transported to other hospitals within two days were not eligible for the present study, 
it is questionable whether this limits generalization of our results. 
In our study, the association between cardiac anxiety and adverse prognosis could 
not be explained by cardiac disease severity parameters, including LVEF and cardiac 
history. Nevertheless, it is still possible that the association is confounded by disease 
severity, especially since some symptoms of cardiac anxiety, such as chest pain, 
might also be symptoms of heart disease. However, most items in the CAQ focus on 
the impact of these symptoms on affect (anxious), thought (worrying) or behavior 
(avoidance and safety seeking behavior).
Although the HRs were particularly large for women, the sex-specific findings should 
be considered preliminary due to lack of statistical power. Moreover, the sex-effect 
was opposite to that found for the association between depression and mortality in 
cardiac patients 27 and two smaller studies with underrepresentation of women did 
not find sex-effects 28,29. Therefore, future studies examining anxiety should preferably 
examine possible interaction effects with sex.
Clinical implications 
The present findings of a prognostic association with MACE, independent from 
cardiac disease severity and depressive symptoms, stress the potential clinical impact 
of cardiac anxiety. Interestingly, when looking at the CAQ score alone, the explained 
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variance increased in the follow up model compared to the baseline measurement (4% 
and 8% respectively), indicating the importance of identifying (persisting) cardiac 
anxiety symptoms in the months post MI. Diagnosing elevated cardiac anxiety 
symptoms and its specific subtypes can be helpful in developing specific interventions 
reducing maintaining or exacerbating factors such as avoidance of cardiac stimuli 
and physical exercise. Cognitive behavioral therapy (CBT) may target anxiety-related 
avoidance behavior which may even result in a better cardiac outcome. General CBT 
focused on stress management has been shown to improve cardiac outcome over 8 
years post MI 43. 
For this reason, cardiac anxiety should be explicitly addressed in cardiac rehabilitation 
programs. Whereas there is awareness for general anxiety in cardiac rehabilitation and 
recent studies did pay attention to specific types of anxiety recognized by the DSM like 
generalized anxiety disorder 9, cardiac anxiety may in fact be relatively unexplored. 
Outcomes of cardiac rehabilitation programs might even further improve if physical 
exercise is used as a behavioral experiment to test out specific cardiac fears patients 
may have. So, the findings of the present study indicate the need to evaluate and target 
cardiac anxiety- in addition to depression and general anxiety- in the future.
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Abstract
Background – Self-rated general health has been associated with worse outcome after 
a myocardial infarction (MI). In previous research, however, concurrent depression 
or anxiety were not taken into account.
Objective – To evaluate the impact of physical health complaints on the prognosis of 
MI adjusting for cardiac disease severity, depression and anxiety.
Methods – The somatic subscale of the Health Complaints Scale (HCS) was 
administered to 424 MI-patients at 3 and 12 months post-MI. Types and trajectories 
of health-complaints were identified with latent-transition-analysis (LTA). The 
prognostic impact of HCS-sum-score at 3 months, and of types and trajectories of 
health-complaints on combined endpoints of new cardiac events and mortality was 
evaluated with Cox-regression. Adjustments were made for age, sex, education-level, 
history of MI, left ventricular ejection fraction, depressive symptoms and generalized 
anxiety disorder. 
Results – 192 (45.3%) MI-patients, had a new cardiac event or died during a mean 
follow-up of 5.7 (3.1) years. In the fully adjusted model HCS-sum-score predicted 
outcome (HR=1.03 [95% CI: 1.01-1.05]). LTA distinguished 5 groups at both 3 and 12 
months characterized by  1) no/minimal symptoms, 2) cardiac complaints, 3) lack of 
energy, 4) sleep-problems, and 5) mixed health-complaints, resulting in 25 transition-
classes. Patients with cardiac complaints at 3 months (HR=1.55 [1.15-2.10]) and those 
with new or persistent cardiac, energy and mixed complaints over time had a worse 
prognosis (HRcardiac=1.55 [1.11- 2.16], HRmixed=1.71 [1.19- 2.47], HRenergy=1.50 
[1.09-2.07]). 
Conclusions – Physical health-complaints are predictors of cardiac outcome 
independent from cardiac disease, depression and anxiety. Type and trajectories of 
health-complaints may have additional prognostic significance.
Keywords – myocardial infarction, energy complaints, cardiac complaints, sleep 
complaints, cardiovascular prognosis, depression, anxiety, physical health.
Chapter 6
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Introduction
Cardiovascular disease, in particular myocardial infarction (MI), is one of the leading 
causes of death in industrialized countries 1. Numerous studies identified factors that 
are associated with cardiac prognosis, including demographics, like age and gender, 
and clinical factors such as hypertension, diabetes and severity of the MI. A systematic 
review describing 34 prospective cohort studies showed that self-rated physical health 
status predicts an adverse cardiac prognosis, even when adjusted for objective disease 
severity 2. In the 7 studies specifically conducted in MI-patients 3-9, neither the severity 
of the MI nor the follow-up time had impact on the predictive value of self-rated health 
status. This suggests a robust predictive effect of self-rated physical health status on 
adverse prognosis in MI patients over and above traditional objective cardiac disease 
severity measures 2. Therefore, health complaints might serve as a valuable low-cost 
addition in the process of risk-stratification, particularly because they are not always 
in agreement with what clinicians observe 10,11. However, self-rated health status is not 
yet mentioned in clinical guidelines for the secondary prevention of cardiovascular 
disease 12,13. 
A limitation of previous studies on self-rated health status and cardiac prognosis is 
that they did not take depression and/or anxiety into account 2,14. Depression and 
anxiety are associated with worse cardiac prognosis following MI 15,16. These findings 
are robust and based on both self-reported depressive or anxiety symptoms and 
clinical diagnoses, like post-MI depression or generalized anxiety disorder. Since 
patients with affective symptoms rate their physical health more negatively 17, the 
impact of self-rated health status on cardiac prognosis may be confounded by affective 
symptoms.  
Another limitation of most previous studies on self-rated health after MI and cardiac 
prognosis is that they did not distinguish between different types of health complaints, 
while there is evidence that different types of complaints can be distinguished in MI 
patients. Factor analysis on the somatic subscale of the Health Complaints Scale 
(HCS) yielded three dimensions: cardiac complaints, sleep complaints, and fatigue/
energy complaints in MI patients 18,19. In another study, in 418 MI patients, principal 
components analysis on the Hospital Anxiety Depression Scale yielded a distinction 
between cardiopulmonary/autonomic symptoms, sleep problems and fatigue/energy 
complaints. Of these three somatic dimensions, only cardiopulmonary/autonomic 
symptoms were related to worse cardiac prognosis 20. These findings suggest  that, 
of the different types of somatic health complaints after MI, particularly cardiac 
complaints may be predictive of cardiac prognosis.
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Finally, most previous studies used only one assessment of self-rated health status. 
However, a single assessment of self-rated physical health may be more prone to 
bias caused by the stress of a recent vascular event.  For example, some patients may 
perceive their health in a less positive way shortly post-MI, but their self-rated health 
perception may improve during time. Therefore, the course over time in self-rated 
health status may be a more accurate predictor of cardiac prognosis. In support of this, 
a recent study in 640 MI patients showed that patients who reported an improvement 
in their physical health status from before to after the MI were more likely to survive 
event-free throughout the next 13 years 14. This effect remained significant when 
adjusted for multiple cardiac risk factors, including cardiac severity and self-rated 
physical health in the year before the MI. Additionally, in two other studies in heart 
failure and MI patients respectively, changes over time in self-rated health provided 
additional predictive value for adverse cardiac outcomes and mortality beyond a 
single assessment of self-rated health 6,21.  
The aim of the present study was to evaluate whether physical health complaints 
predict cardio-vascular events and all-cause mortality in MI-patients, when adjusted 
for both cardiac disease severity as well as depressive and anxiety comorbidity. In 
addition, the type of physical health symptoms as well as their trajectories over time 
were explored.
Methods
Study design, participants and procedures
For the present analysis MI patients enrolled in the Depression after Myocardial 
Infarction study (DepreMI) were included. DepreMI is a naturalistic cohort study 
evaluating the effects of depression on cardiovascular prognosis up till 10 years 
follow-up in MI patients. Details of this study have been described elsewhere 22-24. The 
study protocol was approved by the local medical ethics committee of each of the four 
participating hospitals. 
Patients hospitalized with MI between September 1997 and September 2000 were 
recruited consecutively from four hospitals in the north of the Netherlands. Eligible 
patients had to meet at least 2 out of the 3 following criteria; (1) chest pain for at least 
20 minutes, (2) increased cardiac enzyme levels, (3) new pathological Q-waves on 
the electrocardiogram in at least two leads. Excluded were those patients with a life 
expectancy of less than a year due to a non-cardiac condition, and inability to fill in 
questionnaires (due to poor physical function, cognitive dysfunction, inability to speak 
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or read Dutch, and/or when follow-up visits were scheduled in a nonparticipating 
hospital). Eligible patients received oral and written information about the DepreMI 
study and were asked to sign informed consent.
A total of 1166 patients hospitalized for MI were screened on eligibility, of which 284 
did not meet inclusion criteria, and 354 gave no informed consent. The remaining 528 
patients were included in the study. 
At 3 and 12 months post-MI patients underwent a face-to-face interview with a 
trained research assistant, and filled out questionnaires to assess demographic, 
psychosocial, biological and mental health parameters. In addition, the medical status 
of the participants was examined to determine cardiac disease severity parameters 
and presence of comorbid medical disorders. 
Assessment of cardiac outcomes
Data on all-cause mortality were obtained up until 31 December 2007 from the Dutch 
Central Bureau of Statistics by linkage to the municipal personal records database. 
Data concerning hospital admissions came from the Dutch national registry of 
hospital discharges and were obtained from the Dutch Central Bureau of Statistics by 
linkage to the municipal personal records database. Hospital readmissions with ICD-9 
codes 410, 411, 413, 414 (ischemic heart disease including recurrent MI and unstable 
angina pectoris); 427.1, 427.4, 427.5 (cardiac arrhythmia); 428, 398.91, 402.01, 402.11, 
402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93 (heart failure); 433, 434, 435, 
437.0, 437.1 (cerebrovascular disease); and 440, 443.9 (peripheral vascular disease) 
were included as cardiovascular events. 
The primary end-point of this study was a combined end-point of cardiovascular 
events and all-cause mortality occurring between the self-rated health assessments 
(respectively 3 or 12 months after the index MI) and 31 December 2007. If no event 
or death occurred, the patient was censored at 31 December 2007 in the survival 
analyses.
Assessment of self-rated health status
Self-rated health status was assessed with the Health Complaints Scale (HCS) at 3 
and 12 months post-MI. The HCS is a self-report questionnaire including 12 items 
assessing somatic complaints (e.g. “pain in heart and chest”, “trouble falling asleep”, 
“fatigue”) and 12 items assessing cognitive health complaints (e.g. “worrying about 
health”; 18. In the present study, only the 12-item somatic subscale was administered. 
This somatic subscale has high internal consistency (Cronbach’s alpha was 0.89, 0.91 
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and 0.90 in the study of Denollet 18, Pedersen & Denollet 19 and the present sample 
respectively), adequate test-retest reliability (r=0.69 in the study of Denollet 18, r=0.76 
in the present study), and is sensitive to improvements during cardiac rehabilitation 18. 
In previous studies, factor analysis on the 12 items of the somatic subscale of the HCS 
yielded three symptom dimensions comprising cardiac complaints, sleep complaints 
and energy complaints 18,19. 
Patients rated each health complaint on a 5-point scale ranging from 0 (not at all) to 
4 (extremely), yielding a possible score range of 0-48, with higher scores reflecting 
more health impairment. For the latent class analysis (LCA) and latent transition 
analysis (LTA) the answers on the items were dichotomized into ‘not present’ (HCS 
response 0) or ‘present’ (HCS responses 1 till 4). This was done because especially 
the higher responses were rarely endorsed, leading to problems when computing the 
(polychoric) item correlation matrix used for latent variable modeling.
Types and trajectories of health complaints
Latent transition analysis (LTA) was performed to investigate both quantitative 
change (in experienced severity) and qualitative (in experienced symptom patterns) 
change in self-rated health status between 3 and 12 months post-MI. Based on the 
LTA, patients were classified into a LCA-class at 3 months post-MI and a LCA-class at 
12 months post-MI. In addition, the probabilities of transitioning between the classes 
between 3 and 12 months post-MI were calculated (see Box 1 for details).  
Socio-demographic variables, psychiatric comorbidity and cardiac variables
Demographic data, smoking status and comorbid depressive and anxiety disorder 
were assessed during the face-to-face interview at 3 months post-MI. The presence of 
a post-MI depressive episode and/or current anxiety disorder (including generalized 
anxiety disorder, panic disorder, agoraphobia, social phobia) were established with 
the Composite International Diagnostic Interview (CIDI) during the face-to-face 
interview at 3 months after the index MI. The CIDI is a structured clinical interview 
designed for use in research settings with high validity for depressive and anxiety 
disorders 25,26. Self-reported depressive symptoms were assessed with the Beck 
Depression Inventory (BDI) at 3 months post-MI 27. This 21-item-questionnaire is 
well-validated in MI patients 28. 
Severity of the index-event was assessed by a history of MI, anterior location of the 
MI, the kind of treatment for the index MI and heart failure as indicated by Killip 
class (a standardized four-point clinical assessment of the degree of heart failure) 
at hospitalisation. Furthermore LVEF was determined by wall motion score index, 
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gated single photon emission computed tomography, magnetic resonance imaging 
angiography, or clinical judgment by the treating cardiologist and was dichotomized 
at 40%. Co morbid medical disorders and conditions were extracted from the medical 
status of the patients.
Statistical Analyses
Characteristics
Baseline characteristics were compared between study completers and those who 
dropped out with t-tests and chi-square tests. Baseline demographic and clinical (i.e. 
somatic and psychiatric) characteristics were compared between patients with and 
without a combined endpoint with t- tests and chi-square tests. The variables which 
differed significantly between the two groups (p<0.10) were included as covariates in 
the survival analyses. 
Prognostic impact of HCS sum-score at 3 months post-MI
The prognostic impact of the total HCS-score at 3 months post-MI on the risk of 
combined events was evaluated with Cox regression. Models adjusted for socio-
demographic covariates only, for socio-demographic and somatic covariates, for 
socio-demographic and psychiatric covariates and for all covariates are presented. 
Adjustments were made for variables that were associated with combined endpoint 
univariately (p<0.10), and included age, sex, education-level, history of MI, LVEF, 
anterior location of MI, Killip Class, diabetes mellitus, peripheral vascular disease, 
cerebrovascular disease, having received treatment for psychiatric symptoms post-
MI, depressive symptoms (BDI-sum-score) and generalized anxiety disorder. 
Prognostic impact of types and trajectories of health complaints 
With Cox regression, the prognostic impact on combined events was evaluated for (1) 
the type of health complaints at 3-months post-MI, and (2) the trajectories of health 
complaints from 3 to 12 months after MI, which were obtained with LTA. In these 
survival analyses, the models adjusted for sex, age and education level were presented. 
Because of small group sizes additional covariates (those with p<0.10 in table 1) were 
entered separately. 
Sensitivity analysis
In a population of MI patients which consisted partly of the DepreMI cohort, the 
somatic-affective dimension of the BDI was associated with adverse cardiac outcomes 
[29]. Therefore, in sensitivity analyses we adjusted for the somatic-affective dimension 
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of the BDI instead of the total BDI score. A confirmatory factor analysis revealed very 
good fit for the model found by de Jonge et al 29 on the present sample (CFI: 0.983; 
TLI: 0.989; RMSEA: 0.037).
Descriptive and survival analyses were conducted with SPSS 22 30 for Windows 
with alpha=0.05 (two-tailed). The confirmatory factor analysis, LCA and LTA were 
conducted with Mplus (version 5.2) 31.
Results
Study sample
A total of 424 out of 528 DepreMI patients were available for analyses, due to missing 
values on HCS scores at three months (n=82), the cardiac outcomes  (n=20) or 
both (n=2). The 104 patients with missing data did not differ from the 424 patients 
with respect to age (t=0.26, 526, p=.79), sex (χ2=0.22, 1, p=.64), education-level 
(χ2=0.86, df=1, p=.35), history of MI (χ2=0.49, 1, p=.49), ), Killip class (χ2=0.059, 
df=1, p=.82), anterior location of the MI(χ2=0.68, df=1, p=.41), comorbid diabetes 
mellitus (χ2=0.32, df=1, p=.57), comorbid peripheral (χ2=2.30, df=1, p=.13) and 
cerebro-vascular disease (χ2=0.53, df=1, p=.47), psychiatric diagnosis of any anxiety/
depressive disorder (χ2=1.53, df=1, p=.22), diagnosis of generalized anxiety disorder 
(χ2=0.29, df=1, p=.59) , depressive symptoms (t=0.99, df=511, p=.92) and having 
received psychiatric treatment (χ2=0.02, df=1, p=.88). Baseline characteristics of the 
study sample are presented in table 1.
Characteristics and combined events
A total of 192/424 (45.3%) experienced a combined endpoint during a mean (sd) 
follow-up of 5.7 (3.1) years. Baseline characteristics of the study sample stratified 
according to occurrence of a combined endpoint are presented in table 1. Those with 
combined endpoint were significantly older and lower educated and had significantly 
more often a lower LVEF , a higher Killip class, an anterior location of the MI, a 
history of a MI, comorbid peripheral and cerebro-vascular disease, and depressive 
symptoms, and were less likely to have received treatment for psychiatric symptoms 
post-MI than those without combined endpoint. 
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Table 1: Baseline characteristics of 424 MI patients divided according to incidence
of combined endpoint (yes/no)
Variables Combined 
endpoint 
(n=192;  
45,3%)
No com-
bined 
endpoint 
(n=232; 
54.7%)
Test statistic; p-value
T, χ2 Df R
Socio-demographic variables 
Age (mean, SD) 63,4 (11,2) 58.4 (10.7) T=-4.737 422 <0.001***
Gender (male, n%) 152 (79,2%) 191 (82.3%) 0.679 1  0.410
Higher education (n/%) 50 (26%) 93 (40.1%) 9.271 1 0.002**
Living alone (yes, n/%) 30 (15-6%) 25 (10.8%) 2.188 f=1 0.139
Cardiac  disease status& treatment
LVEF  <40 (n/%) 61 (31,9%) 39 (16.8%) 13.279 1 0.001**
Anterior location of MI (n/%) 73 (38%) 63 (27.2%) 5.693 1* 0.017
Killip class >2 (n/%) 43 (22,5%) 15 (6.5%) 22.632 1 0.001**
PCI during hospitalisation (n/%) 40 (22,7%) 61 (27.7%) 1.287 1 0.257
CAG during hospitalisation (n/%) 39 (22,2%) 62 (28.2%) 1.867 1 0.172
CABG during hospitalisation (n/%) 4 (2,3%) 10 (4.5%) 1.481  1 0.224
Trombolysis during hospitalisation 
(n/%)
88 (45,8%) 100 (43.3%) 0.275 1 0.600
Somatic cardiac risk factors and comorbidity
Previous MI  (yes, n/%) 38 (19,8%) 20 (8.6%) 11.103  1 0.001**
Fam History of CAD (yes, n/%) 72 (37,5%) 87 (37.5%) 0.000 1 1.000
Hypercholesterolemia Yes (n/%) 70 (36,5%) 79 (34.1%) 0.267 1 0.605
Hypertension Yes (n/%) 55 (28,6%) 65 (28%) 0.020 1 0.886
Previous smoker (n/%) 62 (36,5%) 77 (35.8%) 0.018 1 0.894
Current smoker (n/%) 90 (52,9%) 110 (51.2%) 0.120 1 0.729
BMI 26,8 (3,5%) 26.6 (4.4%) T=0.323 347 0.747
Peripheral vascular disease (n/%) 23 (12%) 6 (2.6%) 14.547  1 < 0.001***
Cerebrovascular disease (n/%) 14 (7,3%) 5 (2.2%) 6.476  1 0.011**
Diabetes Mellitus (n/%) 24 (12,5%) 17 (7.3%) 3.218 1 0.073
Psychiatric morbidity
GAD 3 months post MI (n/%) 15 (7,8%) 9 (3.9%) 3.044 1 0.081
Any anxiety disorder 3 months 
post MI (n/%)
26 (13,5%) 25 (10.8%) 0.759 1 0.383
Depression 3 months postMI (n/%) 31 (16,1%) 32 (13.8%) 0.460 1 P 0.498
Received any treatment for psychi-
atric complaints post MI (n/%)
11 (5,7%) 32 (13.8%) 7.496 1 0.006**
HCS 3 months (mean, SD) 21,7 (8,8%) 19.7 (6.9%) T=-2.462 422 0.009**
BDI 3 months (mean, SD) 7,9 (6,7%) 6.4 (5.5%) T=2.552; 420 0.011*
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MI=myocardial infarction; GAD=generalized anxiety disorder; SD=Standard deviation; T=T test ; χ2=Chi 
square test; Degrees of freedom; PCI=Percutaneous Coronary Intervention; CAG=coronary angiogram; 
CABG=coronary bypass graft
*p<0.05; **p<0.01; ***p<0.001
Self-rated health complaints at 3 months post-MI and adverse cardiac outcomes
Results of the survival models are presented in table 2. Total HCS score was 
significantly associated with an increased risk of combined endpoint, after adjustment 
for age, sex, history of MI, LVEF, anterior location of MI, Killip Class, presence of 
diabetes mellitus, comorbid peripheral and cerebro-vascular disease, having received 
treatment for psychiatric symptoms post MI, depressive symptoms (total BDI score) 
and generalized anxiety disorder (HR 1.03 [95% CI: 1.01 – 1.05] (p=.025)). 
Table 2: Hazard ratio’s (95% CI) for combined endpoint associated with HCS sum-
scores at 3 months post-MI
HCS sum score at hospitalization N=192/424 with combined endpoint
HR P
Model 1 HR= 1.03 (1.01-1.05) 0.001**
Model 2 HR=1.02 (1.00-1.04) 0.025*
Model 3 HR=1.03 (1.01-1.06) 0.003**
Model 4 HR=1.03 (1.00-1.05) 0.025*
Model 4b HR=1.03 (1.00-1.05) 0.032*
*p<0.05; **p<0.01; ***p<0.001 
Mean follow-up time (sd) for a combined end-point after HCS at 3 months post-MI was 5.7 (3.1) years.
Model 1: adjusted for age, sex and education level 
Model 2: Model 1 + LVEF, history of MI, anterior location of MI, Kilip Class, Diabetes Mellitus, Peripheral 
vascular disease, Cerebrovascular disease
Model 3: Model 1 + Diagnosis of GAD, BDI, having received treatment for psychiatric complaints post 
MI
Model 4: Model 3 + LVEF, history of MI, anterior location of MI, Killip Class, Diabetes Mellitus, Peripher-
al vascular disease, Cerebrovascular disease 
Model 4 b: Model 4 but instead BDI adjusted for somatic-affective BDI
HCS Health Complaints Scale; CI: confidence interval LVEF: left ventricular ejection fraction; MI: myocar-
dial infarction; GAD: Generalized Anxiety Disorder; BDI: Beck Depression Inventory. 
Type and trajectories of different health complaints by Latent Transition analysis 
(LTA)
LTA analyses included 392 patients, due to missing HCS data at 12 months for 32 
patients. LTA distinguished 5 groups at both 3 and 12 months, characterized by 1) no/
minimal, 2) cardiac,  3) energy, 4) sleep, and 5) mixed health complaints, resulting in 
25 transition-classes (see box 1 for detailed information). 
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Type and trajectories of different types of health complaints and adverse cardiac 
outcomes
During a mean (SD) follow-up period of 5.5 (2.5) years, 153 (39.0%) of the 392 
patients had an a combined event. Table 3 presents the number of patients with a 
combined event in each of the 25 transition classes to give an exploratory overview. 
Table 3: Number of patients with the adverse cardiac outcome in each transition 
class according to type and trajectory of health complaints1
Low 12 Cardiac12 Energy12 Sleep12 Mixed12 Total
Low3 30/81 
(37%)
1/3 (33%) )0/0 0/2 (0%) 0/1 (0%) 31/87 
(35.6%)
Cardiac3 6/12 (50%) 12/28 
(43%)
1/12 (8%) 3/3 (100%) 1/1 
(100%)
23/56 
(41%)
Energy3 4/14 (29%) 2/4 (50%) 24/51 47%) 1/1(100%) 5/7 (71%) 36/7747%)
Sleep3 6/14 (43%) 0/2 (0%) 0/2 (0%) 16/64 
(25%)
0/1 (0%) 22/83 
(27%)
Mixed3 0/1 (0%) 0/0 5/13 (39%) 2/9 (22%) 34/66 
(52%)
41/89
Total 46/123 
(37%)
15/37 
(41%)
30/78 (38%) 22/79 
(28%)
40/76 
(53%)
153/392 
(39%)
1 Follow-up period for adverse cardiac outcomes started after HCS at 12 months
Table 4 shows the results of the survival analysis evaluating the risk of combined 
events according to the type of health complaints at 3 months post-MI and their 
trajectory over time from 3 to 12 months post-MI. Cardiac complaints at 3 months 
post-MI were significantly associated with combined events after adjustment for sex, 
age and education level (HR 1.55 (95% CI 1.15-2.10), p=0.004) ). Adding one-by-one 
the variables that were univariately associated with combined endpoint with p<0.10 
(see table 1) did not change the association between cardiac complaints and combined 
events. 
As shown in table 4, new or persistent cardiac complaints, as well as new or persistent 
lack of energy and new or persistent mixed complaints were associated with an 
increased risk of combined endpoints. Adding one-by-one the variables that were 
univariately associated with combined endpoint with p<0.10 (see table 1) did not 
change these associations (data not shown), but for two exceptions: (1) The HR for 
new and persistent energy complaints attenuated to non-significant after adjusting for 
cerebrovascular disease (1.38 [1.00-1.92], p=0.052) (2) The HR for new and persistent 
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energy complaints attenuated to non-significant after adjusting for depressive 
symptoms ((1.37[0.96-1.96], p=0.081)
Sensitivity analysis: the role of  somatic-affective depressive symptoms
HCS-sum-score was moderately to highly correlated with the somatic-affective BDI 
(r=0.567, p<0.001) at 3 months post MI. However, after adjusting for somatic-affective 
BDI instead of total BDI score in the fully adjusted model the association between 
HCS sum-score and combined endpoints remained significant (HR=1.03 (1.00-1.05), 
p=0.032). 
After adjustment for the somatic-affective BDI the impact of cardiac complaints at 3 
months post-MI on combined endpoint was attenuated to non-significant (HR 1.38 
[0.99-1.92], p=0.055).  
Adjustment for the somatic-affective BDI attenuated the associations of new or 
persistent cardiac complaints, mixed complaints and energy complaints with combined 
endpoint toward non-significant (HRcardiac 1.39 [0.96-2.01], p=0.082, HRmixed 
1.43 [0.92-2.23], p=0.113), HRenergy 1.32 [0.90-1.93] p=0.163 respectively).
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Table 4: Risk of combined endpoint associated with (types of) self-rated health at 
3 months post MI and their course from 3-12 months post MI in 392 MI patients
Model 1
           HR [95% CI] P-value
Three months post MI1:
• Cardiac complaints 1.55  [1.15-2.10] .004**
• Energy complaints 1.33  [1.00- 1.78] .055
• Sleep complaints 1.11  [0.82- 1.50] .517
• Mixed complaints 1.43  [0.99- 2.07] .055
Trajectory from 3-12 months post MI2:
• New or persistent vs no or transient cardiac 
complaints3
1.55  [1.11- 2.16] .009**
• New or persistent vs no or transient energy 
complaints3
1.50  [1.09-2.07] .013*
•New or persistent vs no or transient sleep 
complaints3
0.74  [0.51- 1.09] .128
• New or persistent vs no or transient mixed 
complaints3
1.71  [1.19- 2.47] .004**
*p<0.05; **p<0.01; ***p<0.001
Model 1: adjusted for sex, age, education level
1 Follow-up period for adverse cardiac outcomes started after HCS at 3 months
2 Follow-up period for adverse cardiac outcomes started after HCS at 12 months; reference group 
comprised those with no or transient complaints
3 Patients with cardiac complaints included those with cardiac complaints and mixed complaints, pa-
tients with energy complaints included those with energy complaints and those with mixed complaints, 
patients with sleep complaints included those with sleep complaints and mixed complaints, patients 
with mixed complaints included those with mixed complaints only
MI=Myocardial Infarction; Vs=versus; LVEF= Left Ventricular Ejection Fraction; CIDI=Composite Interna-
tional Diagnostic Interview; BDI=Beck Depression Inventory
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Discussion
Main finding 
In the present study, self-rated worse physical health status at 3 months post-MI was 
a significant predictor of new cardiovascular events and all-cause-mortality after 
adjustment for demographic variables, cardiac disease severity as well as depression 
and anxiety and depression. With each point increase on the somatic subscale of the 
HCS (range 0 to 48), the risk of a new cardiac event increased with 3% in line with 
previous studies 2. Our results extend previous findings 3-9 by having adjusted the 
results for depression and anxiety. 
With LTA we showed that subgroups of patients can be classified based on the type of 
complaints they report, showing that health complaints can be divided into cardiac 
complaints, lack of energy and sleep problems. This is consistent with the results 
of previous studies in MI patients on the HCS which reported on these three types 
of physical health complaints 18, 19. In line with the findings of a previous study 20, 
cardiac complaints at 3 months post-MI were associated with worse cardiac outcome. 
Although the impact of lack of energy and mixed complaints did not reach statistical 
significance, this might be due to limited statistical power.
Patients with new or persisting cardiac complaints, new or persisting lack of energy 
and new or persisting mixed complaints during the first year post-MI showed an 
increased risk of adverse cardiac outcomes. These findings are in line with previous 
research showing that changes in self-reported physical health from before to after 
a myocardial infarction have prognostic value 14. Our findings imply that the course 
of physical health complaints after a MI may provide additional information on 
prognosis as well. 
Adjustment for the somatic-affective BDI in sensitivity analyses attenuated the hazard 
risks of both types and trajectories of physical health complaints to non-significant. 
This suggests an overlap between physical health complaints and somatic-affective 
BDI. Indeed, we found a moderate to high correlation of these scores three months 
post-MI (r=0.567, p<0.001) as can be expected considering the overlap in items of 
these questionnaires; e.g. insomnia (BDI) versus feeling you can’t sleep (HCS) and 
somatic preoccupation (BDI) versus tightness of chest/shortness of breath (HCS) 
and fatigue (BDI) versus exhausted without reason/fatigue (HCS). Nevertheless, the 
sum-score of physical health complaints three months post-MI was still predictive of 
cardio-vascular prognosis independent of the somatic-affective BDI. This stresses the 
clinical impact of physical health complaints, independent of depression, anxiety and 
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cardiac disease severity.
Methodological considerations
An important strength of this study is that we evaluated the prognostic impact of 
physical health complaints adjusted for multiple covariates, including several markers 
of cardiac disease severity, psychiatric comorbidity as well as having received treatment 
for psychiatric symptoms post-MI. With regard to psychiatric comorbidity we took 
both diagnosed and self-reported depression and diagnosed anxiety into account. 
Unfortunately, we did not assess self-reported anxiety symptoms, which may have 
been interesting as we recently showed the prognostic impact of self-reported cardiac 
anxiety post-MI 32. Nevertheless, we did adjust for a diagnosed anxiety disorder. 
In contrast to some studies which measured reported health almost immediately after 
the index MI 7 or one year later 3, we chose, like others 5, 9, to assess baseline HCS three 
months post-MI. We consider this an advantage as the immediate impact of the initial 
stressful cardiac event and hospitalization is settled down and a more representative 
view of which complaints persist can be made. Supportive of this, we previously 
reported that only after 3 months post-MI symptoms of cardiac anxiety stabilized 
in patients with mild, moderate and severe symptom levels of cardiac anxiety 33. A 
potential limitation is that the dropout rate might affect the generalization of our 
results. However, no differences were found between included and excluded patients 
on the parameters of interest. Another potential limitation of the current study is 
that there was no information on objective measures of cardiac disease severity at 
12 months. Therefore we cannot exclude the possibility that the associations in the 
present study could be partly explained by objective cardiac disease severity measures 
at 12 months. Another limitation is the low number of patients in the subgroups with 
new and persisting complaints. Therefore, to avoid over-fitting we could not adjust for 
all covariates simultaneously in these analyses.  
Implications
Taken together, to identify patients at high risk of adverse cardiac outcomes, physical 
health complaints have an added value over and above severity of both cardiac 
morbidity and comorbid anxiety and depression. In the recent decades, much 
attention has been given to the potential impact of depression and anxiety on cardiac 
prognosis 12; 13 and clinicians become more aware of the associated risks. However, 
the present study suggests that self-reported physical health status should also be 
taken into account by clinicians. Our findings indicate that cardiac, energy and 
mixed symptoms become especially informative when they increase or persist over 
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time. This implies that subjective experiences of physical health post-MI should be 
monitored regularly. Overall, our results suggest that the prognostic impact of self-
reported physical health complaints should be mentioned in clinical guidelines, as it 
may serve as an (additional) inexpensive and non-invasive prognostic marker.
Box 1 Description of the Latent Transition Analysis
The preparatory analyses and the LTA itself were conducted in several steps: (1) 
subtype-identification based on the HCS data at 3- and 12-month follow-up by 
preliminary Latent Class Analyses (LCA), (2) investigation of the stability of the 
identified model over time (measurement invariance), and (3) fitting the LTA 
model.
Step 1) Preliminary Latent Class Analyses
To gain preliminary insight into the latent groupings in the data and to decide how 
many classes would be included in the LTA, separate LCA’s were run on the 3- 
and 12-month HCS item-level data using robust maximum likelihood estimation 
package. For each time point, LCA’s were run with increasing numbers of classes. 
The best fitting model was determined by comparison of the Akaike Information 
Criterion (AIC) and Bayesian Information Criterion (BIC) between the models, 
with the lowest AIC/BIC indicating the best fit. In addition, the Bootstrapped 
Likelihood Ratio Test (BLRT) was used to test whether adding a kth class led to a 
significant improvement in model fit compared to the k-1 class model. Eventually, 
both for 3- and 12-months post-MI, the best model was selected based on both 
model-fit and interpretability (sufficient differentiation between classes and no 
overly small classes [n<20]).
Step 2) Investigation of measurement invariance
Before transition between latent classes over time can be investigated, measurement 
invariance of the classes had to be established in order to be sure that class-models 
represented the same concepts at both time-points, and thus, that class-transitions 
can be meaningfully determined. In the context of LTA, measurement invariance is 
investigated by comparison of the log-likelihood of LTA-models with constrained 
and unconstrained model-parameters. The Likelihood-Ratio Test can be used to 
test whether loosening constraints (allowing for measurement non-invariance) 
significantly increases model-fit. If this is not the case, we can assume (partial) 
measurement invariance and interpret transition-probabilities between the classes 
across time.
Step 3) Fitting the LTA model
In case of (partial) measurement invariance, the LTA can be used to define latent 
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transition classes based on the (k3-month by k12-month ) matrix of transition 
patterns. All patients were allocated to these latent groups based on their highest 
posterior class probability.
Results of the Latent Transition Analysis
LTA analyses included 392 patients, due to missing HCS data at 12 months for 
32 patients. Latent Class Analyses (LCA) at 3- and 12 months post-MI showed 
decreasing AIC/BIC values with each class-addition up to 7 classes and significant 
BLRT values (with 100 bootstraps) for each class-addition. However, from the 
5-class model on, adding more classes only resulted in very small BIC changes (3 
months:∆BIC=8; 12 months: ∆BIC =10). Additional inspection of the response 
patterns, suggested that adding more classes only resulted in more intermediate 
classes but no additional qualitative differentiation. Therefore, a 5-class model was 
selected for both 3 and 12 months after MI. 
The five classes (see figure 1) included three classes with more specific symptom 
patterns (respectively scoring predominantly on complaints of “cardiac”, “energy”, 
or “sleep complaints”) and two with similar scores on all symptoms, thus reflecting 
mainly quantitative severity groups (respectively one group scoring on all factors 
[“mixed complaints”] and one group reporting hardly any complaints [“low 
severity”]). These results indicated that a 5-class model could be included in the 
LTA.
No significant difference in model fit was found between a 5-class LTA model with 
constrained parameters over time and an LTA model with class-specific thresholds 
(-2 log-likelihood difference (D)=42.2; with 60; p=0.96). This suggested that 
(partial) measurement invariance could be assumed and it was possible to look 
directly at the transition-probabilities between the classes at 3 and 12 months post 
MI. 
Because 5-classes were modeled at each time-point, the LTA yielded an estimated 
model of 25 latent transition classes. All patients were classified in one class based 
on the highest posterior class probabilities. 
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Figure 1: Latent Class Models based on the Health Complaints Scale at 3 and 12 
months post MI
3 months post-MI
12 months post-MI
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A brief cognitive-behavioral intervention for  
treating depression and panic disorder in patients 
with non-cardiac chest pain: a 24-week randomized 
controlled trial
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Abstract
Background – Most patients with non-cardiac chest pain experience anxiety and 
depressive symptoms. Commonly they are reassured and referred back to primary 
care, leaving them undiagnosed and untreated. Some small studies have suggested 
efficacy of twelve cognitive behavioral therapy (CBT) sessions. Our aim was to examine 
efficacy of brief CBT in reducing anxiety and depressive symptoms in patients with 
non-cardiac chest pain and comorbid panic and/or depressive disorders. 
Methods – In this 24-week randomized controlled trial comparing CBT (n=60) versus 
treatment as usual (TAU, n=53) we included all adults who presented at the cardiac 
emergency unit of a university hospital with non-cardiac chest pain, scored ≥8 on the 
Hospital Anxiety and Depression Scale (HADS) and were diagnosed with a comorbid 
panic and/or depressive disorder with the Mini International Neuropsychiatric 
Interview. CBT consisted of six individual sessions. Main outcome was disease severity 
assessed with the Clinical Global Inventory (CGI) by a blinded independent rater. 
Results – ANCOVA in the intention-to-treat and completer sample showed that 
CBT was superior to TAU after 24 weeks in reducing disease severity assessed with 
CGI (p<0.001). Secondary outcomes on anxiety (HADS-Anxiety, State Trait Anxiety 
Inventory (STAI)-Trait) and depressive symptoms (Hamilton Depression Rating 
Scale) were in line with these results except for HADS-Depression (p=.10), Fear 
Questionnaire (p=.13) and STAI-State (p=.11).
Conclusions – Brief CBT significantly reduces anxiety and depressive symptoms in 
patients with non-cardiac chest pain who are diagnosed with panic and/or depressive 
disorders. Patients presenting with non-cardiac chest pain should be screened for 
psychopathology and if positive, CBT should be considered.
Keywords – anxiety, depression, cardiac, heart, chest pain, cognitive behavioral 
therapy.
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Introduction
Chest pain is one of the most frequent reasons for patients to visit an emergency 
department 1,2, yet only one-quarter of patients who experience chest pain actually 
present to a hospital 3. In more than half of these patients there is no underlying cardiac 
or other somatic cause, and the diagnosis at discharge is non-cardiac chest pain 1,4. It 
is common practice to reassure these patients and refer them back to primary care, 
thus ignoring that their complaints could have other origins, for example a psychiatric 
disorder. The prognosis of non-cardiac chest pain is poor: despite reassurance by 
emergency physicians and cardiologists, more than half of patients continue to report 
chest pain and remain concerned about having a serious heart disease 1,5, resulting in 
high medical care utilization 6. 
High prevalence rates of psychiatric symptoms, predominantly anxiety and 
depressive symptoms, have been reported in patients with chest pain, irrespective of 
an underlying cardiac illness 7,8,9. In patients whose chest pain has  an atypical origin, 
i.e. those diagnosed with non-cardiac chest pain, the prevalence of psychiatric co-
morbidity is reported to be as great as 50% 10,11, with high levels of anxiety, depression, 
catastrophic thinking, and physical disability 12-15. Often patients are diagnosed with 
either depression or an anxiety disorder. Among the anxiety disorders, panic disorder 
is frequently reported 5,16. This is understandable, as the symptoms of a panic attack 
may mimic a myocardial infarction. Since psychiatric symptoms are associated 
with persistent chest pain and continuing functional incapacity 5, these symptoms 
may provide a good starting point for interventions. Furthermore, studies have 
demonstrated the effects of both depression and anxiety on subsequent cardiovascular 
events in both cardiac patients 17-22 and non-cardiac patients 23-25. This makes it relevant 
to devote specific attention to the subgroup reporting psychiatric symptoms.
Previous studies have evaluated a range of different psychological interventions for 
non-cardiac chest pain (NCCP); including relaxation therapy, hypnotherapy and 
cognitive behavioral therapy at both group and individual level. 1,26,27  In most studies, 
the primary outcome was a reduction in chest pain, although some also reported a 
reduction in self-reported depressive symptoms 12,28-33 or anxiety symptoms 28,29,31-34. 
However, these studies included NCCP patients both with and without comorbid 
psychiatric disorders. Some even excluded patients with a comorbid psychiatric 
disorder 12,35,36. A drawback of such studies is that they include a mixture of patients 
with mild and severe symptoms. In clinical practice, however, the challenge is to 
detect and treat those patients who need treatment. Patients who are likely to have a 
favorable course (i.e. those without a psychiatric disorder) should not be over treated. 
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NCCP patients with comorbid anxiety and depressive disorders should be treated 
according to general guidelines. In such cases, cognitive behavioral therapy (CBT) 
is the treatment strategy to be evaluated. First of all, a wealth of studies have shown 
the efficacy and effectiveness of CBT for treating psychiatric symptoms such as 
anxiety, depression and unexplained physical symptoms 37-40. Second, considering the 
population of patients with non-cardiac chest pain, evidence suggests that CBT may 
be effective in reducing anxiety symptoms 1. Unfortunately, these conclusions were 
based on only five studies with relatively small sample sizes. Furthermore, the CBT 
intervention often consisted of twelve sessions, while a shorter intervention may also 
be effective 1,30,41.  
The objective of the present study was to examine the effectiveness of brief CBT on 
anxiety and depressive symptoms after six months in patients presenting at a cardiac 
emergency unit with non-cardiac chest pain with comorbid panic and/or depressive 
disorders. The present randomized controlled trial (RCT) adds value to the five 
previous CBT studies because it 1) examines CBT consisting of six sessions rather 
than twelve, 2) was conducted with a large sample almost equal to the total number of 
subjects in the five previous studies combined (n=113 vs. n=136), 3) was conducted 
over a longer period (six months vs. three months) 1  and 4) addressed the most severe 
cases to specifically target, NCCP patients with a comorbid psychiatric disorder.
Methods
Study design
A 24-week RCT was conducted, comparing brief cognitive behavioral therapy (CBT) 
with treatment as usual (TAU) in patients presenting with non-cardiac chest pain at 
a cardiac emergency unit. We generated the two comparison groups by using simple 
randomization, with an equal allocation ratio, by referring to a table of random 
numbers (to which all researchers and physicians were blinded). The study was 
approved by the VU University Medical Center Ethical Review Committee. 
Study population
Recruitment took place at the cardiac emergency unit of the VU University Medical 
Center. The target population consisted of all subjects aged 18 years or older who 
presented with chest pain and were convinced they were experiencing a heart 
attack. Eligible patients were subjects in whom full medical examination revealed 
no cardiopulmonary, gastrointestinal or endocrinal explanation for their complaints 
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(and thus were diagnosed with “non-cardiac chest pain”) and who scored 8 or higher 
on either or both subscales of the Hospital Anxiety and Depression Scale (HADS) 
42. A cutoff score of 8 is frequently used for both subscales because it provides the 
optimal balance between sensitivity and specificity (for both subscales approximately 
0.80) 43. Eligible patients were asked to provide informed consent for a psychiatric 
interview using the Mini-International Neuropsychiatric Interview (MINI) 44. 
The final inclusion criteria were 1) meeting the DSM-IV criteria for panic disorder 
and/or depressive disorder, and 2) providing signed informed consent after an oral 
and written explanation of the procedures and purpose of the study. Subjects who 
were excluded included 1) those with insufficient knowledge of the Dutch language, 
and 2) those who, in the month before screening, received systematic psychotherapy 
or used antidepressants. Benzodiazepine usage was allowed during the trial, up to a 
maximum of 50 mg of oxazepam or equivalent doses of other medications. Patients 
who used benzodiazepine were required to keep their dosages constant throughout 
the study.
Intervention
Patients randomized to TAU were reassured by the cardiologist that their complaints 
were not caused by cardiac disease. TAU was tailored to the individual needs of 
the patients. However, TAU did not include psychotherapy, including CBT, or 
antidepressants.
CBT consisted of a total of six individual sessions with a duration of 45 minutes. The 
CBT protocol was based on the cognitive model developed by Clark and consisted 
of a combination of psycho-education, cognitive restructuring and influencing 
avoidance behavior, according to the basic concept of CBT that physical complaints 
can be cognitively mediated 45,46. Since the protocol developed by Clark concerns the 
treatment of panic disorder, the CBT protocol was also adjusted to the treatment of 
depressive complaints. At the beginning of the treatment the emphasis was on the 
cognitive model and on cognitive restructuring of the automatic anxiety-provoking 
or depressive mood-provoking cognitions; after that, behavioral interventions were 
added. The treatment was matched to the subject’s diagnosis, so that, if needed, more 
attention was given to psycho-education on the physical symptoms of anxiety or 
physical symptoms associated with depressed mood. For patients with panic disorder, 
with or without agoraphobia, the rationale of exposure in vivo was explained and 
exposure in vivo homework assignments were given. For patients with depression, 
reactivation was explained and reactivation homework assignments were given. 
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The therapists were two clinical psychologists trained in CBT, who received specific 
training for the treatment of patients with non-cardiac chest pain. Extensive manuals 
were used to guide CBT. All CBT sessions were recorded on audiotape. A registered 
supervisor from the Dutch Association for Behavioral Therapy (S.V.) supervised 
them. During supervision, adherence to the treatment protocol was checked and 
assistance was provided in planning future sessions. No formal fidelity ratings were 
used. The supervisor reviewed parts of all audiotapes from all patients to ensure the 
method’s fidelity to the principles of cognitive therapy. In the vast majority of cases, 
the therapists adhered strictly to the therapeutic methodology.
Measures
At baseline and after 24 weeks the patients were assessed by an independent rater, who 
was blinded to the condition to which the patients were allocated.
Primary outcome measure 
Because we included patients with depressive disorder and/or panic disorder, we 
chose the assessor-rated Clinical Global Impression Severity Scale (CGI-Severity) as 
the primary outcome measure. CGI-Severity scores the global severity of the illness, 
varying from normal to severe, on a scale of 1-7 47, with 1 indicating “normal, not at all 
ill”, 4 “moderately ill” and 7 “among the most extremely ill patients”. The CGI is widely 
used in psychiatric clinical trials and has been shown to correlate with standard drug-
efficacy scales in diseases such as major depressive disorder, panic  disorder, social 
anxiety disorder 48 and generalized anxiety disorder 49. Various studies have tested 
the reliability of the CGI scale 50-53 and have demonstrated good inter-rater reliability 
for the above diseases. The standard CGI scale has been demonstrated to be just as 
effective as an improved CGI scale in depression 50. However, less convincing data 
have also been published 54, emphasizing the need for secondary outcome measures 
(see below). 
Secondary outcome measures  
The presence and severity of anxiety and depressive symptoms were measured with:
1) The assessor-rated 17-item Hamilton Depression Rating Scale (HDRS) 55. 
2) The self-rated Hospital Anxiety and Depression Scale (HADS), assessing the 
severity of anxiety and depression in subjects in non-psychiatric hospital settings 42 
and in subjects with non-cardiac chest pain 56. Anxiety (HADS-A) and depression 
(HADS-D) are assessed as separate subscales.
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3) The self-rated State-Trait Anxiety Inventory (STAI), which consists of two subscales: 
STAI-S, the state subscale, which assesses transient emotional symptoms evoked by 
a stressful situation and the STAI-T, the trait subscale which assesses proneness to 
anxiety in an individual 52. 
4) The self-rated 21-item Fear Questionnaire (FQ), yielding three subscales 
(agoraphobia, social phobia and blood phobia) 58,59. 
5) In the completer sample, at 24 weeks the assessor-rated Clinical Global Impression-
Improvement Scale (CGI-Improvement) was administered. The CGI-Improvement 
measures change in the clinical condition over time. This scale has a range of 1-7, with 
1 indicating “much improvement,” 4, “no change” and 7, “much deterioration” of the 
clinical condition 47. 
Power considerations
For CBT targeting patients with panic and/or depressive disorders, large effect-sizes 
of about .80 and higher can be expected 26,28,29. However, although all the subjects 
included had to meet the diagnostic criteria for panic and/or depressive disorders, 
they were also diagnosed with non-cardiac chest pain. Therefore, acknowledging the 
more difficult population under study and the reported moderate effect-sizes, we a 
priori expected an effect-size of 0.6. Assuming a two-sided α set at 0.05 and a β of 0.20, 
we required an intent-to-treat sample size of 45 subjects per condition. Assuming a 
dropout rate of 30% (n=27), a total of 117 persons had to be included.
Statistical analysis
Baseline characteristics were compared between groups with chi-square tests in case 
of categorical variables and t-tests in case of continuous variables.
The primary analyses were conducted on the intent-to-treat sample including patients 
who refused treatment sessions (treatment dropouts) and those who did not complete 
the outcome measurements (data dropouts) on an “as-randomized basis” (n=113; 
CBT n=60; TAU=53). In the intent-to-treat sample missing measures were imputed 
with the Last Observation Carried Forward method. 
The primary analyses were repeated in the completer sample, to evaluate the treatment 
effect in those subjects who really had undergone the treatments to which they were 
assigned. Subjects were included in the completer sample in CBT when they had 
attended at least four CBT sessions and had completed the outcome assessment and 
in TAU when they had completed the outcome assessment. The completer sample 
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consisted of 75 subjects (CBT n=41; TAU n=34).
Differential treatment outcome after 24 weeks was analyzed with analyses of covariance 
(ANCOVA) with the posttest as dependent variable and the pretest as covariate. 
Because of differences found at baseline between CBT and TAU, the following 
other covariates were included in all of the ANCOVAs: pretest CGI-Severity, pretest 
HADS-A, and pretest STAI-T (see under results). Time effects were analyzed with 
paired t-tests (pretest vs. posttest) within each condition. 
DSM-IV diagnoses were not evenly distributed over the two conditions. Therefore 
we repeated ANCOVA on the primary outcome variable in two subsamples: 1) all 
patients with panic disorder, with or without depression, and 2) all patients with 
depression, with or without panic disorder. Analyses were conducted in SPSS version 
18 (SPSS Inc., Chicago, IL) with a two-tailed alpha=0.05.
Results
Attrition
Figure 1 shows the flow of participants throughout the study. In total, 38 of 113 
participants (34%) dropped out, respectively 19/60 (32%) in the CBT group and 
19/53 (36%) in TAU. The dropout percentages did not differ significantly over the 
two conditions (χ2 (1)=0.22; p=0.64). When comparing the completer sample with 
the sample consisting of treatment dropouts plus data dropouts on the baseline 
characteristics, the completer sample appeared to be somewhat less depressed (score 
on HADS-D for completer: mean:17.1, SD:3.9; for dropouts/refusers: mean: 18.6, 
SD:3.6; t=1.96; 110; p=0.05).
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Figure 1 CONSORT Diagram
Posttest
Treatment Dropout (n=19) 
♦ Refused further cooperation (n=3) 
♦ Psychiatric hospitalization (n=2) 
♦ No improvement (n=11)
♦ Unknown (n=3)
Data Dropout (n=0)
Randomized (n=113)
Psychiatric Assessment with
 MINI (n=144)
Allocated to TAU (n=53) 
♦ Received allocated intervention (n=53) 
♦ Did not receive allocated intervention (n=0)
Allocated to CBT (n=60) 
♦ Received allocated intervention (n=41) 
♦Did not receive allocated intervention (n=19)
Treatment Dropout (n=0) 
Data Dropout (n=19) 
♦ Refused further cooperation (n=12) 
♦ Psychiatric hospitalization (n=1) 
♦ Unknown (n=6)
Analyzed Intent-to-treat sample (n=60) 
Analyzed completer sample (n=41) 
♦Excluded from analysis (n= 0)
Analyzed Intent-to-treat sample (n=53) 
Analyzed completer sample (n=34 
♦ Excluded from analysis (n=0)
Enrollment
Excluded  (n= 31)
Not meeting inclusion criteria (n=7) 
♦ Declined to participate (n=23) 
♦ MINI diagnosis lost (n=1)
Analysis
Allocation
Thesis Marleen.indd   139 15-9-2016   10:48:48
Processed on: 15-9-2016
505364-L-bw-vanBeek
140
Chapter 7
Baseline characteristics
The sociodemographic and clinical status variables of the intent-to-treat sample are 
presented in Table 1. When comparing the CBT and TAU group at baseline, the TAU 
group had significantly more males. Moreover, in comparison to the CBT group, in 
the TAU more subjects suffered from panic disorder with or without agoraphobia 
and fewer subjects were diagnosed with a depressive disorder. With respect to the 
other clinical status variables, the patients in CBT appeared to have significantly 
higher scores on the CGI severity scale. In addition, a trend to significance was found 
with respect to scores on the HADS-A and STAI-T, indicating greater severity among 
patients in CBT.
Primary outcome measures
The means and SDs of CGI-Severity are presented in Table 2. ANCOVA yielded 
significant results (F(4,91)=14.3; p<0.001), indicating the superiority of CBT over 
TAU in decreasing clinical severity. Time effects were analyzed with paired t-tests 
within each condition, indicating that the symptoms in CBT improved significantly (t 
(53)=6.12; p<0.001), in contrast to no significant improvement in TAU (t (47)=0.70; 
p=0.49). 
Since the TAU and CBT groups differed significantly at baseline with respect to the 
distribution of MINI diagnoses, we repeated the ANCOVA with 1) all patients with 
a diagnosis of panic disorder, with or without comorbid depression (ANCOVA: 
F(4.78)=9.5; p=0.003), and 2) all patients with a diagnosis of depressive disorder, 
with or without comorbid panic disorder (ANCOVA: F(4.54)= 9.5; p=0.003). The 
ANCOVA results did not change critically and indicated the superiority of CBT 
over TAU, suggesting that the results could not be explained by differences in MINI 
diagnoses between the groups.
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Table 1: Baseline characteristics of intent-to-treat sample (n=113)#
CBT TAU Statistics 
n=60 n=53  P value 
Sociodemographics
Male (n, %) 26  (43.3) 38 (71.7) χ2(1)=9.20  0.002 
Single (n, %) 24  (40.0) 17 (32.1) χ2(1)=0.76   0.38 
Paid employment (n, %) 39  (65.0) 32 (60.4) χ2(1)=0.14   0.70 
Higher education (n, %) 23  (38.3) 14 (26.4) χ2(1)=1.81   0.18 
Age (year) (Mean, SD) 48.7 (13.0) 49.9 (11.0) t(110)= .53   0.60 
Psychiatric status   
MINI Diagnosis χ2(2)=6.95   0.003
Panic disorder + agoraphobia (n, %) 18  (30.0) 28 (52.8)  
Depressive disorder (n, %) 9   (15.0) 8 (15.1)   
Co morbid Panic + Depression (n, %) 33  (55.0) 17 (32.1)   
Previous psychiatric treatment (n, %) 17  (28.3) 15 (14.9) χ2(1)=0.10   0.75 
Previous use of antidepressants (n, %) 17  (28.3) 14 (26.4) χ2(1)=0.08   0.77 
Benzodiazepine use (n, %) 27  (45.0) 16 (30.1) χ2(1)=1.70   0.19 
Positive family history (n, %) 13  (21.3) 20 (37.7) χ2(1)=3.11   0.08 
CGI severity (Mean, SD) 4.2  (1.0) 3,8 (0.7) t(100)=2.28   0.03 
HADS-A (Mean, SD) 19.9 (3.3) 18.6 (3.8) t(110)=1.82   0.07 
HADS-D (Mean, SD) 18.2 (4.0) 17,3 (3.7) t(110)=1.22   0.22 
HAM-D (Mean, SD) 19.2 (5.9) 17.3 (5.4) t(91)=1.59   0.12 
FEAR-Q (Mean, SD) 34.9 (23.6) 35,8 (26.5) t(106)=0.19   0.85 
STAI-S (Mean, SD) 52.1 (11.7) 48,7 (12.2) t(106)=1.49   0.14 
STAI-T (Mean, SD) 54.8 (11.0) 50,9 (11.7) t(106)=1.77   0.08 
Somatic Status   
Heart disease (n, %) 6   (10.0) 6 (11.3) χ2(1)=0.03   0.86 
Hypertension (n, %) 22  (36.6) 19 (35.8) χ2(1)=0.05   0.83 
Previous stroke (n, %)  0  0 1  (1.9) χ2(1)=1.11   0.29 
Renal disease (n, %)  1  (1.6) 0 (0) χ2(1)=0.92   0.34 
Lung disease (n, %)  8  (13.3) 6 (11.3) χ2(1)=0.15   0.70 
Diabetes mellitus (n, %)  3  (5.0) 1 (1.9) χ2(1)=0.86   0.36 
Thyroid disease (n, %)  8  (13.3) 2 (3.8) χ2(1)=3.38   0.07 
# Not all measures were available for all patients; the n of several measures may vary.
CBT = Cognitive Behavioral Therapy; TAU = Treatment as Usual
CGI severity= Clinical Global Impression Severity Scale; HADS= Hospital Anxiety Depression Scale; 
HADS-D Hospital Anxiety Depression Scale, depression subscale; HADS-A Hospital Anxiety Depression 
Scale, anxiety subscale; HAM-D=Hamilton Depression Rating scale; FEARQ=Fear Questionnaire; STAI-S 
State-Trait Anxiety Inventory, state part; STAI-T; State-Trait Anxiety Inventory, trait part.
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Table 2 Means and standard deviations and ANCOVA outcomes of 
intent-to-treat sample (n=113)a
CBT   (n=60) TAU (n=53) 
ANCOVA
Pretest Posttest Pretest Posttest
Measure M SD M SD M SD M SD F(df) p
Primary 
Outcome 
        
CGI severity 4.2 1.0 3.1b  1.6 3.8 0.7 3.8 1.1 F(4,91)= 14.3 <0.001
Secondary 
Outcomes    
  
-HADS-D 18.1 4.0 15.7b 4.9 17.3 3.7 16.1b 4.5 F(4,91) = 1.6 0.20
-HADS-A 19.8 3.4 16.7 
b
5.3 18.6 3.8 17.2b 4.4 F(4,91) = 4.0 .048
HAM-D 19.2 5.9 13.5b 9.8 17.6 5.6 16.6 6.5 F(4,91) = 4.0 .001
FEARQ   34.9 23.4 28.5b 25.6 35.8 26.5 33.9 27.1 F(4,92) = 3.7 0.56
-agora 11.6 10.8 9.8b 12 10.5 11.2 10.6 12.2 F(4,97) = 1.9 0.18
-blood 10.7 9.7 7.9b 9.0 10.5 9.6  9.6 9.3 F(4,92) = 4.1 0.045
-social 12.6 9.6 10.7 10.2 14.8 9.8 13.7 9.7 F(4,92) = 1.6 0.20
STAI-S 52.4 11.8 46.6b 14.4 48.7 12.2 46.2 13.0 F(4,93) = 1.7 0.19
STAI-T 55.1 11.0 49.0b 12.6 50.9 11.7 50.0 12.8 F(4,91) =  4.5 0.004
a Not all measures were available for all patients; the n of several measures may vary.
b Paired t-test (pretest versus posttest) revealed a significant decrease of symptoms within condition. 
ANCOVA = Analysis of CoVariance. Posttest served as dependent variable. Covariates were: pretest 
variable and: pretest CGI severity, pretest HADS-A and pretest STAI-T. 
CBT = Cognitive Behavioral Therapy; TAU = Treatment as Usual; HADS= Hospital Anxiety Depression 
Scale; HADS-D Hospital Anxiety Depression Scale, depression subscale; HADS-A Hospital Anxiety De-
pression Scale, anxiety subscale; HAM-D=Hamilton Depression Rating scale; FEARQ=Fear Questionnaire; 
subscales agoraphobia, blood/injury phobia and social phobia; STAI-S State-Trait Anxiety Inventory, 
state part; STAI-T; State-Trait Anxiety Inventory, trait part; CGI Clinical Global Impression scale (subscales 
severity and improvement); n.a.=not applicable.
Secondary outcome measures 
Means, standard deviations and outcomes of the ANCOVAs on the secondary 
outcome easures are presented in Table 2. As follows from this table, after 24 weeks 
CBT improved significantly in contrast to TAU on HAM-D, HADS-A and STAI-T. 
Time effects, analyzed with paired t-tests within each condition, indicated that 
the symptoms in CBT improved significantly on HAM-D (t(59) =4.68; p<0.001), 
HADS-A (t(58)=5.24; p<0.001) and STAI-T (t(56)=3.85; p<0.001), while none of the 
paired t-tests in TAU was significant. As follows from Table 2, ANCOVA did not 
reveal significant differences between the two treatment conditions on HADS-D, 
STAI-T and FQ. 
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Completer analyses 
The completer analyses of both the primary and secondary outcome measures were in 
line with the results of the intent-to-treat analyses and are therefore not reported here.
In addition, in the completer sample, the CGI-Improvement at 24 weeks revealed 
the superior effect of CBT (mean=2.3; SD=1.1) over TAU (mean=4.0; SD=1.1). 
When dichotomizing the CGI improvement score (‘very much’ or ‘much  mproved’ 
vs. ‘minimally improved or less’) CBT appeared to be superior to TAU (CBT 12 
responders among 42 patients  s TAU 2 responders among 34 patients; 2(1)=33.11; 
p<0.001).
Discussion 
This study reports the results of  BT compared to TAU in a patient population that 
visited a cardiac emergency unit for non-cardiac chest pain and was diagnosed with 
panic and/or depressive disorder. In accordance with our hypothesis, CBT was found 
to be superior to TAU in the improvement on the primary outcome measure CGI-
Severity after 24 weeks. In addition, on the secondary outcome measures of anxiety 
and depressive symptoms, CBT showed superior results compared to TAU. For the 
secondary outcome measures HADS-D, Fear Questionnaire and STAI-S, we did not 
find CBT to be superior to TAU. The results in the completer sample were in line with 
those in the intent-to-treat sample. 
These findings are in line with the findings of five previously performed trials 
evaluating psychological symptoms and included in a Cochrane review 1. In that 
review, reporting on psychological interventions in subjects with non-cardiac chest 
pain, CBT improved anxiety and depressive symptoms 12,33,34,36. Our study, however, 
adds to this literature for the following reasons. 
Firstly, three 12,34,36, of the four studies included up to twelve individual CBT sessions, 
whereas our study offered a maximum of six sessions. The only other study also offering 
six sessions 33 offered CBT within a group format. Although a group format may be 
more costeffective compared to individual therapy and may therefore be promising, 
that study did not reach significance based on the Cochrane criteria. Interestingly, a 
small pilot study recently suggested efficacy on the experience of bodily sensations of 
only three CBT sessions in a combined group of patients suffering from non-cardiac 
chest pain and benign palpitations 30. However, the CBT was conducted by one 
therapist and ratings were not blinded. Very recently, an intervention cohort study 
in NCCP patients diagnosed with a panic disorder compared three interventions 
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with supportive care, including a seven-session CBT intervention. There was an 
improvement in the severity of panic disorder, relative to supportive care. Although 
the sample size was small (n=19) this promising result was in line with the results of 
our study 41,60. 
Secondly, the inclusion criteria of the five studies in the Cochrane review 1 were 
largely based on non-cardiac chest pain irrespective of the presence of psychiatric 
pathology. None of the studies selected cases based on the presence of psychiatric 
comorbidity, which may have led to floor effects of CBT on general measures of 
depression and anxiety. Moreover, three studies even excluded patients suffering from 
major depressive disorder 12,35,36 which may have seriously limited the generalization 
acknowledging the high prevalence of depressive isorder among patients with non-
cardiac chest pain 9,10,13. In contrast, we included noncardiac chest pain patients with 
comorbid psychiatric disorders as CBT has been shown to be particularly effective in 
this subgroup, whereas floor effects can be expected when there is a low severity of 
depression and anxiety symptoms. 
Although we acknowledge that limiting the included anxiety disorders to panic 
disorder alone may have consequences for the generalization of  ur results, the validity 
of our choice is strengthened by data suggesting panic disorder is the most prevalent 
anxiety disorder in a non-cardiac chest pain population 5,16. As we focused exclusively 
on patients with NCCP and comorbid depression and/or panic disorder, our results 
cannot be generalized to NCCP patients without these conditions. Interestingly, 
our effect-size is indeed larger than the pooled effect-size of the five studies in the 
Cochrane meta-analysis. This is a promising finding for cost-effectiveness, although 
not specifically addressed by our study. 
A disadvantage of combining both depressed and anxious subjects in our study is that 
we cannot demonstrate the effectiveness of CBT on both groups separately. However, 
we repeated the main analysis in these subgroups post hoc. The results were in line 
with the analysis of the primary outcome measure. An advantage of the mixed group 
approach is that it enhances external validity of the trial results. 
Some methodological issues should be mentioned. Although our population almost 
equals the total number of subjects in the five studies combined within the Cochrane 
study 1 (n=136), we do have to acknowledge the high dropout rate of 35%. The dropout 
percentages did not differ significantly over the two conditions. When comparing 
the baseline haracteristics of the completer sample with patients who dropped out 
prematurely or who refused to cooperate, the per-protocol sample appeared to be 
somewhat less depressed. The non-significant results on the Depression subscale of 
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the HADS, the Fear Questionnaire and the STAI Trait, may represent insufficient 
statistical power due to the heterogeneity of the included sample. 
In the review of Kisely  et al. 1, most studies included patients with and without 
established psychiatric comorbidity. Therefore, lower dropout rates might be caused 
by a differential dropout between cases with and without psychiatric comorbidity, 
as people may feel stigmatised by receiving a psychiatric diagnosis. Nonetheless, as 
long as we do not know the reasons for this relatively high dropout rate, it remains an 
interesting point whether our focus on psychiatric cause may have consequences for 
the engagement of those patients with a somatic attribution.
Some methodological limitations concern the outcome parameters used. 1) Our 
primary outcome measure was the Clinical Global Impression Scale (CGI). Although 
the psychometric properties of the CGI are questioned by some authors, in our 
study outcome assessed using the CGI paralleled the outcome assessments using the 
well-validated and disorder-specific instruments we applied. The CGI was chosen 
because we included patients with two types of psychiatric disorders. 2) Perhaps we 
should have stratified for type of MINI diagnosis since that was significantly different 
between both conditions. However, post-hoc analyses with subgroups did not change 
the results. If all, the effect may be an underestimation because of more comorbidity in 
the CBT condition as opposed to more “simple” anxiety problems in the TAU group. 
Unfortunately we did not repeat the MINI at follow-up. As a result, no evaluation was 
made of the number of patients who fulfilled the diagnostic criteria of panic and/or 
depressive disorder after six months. However, when dichotomizing our sample into 
responders versus non-responders on the CGI improvement scale, CBT appeared 
to be superior to TAU, which corroborates our dimensional outcome measures. 3) 
Regretfully we did not evaluate the frequency and severity of non-cardiac chest ain at 
follow-up. We focused on the presence and severity of panic and depressive symptoms, 
which are aspects of the differential diagnosis of NCCP. We consider chest pain just 
one symptom of a broader problem (i.e. panic and/or depressive disorder) that we 
plan to target. We have demonstrated a significant and clinically relevant amelioration 
of panic and depressive symptoms, suggesting an improvement in NCCP symptoms 
as well 34,61. 4) A disadvantage of combining both depressed and anxious subjects in 
our study is that we cannot demonstrate the effectiveness of CBT on both groups 
separately. However, we repeated the main analysis in these subgroups post hoc. The 
results were in line with the analysis of the primary outcome measure. An advantage 
of the mixed group approach is that it enhances external validity of the trial results. 
We conclude that CBT of up to six individual sessions significantly reduces anxiety 
and depressive symptoms in patients with non-cardiac chest pain who are diagnosed 
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with panic and/or depressive disorders. The high prevalence of affective disorders 
among patients with non-cardiac chest pain and the effectiveness of our intervention 
argue for psychiatric screening in this specific population. Taking into account the 
reduced quality of life due to untreated anxiety and depression, high levels of persistent 
medical consumption, and finally the higher risk of subsequent vascular events, non-
screening in this specific population or issing important psychiatric diagnoses should 
be considered as an omission that carries a high risk of iatrogenic damage.
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Summary 
Anxiety is a common emotion to a perceived threat. When the heart is thought to be 
in danger, this can be experienced as life-threatening and as such provoke a specific 
fear related to the heart: cardiac anxiety. 
Two diseases in which patients may experience cardiac anxiety are a myocardial 
infarction (MI) and non-cardiac chest pain (NCCP). MI patients suffer from symptoms 
of cardiac disease, most frequently chest pain or chest discomfort, caused by blockage 
of the coronary arteries which supply the heart of oxygen: a well-known type of 
coronary artery disease (CAD). In contrast, NCCP patients experience symptoms of 
cardiac disease (i.e. chest pain) in the absence of a diagnosed cardiac origin. 
In case anxiety is disproportionate, and limits a person to function adequately in daily 
life, it becomes pathological. At the pathological end of the spectrum are the anxiety 
disorders, like a panic disorder, which is characterized by sudden and repeated panic 
attacks. Pathological anxiety often coincides with depression: a state of low mood and/
or anhedonia (loss of interest in activities formerly found amusing) that influences 
wellbeing and interferes with daily life. 
Post MI, both depression and anxiety are shown to be associated with a worse quality 
of life and with adverse cardiac outcome 1,2. However, considering the latter, findings 
are inconsistent. Various attempts to treat depressive symptoms post MI did not result 
in improving effects on cardiac outcome 3-5. Several explanations can be put forward. 
One is that measurements of depression and/or psychological stressors might not 
be specific enough, as constructs related to mood and anxiety disorders may party 
overlap. Recent findings suggest that different types of anxiety and depression may be 
related to different outcomes in terms of increased mortality and increased incidence 
of cardiac events 6-10. Therefore, the focus on a specific construct –i.e. cardiac anxiety- 
may be of help in disentangling the specific roles of anxiety. 
Only few studies have evaluated cardiac anxiety in cardiac patients (mainly 
heterogeneous populations of both CAD and non-CAD patients) and all but one 11 
had a cross-sectional design 12-14. To date, no studies in a homogeneous sample of MI 
patients have focused on cardiac anxiety.
NCCP patients report similar to higher levels of cardiac anxiety compared to patients 
with established CAD 15. Despite reassurance by medical professionals, the majority 
continues to report chest pain and remains concerned about having a serious heart 
disease 16,17. Perhaps avoidable, since psychiatric disorders like panic disorder and 
depressive disorder can be treated effectively, e.g. with cognitive behavioral therapy 
18,19.
Thesis Marleen.indd   155 15-9-2016   10:48:52
Processed on: 15-9-2016
505364-L-bw-vanBeek
156
Chapter 8
The present thesis aimed to evaluate cardiac anxiety comprehensively by evaluating 
1) the validity and reliability of an assessment tool for cardiac anxiety in patients 
with a myocardial infarction (MI), 2) the prevalence and characteristics of 
cardiac anxiety during hospitalization for an MI, 3) the course and trajectories 
of cardiac anxiety in the year after an MI and its association with quality of life, 
4) the prognostic impact of cardiac anxiety on cardiac prognosis in terms of new 
cardiac events and all-cause mortality post MI, 5) the effect of a short cognitive 
behavioral therapy (CBT) intervention in non-cardiac chest pain (NCCP) patients 
assumed to experience cardiac anxiety. Three independent samples were used: a 
cohort of patients hospitalized for an MI at the Radboud UMC, a cohort of MI 
patients included in the Depression after Myocardial Infarction (DepreMI) study 
20,21 - and a sample of NCCP patients who presented themselves at the emergency 
department of the VU and were diagnosed with a panic and/or depressive disorder. 
Assessment of cardiac anxiety 
Chapter 2 described a cross-validation study of the self-report Cardiac Anxiety 
Questionnaire (CAQ) in 237 patients admitted for a myocardial infarction (MI). The 
CAQ and five other well-established self-report questionnaires, assessing general 
anxiety, avoidance and depression, were administered. Confirmatory factor analysis 
revealed that the original three-factor solution of the CAQ as described by Eifert 
et al. (2000) 12, consisting of the three subscales fear, attention and avoidance, was 
acceptable. However, our data were better explained by a model including a fourth 
subscale reflecting safety seeking behaviors. This is consistent with the findings of 
a previous study in a mixed sample of both patients with and without coronary 
atherosclerosis 22. Internal consistency and test-retest reliability in our sample were 
good. The CAQ had moderate correlations with the other questionnaires, reflecting 
reasonable to good convergent validity. Entering the subscales of all questionnaires 
in a factor analysis identified different factors, including one that contained all CAQ 
subscales. This implies that cardiac anxiety is a separate construct distinct from 
depressive and general anxiety symptoms. Patients who were recently admitted with 
MI had significantly higher scores than patients with rheumatoid arthritis, even after 
controlling for general anxiety and depressive symptoms. Therefore, divergent validity 
was good.
In conclusion, the findings of this validation-study imply that the CAQ is a reliable 
and valid self-report-instrument to assess cardiac anxiety in patients hospitalized 
with MI.
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Prevalence and characteristics of cardiac anxiety post MI
Chapter 3 showed the findings of a cross-sectional study in the same cohort MI 
patients as described in chapter 2. Cardiac anxiety was assessed with the CAQ and 
information on socio-demographic, psychological and cardiac disease characteristics 
was gathered. Univariate and multivariate logistic and linear regression analyses were 
conducted to determine which characteristics were associated with cardiac anxiety. 
Cardiac anxiety was not associated with socio-demographic variables. However, 
cardiac anxiety did appear to be associated with psychological distress such as 
depressive symptoms, agoraphobic cognitions and avoidance behaviour. Interestingly, 
there was an inverse relationship between cardiac anxiety and severity of cardiac injury 
- as indicated by ST-Elevated Myocardial Infarction (STEMI) and troponin level. 
Two possible explanations seem likely for this latter finding. Anxious persons might 
seek help earlier, thus being more often diagnosed with minor cardiac pathology. 
Secondly, cardiac anxiety might partly be caused by diagnostic uncertainty. Although 
there has to be noted that the size of the correlations in this study seemed rather 
small, these postulated underlying explanations may be of impact for clinical practice. 
Communication strategies to reassure patients efficiently should be developed as these 
might be relevant for the subgroup of patients placed in a situation of uncertainty 
due to minor cardiac injury as well as the subgroup of patients with higher levels of 
cardiac anxiety in general.
To conclude, these cross-sectional findings showed that in patients admitted for MI 
higher cardiac anxiety was associated with more psychological distress but lower 
severity in cardiac injury.
The course of cardiac anxiety and its predictors
Chapter 4 reported on a longitudinal cohort study in the subsample (n=194) of the 
cohort of MI patients described in chapter 2 which filled out the CAQ after admission. 
Follow-up assessments took place at approximately one, three, six and twelve months 
after discharge. Latent class analysis identified four trajectories of cardiac anxiety; 
three groups had continuous CAQ levels of respectively high, intermediate and 
low intensity, while the fourth group had high scores at the beginning, but these 
decreased with time. Between group differences were of particular interest for the two 
subgroups which started high in cardiac anxiety, since these may differentiate patients 
with spontaneous remission from those who might be in need of treatment. Patients 
in whom cardiac anxiety persisted were more frequently unemployed, had more 
often diabetes mellitus and previous MI, and had higher baseline levels of depressive 
symptoms, anxiety and avoidance.
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Unfortunately the number of persons in the two subgroups of interest were too small 
to control for possible confounders in a multivariate analysis. Therefore, we consider 
the comparison as a first step in exploring possible confounders.
Overall, this longitudinal cohort study addressing cardiac anxiety during the year 
post MI, identified four trajectories of cardiac anxiety. Future research should 
focus on cardiac outcome and efficacy of treatment strategies for cardiac anxiety 
especially in the subgroup of patients with persistent high cardiac anxiety levels. 
Impact of cardiac anxiety on cardiac outcome 
Chapter 5 assessed the prognostic impact of cardiac anxiety -measured with the CAQ 
-on cardiac outcome in the same cohort of MI patients as described in chapter 4. 
In previous studies anxiety symptoms were measured directly after hospitalization 
or surgery 23. However, temporary distress due to hospitalization or surgery may 
inflate the rates of psychopathology whereas long-term functional outcome may only 
be affected by psychopathological symptoms that persist, or develop during the first 
weeks as has been demonstrated for depressive symptoms 24. Furthermore, we showed 
in chapter 4 that trajectories of cardiac anxiety after a MI are largely determined within 
the first three months after the event. Therefore, we chose to investigate the prognostic 
association of the CAQ at both hospitalization and approximately four months after. 
Study endpoint was a major adverse cardiac event (MACE) defined as a readmission 
for ischemic cardiac disease or all-cause mortality within approximately 4-5 years 
after the index-MI. The prognostic impact of CAQ on MACE was evaluated with Cox 
regression analysis, adjusted for age, cardiac disease severity (Left Ventricular Ejection 
Fraction, cardiac history), and depressive symptoms (Beck Depression Inventory). 
CAQ overall score both at hospitalization and after four months significantly predicted 
the occurrence of MACE over the 4 to 5 year follow-up period. Subsequent analyses 
of subscale scores revealed that this effect was particularly driven by “Avoidance”, 
especially at four months post MI. These results imply that anxiety and its related 
behavior (especially avoidance of physical exercise) should be addressed, e.g. in 
rehabilitation programs. It could be targeted with cognitive behavioral therapy (CBT).
In conclusion, cardiac anxiety in MI patients, particularly anxiety-related avoidance 
of physical exercise, seemed an important prognostic factor for cardiac outcome in 
MI patients, independent of cardiac disease severity and depressive symptoms.
Chapter 6 tried to capture the prognostic impact of cardiac anxiety by investigating 
the association of patient-reported physical health with cardiovascular prognosis. In 
MI patients of the DepreMI cohort the somatic subscale of the self-report Health 
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Complaints Scale (HCS) was filled out at 3 and 12 months post-MI. Unfortunately, 
the CAQ was not administered. As previous research in cardiac patients undergoing 
planned surgery 25 showed that (negative) correlations of cardiac anxiety-assessed with 
CAQ- were stronger related with physical quality of life than with psychological quality 
of life, we hoped that (some type of) physical health could serve as a surrogate marker 
for cardiac anxiety. The prognostic impact of the HCS on a combined endpoint of 
new cardiac events and mortality was evaluated with Cox regression analysis adjusted 
for all socio-demographic, cardiac and psychiatric variables that were associated with 
combined endpoint univariately (p<0.10), including age, sex, education-level, history 
of MI, left ventricular ejection fraction, anterior location of MI, Killip Class, diabetes 
mellitus, peripheral vascular disease, cerebrovascular disease, having received 
treatment for psychiatric symptoms post-MI, depressive symptoms (BDI-sum-score) 
and generalized anxiety disorder. In addition, the type of physical health symptoms as 
well as their trajectories over time were explored.
Latent transition analysis (LTA) on the HCS yielded five groups of patients with 1) 
no/minimal symptoms, 2) cardiac complaints, 3) lack of energy, 4) sleep-problems, 
and 5) mixed health-complaints respectively, resulting in 25 latent transition classes.
 In contrast to what we hoped, none of these groups seemed to resemble cardiac 
anxiety specifically. Nevertheless, we found interesting results. Of 424 MI-patients, 
192 (45.3%) experienced a cardiac event or died during a mean (sd) follow-up of 
5.7 (3.1) years. Physical health complaints 3 months post MI were associated with 
adverse cardiac outcome, even when adjusted for cardiac and psychiatric morbidity. 
Considering type of complaints, particularly cardiac complaints were important 
predictors of cardiac outcome, whereas mixed and energy complaints showed a trend 
of being a predictor. With respect to their course over time, new or persistent mixed, 
cardiac and energy complaints showed significant prognostic impact. However, 
obviously, replication of these findings in an independent sample, large enough to 
adjust not only for baseline cardiac and psychiatric disease severity but also for their 
changes during follow-up, is needed to see if this information from the patient’s 
history may indeed serve as a prognostic marker.
Overall, although we failed to construct a measure for cardiac anxiety in this 
DepreMI cohort, research findings were interesting. Physical health complaints after 
a heart attack are predictors of cardio-vascular outcome independent from cardiac 
disease, depression and anxiety. These physical health complaints post- MI can be 
classed into different type and course over time, consisting of cardiac complaints, 
lack of energy, sleep problems, mixed and minimal health complaints. Type and 
trajectories of health-complaints may have additional prognostic significance.
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Impact of cognitive behavioral therapy on cardiac anxiety 
Chapter 7 showed the results of a 24-week randomized controlled trial comparing 
cognitive behavioral therapy (CBT) (n=60) versus treatment as usual (TAU, n=53) 
in adults who presented at the cardiac emergency unit of a university hospital with 
non-cardiac chest pain, who scored ≥8 on the Hospital Anxiety and Depression Scale 
(HADS) and were diagnosed with a comorbid panic and/or depressive disorder. CBT 
consisted of six individual sessions. Main outcome was global functioning assessed 
with the Clinical Global Inventory (CGI) by a blinded independent rater. ANCOVA 
in the intention-to-treat and completer sample showed that CBT was superior to TAU 
after 24 weeks in reducing disease severity assessed with CGI. Secondary outcomes on 
anxiety (HADS-Anxiety, State Trait Anxiety Inventory (STAI)-Trait) and depressive 
symptoms (Hamilton Depression Rating Scale) were in line with these results except 
for HADS-Depression, Fear Questionnaire and STAI-State.
In short, this randomized controlled trial showed that brief CBT significantly 
improves global functioning and reduces anxiety and depressive symptoms 
in patients with non-cardiac chest pain who are diagnosed with panic and/or 
depressive disorder. 
 Main Finding/Overall conclusion
The four studies in a cohort of MI patients as described in chapters 2-5 of this 
thesis indicate that cardiac anxiety can be reliably assessed with the self-rated CAQ, 
that patients report different trajectories of cardiac anxiety over time following a 
MI, and that higher cardiac anxiety is associated with more general anxiety and 
depressive symptoms, a worse quality of life one year post MI, and a worse cardiac 
prognosis up to five years after the MI. The study reported in chapter 6 in another 
cohort of MI patients showed that it is difficult to approximate cardiac anxiety 
when it is not explicitly assessed. Finally, the randomized controlled trial presented 
in chapter 7 of this thesis found that a CBT intervention in NCCP with a comorbid 
panic and/or depressive disorder can significantly reduce disease severity, anxiety 
and depressive symptoms. A logical follow-up would be to treat cardiac anxiety 
post MI. 
Overall, these results imply that cardiac anxiety is relevant as it affects quality of 
life, psychiatric and cardiac outcome and is potentially modifiable. As such, cardiac 
anxiety may be a useful construct to detect persons at risk and to guide treatment.
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General discussion
Findings of the present thesis show that cardiac anxiety post MI is relevant as it can 
be persisting, and is associated with other psychiatric symptomatology like more 
depressive symptoms and avoidance, with a worse quality of life and with a worse 
cardiac prognosis. 
Historically, the main focus of research of psychiatric symptoms and their prognostic 
significance in MI patients used to be on depression rather than anxiety. As explained 
in chapter 1 of this thesis, depression post MI has been shown to be common and to 
have a negative impact on quality of life and cardiovascular outcome 1,2. However, most 
studies evaluating antidepressant treatments in MI patients did not find beneficial 
effects on cardiac prognosis 3-5. Secondly, some studies suggest that in particular 
somatic-affective but not cognitive-affective depressive symptoms are associated 
with cardiac prognosis 6-9. Thirdly, pooled odds ratios in meta-analysis of studies 
evaluating the association between depression and cardiac prognosis were attenuated 
when adjusting for left ventricular function as marker for cardiac disease severity 1. 
Therefore, it has been suggested that the effect of depression on post MI prognosis 
may be partly due to cardiac disease severity.  
As post MI depression often co-occurs with anxiety 10, over the last decade the 
research focus has been extended to anxiety. Indeed, a meta-analysis of previous 
studies on anxiety found that post MI anxiety was associated with a 36% increased 
risk of adverse cardiac outcomes 11. In this meta-analysis outcome was not adjusted 
for measures of cardiac disease severity. However, in the studies which did control 
for disease severity effect estimates appeared to be only slightly or not attenuated 12-14. 
This suggests that the relationship between anxiety and cardiac prognosis might be 
less confounded by cardiac disease severity than that between depressive symptoms 
and cardiac prognosis. In a more recent-analysis evaluating the association of anxiety 
post-MI and in stable CAD with cardiac outcome, results were varying, depending on 
the operationalization of both the anxiety and the outcome variables 15. A significant 
association was found between anxiety as a continuous predictor with a worse 
cardiac prognosis defined as a composite outcome, which is similar to our design. In 
the corresponding analysis adjusted for relevant covariates a one-standard increase 
in anxiety was associated with a 21% increase risk of a new cardiac event or death. 
Our results are consistent with these previous findings, demonstrating a prognostic 
association of anxiety with cardiac outcome independent from several cardiac severity 
parameters. As we have shown that cardiac anxiety was inversely related to other 
variables of cardiac disease severity (chapter 3), it seems unlikely that these findings 
were driven by residual confounding due to cardiac disease severity. Moreover, we 
Thesis Marleen.indd   167 15-9-2016   10:48:58
Processed on: 15-9-2016
505364-L-bw-vanBeek
168
Chapter 9
demonstrated that after additional adjustment for depressive symptoms, next to age, 
sex and parameters of cardiac disease severity, higher cardiac anxiety still increased 
the risk of adverse prognosis. Summarizing, the findings of this thesis show that 
anxiety post MI matters.
In line with the previously mentioned results for depression showing different 
prognostic associations for different types of depressive symptoms, the question can 
be raised which type of anxiety matters or matters the most. As reported in chapter 
1, a recent study in CAD patients undergoing coronary artery bypass graft surgery 
showed different types of anxiety had a different relationship with cardiac prognosis: 
fear and panic disorders did not have an adverse association with cardiac prognosis, 
but generalized anxiety disorder did 16. Commonly used anxiety questionnaires 
predominantly assess general anxiety, avoidance behavior, worrying and fear of 
bodily sensations. After a MI, cardiac-related stimuli and sensations may trigger 
specific anxiety symptoms, based upon their assumed negative consequences 17. These 
specific fears and anxiety-related behaviors like increased attention, avoidance and 
safety-seeking behavior can be conceptualized as cardiac anxiety. The present thesis 
focused on cardiac anxiety rather than general anxiety and confirmed its association 
with cardiac prognosis, implying that cardiac anxiety indeed matters. 
Unfortunately, the present thesis did not examine whether a focus on cardiac anxiety 
has additional value over general anxiety. However, the present findings do show that 
cardiac anxiety has an adverse association to cardiac outcome independent from 
depression. Given this fact, it would be worthwhile to hypothesize if and how cardiac 
anxiety post MI could be treated. In line with medical reasoning and common sense, 
one might argue that the more specific the problem, the more specific the treatment, 
the more effective the treatment might be. This could be further investigated in 
randomized controlled trials comparing cardiac outcome of specific interventions for 
cardiac anxiety with those  of interventions targeting more general  anxiety. 
Methodological Considerations
Study type/design
This thesis tried to explore cardiac anxiety in a comprehensive way by using several 
research designs; observational studies, with either a cross-sectional (chapter 3) 
or longitudinal design (chapters 4-6) and an intervention study (chapter 7). The 
cross-sectional data enabled us to descriptively explore prevalence and associations 
of cardiac anxiety at one specific time point (immediately after a MI), whereas the 
longitudinal designs made it possible to explore the course of cardiac anxiety and 
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its prognostic association with cardiac outcome. Both indicated cardiac anxiety 
was associated with a worse outcome in terms of psychological distress and cardiac 
morbidity. A disadvantage of the longitudinal design used in this study is that the 
timing of the assessments was determined and the course of  cardiac anxiety in 
between those time points was not taken into account. However, we did assess cardiac 
outcome for the whole period. Furthermore, we tried to target this issue by assessing 
cardiac anxiety for five times at regular intervals during the year post-MI (see chapter 
4). More frequent assessments might  have led to more drop-outs or to learning effects 
and both might have led to less valid findings. Although the RCT had a shorter follow-
up period than the observational studies, the use of this experimental design provided 
additional value with respect to treatment outcome, although unfortunately we did 
not assess effects of CBT on reported chest-pain.
As the study designs in the three independent populations were different, their results 
may complement each other in the present thesis. Ideally, research implications of 
one study are addressed in the next. Unfortunately, as the studies were developed 
independent of each other and at other points in time, this was not possible. If they had 
been, we would have assessed cardiac anxiety with the CAQ in all studies including 
the RCT (chapter 7) and the Depremi study (chapter 6). Furthermore, we would have 
done a structured psychiatric interview in all studies in order to diagnose relevant 
psychiatric disorders, as was done in the RCT with the Composite International 
Diagnostic Interview (CIDI) and in the DepreMI cohort with the Mini-International 
Neuropsychiatric Interview (MINI). Next, we would have administered a general 
anxiety measure in addition to a cardiac anxiety measure. Finally, the cardiovascular 
outcome parameters of the DepreMI study (chapter 6) would have been defined 
more strictly, excluding minor non-ischaemic cardiac pathology, as they were in the 
prognostic CAQ study (chapter 5). 
Population and generalizability
A clear strength of the present thesis and an indication of the external validity is that 
its findings are based on three independent populations: 1) MI patients recruited at 
the Radboud UMC (chapters 2 to 5); 2) MI patients included in the Depremi study 
(chapter 6);  and 3) NCCP patients recruited at the VU University Medical Center 
(chapter 7). Two of the studies described a population recruited in university medical 
centres. The exception was the DePreMI study (chapter 6) which described a mixed 
sample of MI patients recruited in both academic as well as non-academic hospitals. 
As patients admitted to an academic setting may suffer from more complex pathology 
compared to patients in non-academic hospitals, their results may not automatically 
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be generalized to patients in non-academic hospitals. However, the cardiology 
department of the Radboud UMC (chapters 2-5) has a major regional function in 
the acute care of MI. Consequently, the pathology of many of the patients admitted 
for a MI in the Radboud UMC may in fact be comparable to non-academic hospitals. 
Nevertheless, replication of our findings in a multicenter study is needed. 
Cardiac anxiety: A neglected psychiatric problem?
Cardiac anxiety is a specific type of anxiety not (yet) recognized by the DSM. 
Consequently, in most (psychiatric) research it has not been assessed explicitly, as is 
the case in the DepreMI study (chapter 6) and the RCT (chapter 7). Therefore, in this 
thesis several strategies to address cardiac anxiety were used: a dimensional approach 
(chapters 2 to 6) versus  a categorical approach (chapter 7); and explicit assessment 
with a self-report questionnaire (chapters 2 to 5) versus trying to examine cardiac 
anxiety more implicitly (chapter 6 and 7). Obviously, when aiming to explore cardiac 
anxiety, the preferred method is to assess it directly, e.g. with an instrument like the 
CAQ. Such a standardized approach would have made it easier to relate the research 
results to each other. Even though we tried our best to use measures assessing similar 
constructs as the CAQ, the underlying inconsistencies obviously hampered relating 
the findings of the different studies to each other. The Health Complaints Scale (HCS) 
(chapter 6) and panic disorder in patients with non-cardiac chest pain (NCCP) 
(chapter 7) are reasonable measures as both are associated with cardiac anxiety. 
However, both constructs are broad and may in fact only partly capture the concept 
of cardiac anxiety. Therefore, in the future replication of these findings with the CAQ 
as direct measure of cardiac anxiety in these populations is desirable. Preferably, the 
CAQ should be assessed together with psychiatric diagnoses and general measures 
of psychopathology, in order to evaluate the specific contribution of each of these 
concepts.
Psychometric aspects
Cardiac anxiety is a multidimensional construct as can be seen by the different 
subscales of the CAQ (chapter 2). This thesis showed that the association with cardiac 
outcome is especially mediated by avoidance behavior, which may provide a focus for 
treatment. On the other hand, the association of higher cardiac anxiety with worse 
quality of life, seemed to apply to all dimensions of cardiac anxiety. These findings 
point to the relevance of a dimensional approach.
A recent German study tried to set percentiles based on a normative sample of the 
general population for the CAQ 18. However, these cut-offs are based on statistical 
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norms only and lack confirmation by a gold standard. For clinical care, the lack of 
a gold standard is less relevant as it is most useful to know the predictive validity of 
cardiac anxiety with respect to its association with quality of life, its course over time, 
and cardiac prognosis. The optimal cut-off points probably differ for these different 
endpoints. Acknowledging the limited empirical data on cardiac anxiety, we prefer 
the dimensional approach to support clinical (and shared) decision making. 
Cardiac aspects
In the cohort studies evaluating the prognostic association, several cardiac disease 
severity parameters were assessed and taken into account, which is a clear strength of 
these studies. Ideally, these parameters should have been assessed repeatedly during 
follow up for a more accurate adjustment of cardiac disease severity on the prognostic 
association of cardiac anxiety. 
Furthermore, although the longer follow-up period is an advantage, during the years 
inevitably clinical guidelines and as such preferred cardiac treatment may change due 
to progressive insight. This is particularly relevant for the outcome of the DepreMI 
cohort, which was performed in the era before the treatment of choice for MI was a 
primary percutaneous intervention (PCI), which was been shown to improve outcome 
when compared to thrombolytic medication 19. However, the effect on prognostic 
impact of cardiac anxiety may be minimal: in the cohort of the Radboud UMC we 
performed a sensitivity analysis in which we included “having received PCI treatment 
(yes/no)”, in the model with CAQ, sex and age, which hardly affected the association 
between overall CAQ score and adverse prognosis.
Interestingly, the prognostic association of cardiac anxiety on cardiac outcome in 
our study seemed to be mediated by avoidance. In light of these findings, the role 
and effect of cardiac rehabilitation is important. In recent years, more attention 
has been given in the national guidelines of cardiac rehabilitation to awareness and 
treatment of anxiety and depression. In our prognostic study on the CAQ (chapter 
5), we adjusted in sensitivity analysis for “being assigned to cardiac rehabilitation”, 
and although assignment in fact was an independent predictor of cardiac outcome in 
this model, it  hardly affected the association between overall CAQ score and adverse 
prognosis. Furthermore, in the latent class analysis-study (chapter 4) assignment 
for cardiac rehabilitation did not significantly differ between the four latent groups 
of patients with different course of cardiac anxiety, implying that despite cardiac 
rehabilitation cardiac anxiety may still be present. More research is needed to evaluate 
which patients profit from cardiac rehabilitation and which ones do not with respect 
to both general and more specific cardiac anxiety. This may provide starting points to 
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optimize treatment 
Future directions and implications
Research directions
Future research in MI and NCCP patients should address how cardiac anxiety 
relates to psychiatric diagnoses and general anxiety by combining these variables in 
assessments. By identifying the overlap between these different constructs, cardiac 
anxiety could be further delineated.
The findings of this thesis suggest a behavioral mechanism of cardiac anxiety on cardiac 
prognosis as particularly anxiety-related avoidance of physical exercise predicted 
future cardiac events in MI patients, which was independent of cardiac disease 
severity and depressive symptoms. More research investigating possible biological 
mechanisms of cardiac anxiety, such as rhythm disturbances due to increased 
sympathetic or decreased parasympathetic nervous activity or atherosclerosis 
promoting abnormalities like increased platelet activity and inflammation, is needed.
Although the results of the RCT (chapter 7) might imply that CBT could decrease 
cardiac anxiety and avoidance in NCCP patients, more research explicitly assessing 
cardiac anxiety in this population is needed. Preferably this could be done with the 
CAQ, as a recent study that cross-validated the CAQ in NCCP patients 20 indicated 
good psychometric properties for this instrument. As our study findings in NCCP 
patients cannot automatically be generalized to MI patients, future studies should 
examine the effect of a CBT intervention or related treatments in reducing cardiac 
anxiety in MI patients specifically. 
Clinical implications
The findings of the present thesis give an indication of the clinical relevance of cardiac 
anxiety post MI. When translating these results into clinical practice, we should 
acknowledge that more information about cardiac anxiety is needed on when best to 
assess it, whether it is amenable to treatment and the potential beneficial effects of this 
treatment on psychological and cardiac outcome. With respect to treatment options, 
it is interesting that the present thesis showed that anxiety indeed can be targeted with 
CBT in a NCCP population (Chapter 7). Although the CAQ was not administered 
in this trial and replication is needed in a population with established high levels 
of cardiac anxiety, it is likely that NCCP patients experience a certain level cardiac 
anxiety (chapter 7). One might assume such an intervention could also be helpful 
for anxiety with a cardiac origin (i.e. anxiety post MI), especially since we showed 
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an association between cardiac anxiety and cardiac prognosis independent of cardiac 
disease severity.  However, we should acknowledge that the NCCP patients who 
received CBT in our RCT (chapter 7) were diagnosed with a panic disorder and/or 
depressive disorder. As such, their treatment was based on the cognitive model of panic 
disorder developed by Clark 21, if needed extended with the treatment of depression. It 
consisted of a combination of psychoeducation, cognitive restructuring and reduction 
of avoidance behavior 22. When hypothesizing about the appropriate treatment for 
cardiac anxiety, it is important to realize that patients experiencing cardiac anxiety 
may not necessarily fulfill the criteria of a panic and/or depressive disorder. Some 
may meet the criteria for hypochondriasis, their CBT may need to consist of elements 
of hypochondriasis: health anxiety with an emphasis on maintaining this anxiety by 
safety seeking behavior. Others may not fulfill the criteria of a psychiatric disorder, 
but may nevertheless profit from treatment, as CBT has previously been shown to be 
effective for sub syndromic anxiety symptoms 23. As this thesis demonstrated that the 
prognostic association of cardiac anxiety was particularly explained by  avoidance 
behavior, and it is common knowledge that avoidant behavior can be (unintendedly) 
maintained by significant others, another suggestion may be to explicitly involve 
family members in treatment programs.
Using the subscale scores of the CAQ, it may be possible to identify which specific 
aspects of cardiac anxiety are important. This can be of help in tailoring interventions 
to the specific processes which each could elevate or maintain anxiety: increased 
attention to cardiac stimuli, catastrophic worries and interpretations, avoidance 
of cardiac stimuli and physical exercise, and safety seeking behaviors. Cognitive 
behavioral therapy (CBT) techniques may target anxiety-related avoidance behaviors 
which may even result in a better cardiac outcome. An efficacy study examining 
CBT, paroxetine and placebo in patients with non-cardiac chest pain, showed that an 
early reduction of cardiac anxiety (assessed with the CAQ) mediated pain reduction 
afterwards 24. This may also be the case for MI patients. A multi-center-RCT in MI 
patients is planned investigating the effect of internet-based CBT on anxiety and 
interestingly, cardiac anxiety (assessed with CAQ) will be one of the secondary 
outcomes 25. 
In the future, the assessment of cardiac anxiety may be helpful in identifying patients 
at risk for developing high and persisting levels of anxiety with negative consequences 
17,26. High levels of cardiac anxiety may indicate the need for therapeutic interventions 
targeted at reduction of anxiety 18. However, even when all the necessary evidence is 
available, implementing such screening programs is still quite a challenge. A Dutch 
study trying to implement screening on panic disorder in NCCP patients attending 
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the emergency department demonstrated that implementation was limited because 
screening frequently conflicted with provision of acute care and because patients 
showed relatively high refusal rates 27. As several heterogeneous psychiatric disorders 
in this particular cohort were diagnosed, the authors call for a more personalized 
approach, instead of a screening program aimed at identifying only those with panic 
disorder. Considering the findings of the present thesis, the assessment of cardiac 
anxiety within this context might be more acceptable and possibly of more use.  
Final remarks:
Cardiac anxiety may be a valuable construct to further explore the role of anxiety in 
MI and NCCP patients and its association with cardiac prognosis. In the future it 
may be used as a feature to optimize risk assessment and guide treatment. Just like 
psychologists and psychiatrists should be aware of cardiac diseases and risk factors in 
their patients, cardiologists should acknowledge and treat anxiety in theirs.
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Cardiac anxiety Questionnaire 
Please rate each item by circling the answer (number) that best applies to you:
 Never Rarely Sometimes Often Always
1. I pay attention to my heart beat  0  1  2  3  4
2. I avoid physical exertion  0  1  2  3  4
3. My racing heart  
wakes me up at night 0  1  2  3  4
4. Chest pain/discomfort  
wakes me up at night 0  1  2  3  4
5. I take it easy as much as possible  0  1  2  3 4
6. I check my pulse  0  1  2  3  4
7. I avoid exercise  
or other physical work 0  1  2  3  4
8. I can feel my heart in my chest  0  1  2  3  4
9. I avoid activities  
that make my heart beat faster 0  1  2  3  4
10. If tests come out normal,  
I still worry about my heart 0  1  2  3  4
11. I feel safe being around a hospital, 
physician or other medical facility 0  1  2  3  4
12. I avoid activities  
that make me sweat 0  1  2  3  4
13. I worry that doctors do not believe 
my symptoms are real 0  1  2  3  4
When I have chest discomfort or when my heart is beating fast:
14.  I worry that I may have a  
heart attack  0  1  2  3  4
15.  I have difficulty concentrating on 
anything else 0  1  2  3  4
16. I get frightened  0  1  2  3  4
17. I like to be checked out by a doctor 0  1  2  3  4
18. I tell my family or friends  0  1  2  3  4
- G.H. Eifert et al. / Behaviour Research and Therapy 38 (2000) 1039-1053
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Cardiale Angst Vragenlijst
Omcirkel aub het antwoord (nummer) dat het beste past volgens u:
 Nooit  Zelden Soms Vaak Altijd
1. Ik let op mijn hartslag 0 1 2 3 4
2. Ik vermijd lichamelijke inspanning 0 1 2 3 4
3. Mijn hartslag  
maakt me ‘s nachts wakker 0 1 2 3 4
4. Pijn op de borst/ 
een gespannen gevoel  0 1 2 3 4 
maakt me wakker ‘s nachts
5. Ik doe het zo rustig mogelijk aan 0 1 2 3 4
6. Ik controleer mijn pols 0 1 2 3 4
7. Ik vermijd inspanning  
of fysieke arbeid 0 1 2 3 4
8. Ik kan mijn hart  
in mijn borstkas voelen 0 1 2 3 4
9. Ik vermijd activiteiten  
die mijn hartslag versnellen 0 1 2 3 4
10. Als onderzoeken  
goede resultaten hebben, 0 1 2 3 4 
maak ik me toch zorgen om mijn hart
11. Ik voel me veilig in een ziekenhuis,  0 1 2 3 4 
bij een arts of andere medische voorziening
12. Ik vermijd activiteiten  
die me laten zweten 0 1 2 3 4
13. Ik maak me zorgen  
dat de artsen niet geloven  0 1 2 3 4 
dat mijn klachten echt zijn 
Als ik pijn op de borst voel, of een drukkend gevoel heb, of als mijn hartslag snel is
14. ……maak ik me zorgen  0 1 2 3 4 
dat ik een hartaanval heb
15. …heb ik moeite me op iets  0 1 2 3 4 
anders te concentreren
16. …word ik bang 0 1 2 3 4
17. …wil ik onderzocht worden  
door een arts 0 1 2 3 4
18. …vertel ik het mijn familie  
of vrienden 0 1 2 3 4 
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Acronyms
ACQ Agoraphobic Cognitions Questionnaire
ACS Acute Coronary Syndrome
AIC Akaike Information Criterion
ANCOVA Analyses Of Covariance
ANOVA Analysis of Variance
BAI Beck Anxiety Inventory
BDI Beck Depression Inventory
BIC Bayesian Information Criterion
BLRT Bootstrapped Likekihood Ratio Test
CAD Coronary Artery Disease
CAQ Cardiac Anxiety Questionnaire
CBS Statistics Netherlands (Centraal Bureau voor de Statistiek)
CBT Cognitive Behavioral Therapy
CFA Confirmatory Factor Analysis
CFI Comparative Fit Index
CGI Clinical Global Inventory
CGI-Severity Clinical Global Impression Severity Scale
CI Confidence Interval
CIDI Composite International Diagnostic Interview
CK Creatine Kinase
CPK max Maximum Creatinin PhosphoKinase level
CRP C-Reactive Protein
DALYs Disability Adjusted Life Years
DepreMI Depression after Myocardial Infarction
DM Diabetes Melitus
ECG Electrocardiogram
EFA Exploratory Factor Analysis
EQ-5D EuroQol- 5 dimensions
FQ Fear Questionnaire
GAD Generalized Anxiety Disorder
HADS Hospital Anxiety and Depression Scale
HADS-A Hospital Anxiety Depression Scale, anxiety subscale
HADS-D Hospital Anxiety Depression Scale, depression subscale
HCS Health Complaints Scale
HDRS Hamilton Depression Rating Scale
HPA-axis Hypothalamic–Pituitary–Adrenal axis 
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HR Hazard Ratio
ICD International Classification of Diseases
LCGA Latent Class Growth Analysis
LOCF Last-Observation Carried Forward
LTA Latent Transition Analysis
LVEF Left Ventricular Ejection Function
MACE Major Adverse Cardiac Event
MI Myocardial Infarction (chapters 1, 3-6, 8, 9)
MI Mobility Inventory (chapters 2, 4)
MINI Mini-International Neuropsychiatric Interview
NA Not Applicable
NCCP Non-Cardiac Chest Pain
NSTEMI/Non-Stemi Non-ST Elevated Myocardial Infarction
PCI Percutaneous Coronary Intervention
PTCA Percutaneous Transluminal Coronary Angioplasty
PTSD Post-Traumatic Stress Disorder
RA Rheumatoid Arthritis
RCT Randomized Controlled Trial
SPSS Statistical Package for the Social Sciences
STAI State-Trait Anxiety Inventory
STAI-S State-Trait Anxiety Inventory, state part
STAI-T State-Trait Anxiety Inventory, trait part
STEMI ST-Elevated Myocardial Infarction
TAU Treatment As Usual
TLI Tucker-Lewis Index
VLMR Vong-Lo-Mendell-Rubin ratio test
WHO World Health Organization
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Summary in Dutch | Nederlandse samenvatting
Cardiale angst  - als je vreest dat je hart in gevaar is - 
Achtergrond (hoofdstuk 1)
Angst is een emotie die wordt opgeroepen bij dreigend gevaar. Angst stelt je lichaam 
in staat van paraatheid, waardoor je kunt vechten tegen of vluchten van gevaar. Als 
de angstreactie onevenredig is met het gevaar (in type, duur of intensiteit), wordt het 
afwijkend (of pathologisch), zeker als een persoon hierdoor niet meer adequaat in het 
dagelijks leven kan functioneren. Aan het pathologische eind van het angstspectrum 
staan de angststoornissen, zoals een paniekstoornis, die gekenmerkt wordt door 
onverwachte en herhaalde paniekaanvallen. Pathologische angst gaat vaak gepaard 
met depressie 1-3 ; een staat van verminderde stemming en/of anhedonie (het verlies 
van interesse in activiteiten die eerder als plezierig werden ervaren) die interfereert 
met het welzijn en het functioneren in het dagelijks leven.
Als je (vreest dat je) hart in gevaar is, kun je dat als levensbedreigend ervaren. Dit 
kan specifieke angst uitlokken: cardiale angst. Cardiale angst omvat alert zijn op 
hart-gerelateerde sensaties (zoals pijn op de borst), catastrofale gedachten hierover 
(bijvoorbeeld “ik heb een hartaanval”), het vermijden van activiteiten die deze 
sensaties kunnen oproepen (zoals lichamelijke inspanning), en het zoeken naar 
geruststelling (bijvoorbeeld het controleren van je pols).
Twee ziektes waarbij mensen die hieraan lijden cardiale angst kunnen ervaren, zijn 
een hartaanval, ook wel myocardinfarct (MI) genoemd, en niet-cardiale-pijn-op-de-
borst (NCPB). MI patiënten lijden aan symptomen van een hartziekte, met name pijn 
of een drukkend gevoel op de borst. Dit wordt veroorzaakt door vernauwing en/of 
blokkade van de kransslagaders, die het hart van zuurstof voorzien: een welbekende 
vorm van coronaire hartziekte. Daarentegen ervaren NCPB patiënten symptomen 
van een hartziekte, te weten pijn op de borst, zonder dat er een cardiale oorzaak is 
gediagnostiseerd die hieraan ten grondslag ligt.
In eerdere onderzoeken is aangetoond dat angst en depressie na een hartaanval 
samenhangen met een slechtere kwaliteit van leven 4,5 en een ongunstiger cardiaal 
beloop, namelijk meer kans op het krijgen van een nieuwe hartaanval 6,7 of op overlijden 
6-8 . Echter, in tegenstelling tot wat je op basis hiervan zou verwachten, hebben 
verschillende pogingen om depressieve klachten na een hartaanval te behandelen niet 
geresulteerd in een verbetering van de cardiale prognose voor de patiënten die deze 
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klachten rapporteerden 9-11. Daarvoor zijn verschillende verklaringen te bedenken. 
Een mogelijke verklaring is dat instrumenten waarmee depressie en/of psychologische 
stress wordt gemeten niet specifiek genoeg zijn. Recente onderzoeksbevindingen 
suggereren dat verschillende typen angst en depressie samenhangen met een 
verschillende cardiale prognose 12. Het focus specifiek op cardiale angst geeft mogelijk 
meer inzicht in de bijdrage van verschillende typen angst aan het geheel.
Slechts in enkele studies is cardiale angst bij hartpatiënten bekeken. Dit betrof vooral 
gemêleerde onderzoekspopulaties van zowel patiënten met als zonder coronaire 
hartziekte. Voor deze onderzoeken 13-15  met uitzondering van één 16 geldt bovendien 
dat cardiale angst slechts op één tijdstip en niet  op meerdere momenten is gemeten. 
Tot op heden zijn er geen studies verschenen waarin cardiale angst in een homogene 
groep van patiënten met een hartaanval is onderzocht. 
Patiënten met NCPB rapporteren vergelijkbare tot zelfs meer symptomen van 
cardiale angst dan  patiënten met aangetoonde coronaire hartziekte 17. Ondanks 
de geruststelling door artsen dat er geen cardiale oorzaak is gevonden, blijft de 
meerderheid van de patiënten last houden van pijn-op-de-borst en blijven ze bezorgd 
een ernstige hartziekte te hebben. Misschien kunnen we hier iets aan doen, aangezien 
psychiatrische stoornissen zoals een paniekstoornis en depressie effectief behandeld 
kunnen worden met bijvoorbeeld cognitieve gedragstherapie (CGT). CGT is een 
psychologische behandeling die gebaseerd is op twee principes. Disfunctioneel gedrag 
-dat leidt tot problemen- kan worden aangeleerd, maar is ook weer af te leren (de 
gedragskant). Dit gedrag kan het gevolg zijn van het feit  dat je slecht over jezelf denkt 
en je vervolgens ook slecht voelt (de cognitieve kant). CGT pakt zowel de gedachten 
en gevoelens als het in standhoudend  gedrag  aan. 
Vraagstelling proefschrift (hoofdstuk 1)
Het doel van dit proefschrift  is om cardiale angst te onderzoeken aan de hand van 
de volgende vragen:
 1. a. Hoe is de validiteit (meet het wat je wilt dat het meet?) en betrouwbaarheid 
(hoe nauwkeurig wordt het gemeten?) van de Cardiale Angst Vragenlijst  (zie 
appendix 2) - een vragenlijst die cardiale angst beoogt te meten- in patiënten met 
een hartaanval ? 
1. b.Wat is het vóórkomen en wat zijn de kenmerken van cardiale angst gedurende 
de ziekenhuisopname wegens een hartaanval ?
2. a. Hoe is het beloop van cardiale angst in het jaar na een hartaanval en hangt het 
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samen met kwaliteit van leven? 
2.b. En (hoe) hangt cardiale angst samen met de cardiale prognose als het gaat om 
nieuwe cardiale incidenten of overlijden?
3   Wat is het effect van een korte cognitieve gedragstherapie voor patiënten met 
NCPB die verondersteld worden cardiale angst te ervaren?
Methode
Om deze vragen te beantwoorden werkten we met drie onafhankelijke groepen: 
-een groep van 237 patiënten die met een hartaanval opgenomen waren op de 
afdeling cardiologie in het Radboud Universitair Medisch Centrum (RadboudUMC) 
te Nijmegen. Zij vulden de CAV en enkele andere vragenlijsten in tijdens de 
ziekenhuisopname (vraag 1: beschreven in hoofdstukken 2 en 3) en diverse keren in 
het jaar na ontslag (vraag 2: beschreven in hoofdstukken 4 en 5). Ook werden gegevens 
omtrent de ernst van de hartziekte en sociaal-demografische gegevens verzameld. 
Tevens werd bij hen gekeken of en zo ja wanneer ze gedurende de vijf jaar na ontslag 
opnieuw werden opgenomen met een hartaanval (of soortgelijke problematiek) of 
overleden waren (vraag 2: beschreven in hoofdstuk 5).
-een groep van 424 patiënten opgenomen met een hartaanval die deel hadden 
genomen aan het Depressie na Myocardinfarct (DePreMI) onderzoek, geworven uit 
vier Groningse ziekenhuizen te weten het Universitair Medisch Centrum Groningen 
(UMCG), het Martini ziekenhuis te Groningen, het Refaja ziekenhuis in Stadskanaal 
en het St. Lucasziekenhuis te Winschoten (vraag 2: beschreven in hoofdstuk 6). Zij 
vulden na 3 en 12 maanden een gezondheidsklachten vragenlijst  in. Tevens werd 
beoordeeld of de diagnose van een depressieve en/of angststoornis bij hen gesteld kon 
worden en vulden patiënten een vragenlijst in over depressieve klachten. Daarnaast 
werden ook bij hen gegevens over de ernst van de hartziekte en sociaal-demografische 
gegevens verzameld en werd bekeken of en zo ja wanneer ze gedurende de vijf 
jaar na ontslag opnieuw werden opgenomen met een hartaanval (of soortgelijke 
problematiek) of overleden waren (vraag 2).
-een groep van 113 patiënten met NCPB die zich melden bij de eerste hulp van Vrije 
Universiteit Medisch Centrum (VUMC), 8 of meer punten scoren op een screenende 
vragenlijst voor depressieve en/of angstige klachten (de HADS) en gediagnostiseerd 
werden met een paniek- en/of depressieve stoornis (vraag 3: beschreven in hoofdstuk 
7). Zij werden verdeeld over twee groepen: 60 patiënten kregen zes individuele 
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sessies cognitieve gedragstherapie (CGT) en 53 patiënten kregen de gebruikelijke 
behandeling. De twee groepen werden met elkaar vergeleken op het effect van de 
behandeling. De hoofduitkomstmaat was het globale functioneren zoals gemeten 
met de Clinical Global Inventory (CGI) door een onafhankelijke beoordelaar. Tevens 
werden depressieve en angstklachten in kaart gebracht middels vragenlijsten.
Bevindingen
De resultaten van de studies zijn in hoofdstukken 2 tot en met 6 van dit proefschrift 
beschreven. Hieronder volgt een korte opsomming van de belangrijkste bevindingen 
per vraagstelling/hoofdstuk.
(1a) Hoe is de validiteit en betrouwbaarheid van de Cardiale Angst Vragenlijst in 
patiënten met een hartaanval ?
In hoofdstuk 2 is een validatie-onderzoek beschreven naar de Cardiale Angst 
Vragenlijst (CAV), een vragenlijst die oorspronkelijk is ontwikkeld door Eifert en 
anderen 13. Onze bevindingen hebben we vergeleken met de resultaten van de eerste 
studie naar deze vragenlijst 13, waarin drie subschalen van de vragenlijst werden 
beschreven die respectievelijk angst, aandacht en vermijding meten. In onze populatie 
paste een verdeling in vier subschalen beter, net als in een andere studie 15. De vierde 
categorie werd gekenmerkt door geruststelling zoekend gedrag. Als je de CAV een 
aantal dagen na de eerste keer nog een tweede keer af nam, waren de resultaten 
consistent. Dit duidt erop dat de vragenlijst betrouwbaar is. Als we alle vragenlijsten 
met elkaar vergeleken, zagen we dat de CAV aansluit bij andere vragenlijsten die 
psychische klachten meten, maar dat cardiale angst wel een aparte factor was. Ook 
was duidelijk dat een controlegroep van patiënten die last hadden van reuma lager op 
de CAV scoorden dan de patiënten met een hartaanval, zelfs als we rekening hielden 
met hun niveau van algemene angst. 
Deze resultaten duiden erop dat de CAV bij patiënten met een hartaanval inderdaad 
cardiale angst lijkt te meten en dat op een betrouwbare manier doet.
(1b) wat is het vóórkomen en wat zijn de kenmerken van cardiale angst gedurende de 
ziekenhuisopname wegens een hartaanval ?
In hoofdstuk 3 worden de bevindingen gerapporteerd van een studie naar cardiale 
angst in dezelfde groep patiënten als beschreven in hoofdstuk 2. Met behulp van 
regressie-analyses werd bekeken welke variabelen samenhingen met cardiale angst. 
Er was geen samenhang tussen cardiale angst en sociaal-demografische gegevens. 
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Wel hing meer cardiale angst samen met meer psychische klachten  zoals depressie, 
algemene angst en vermijdingsgedrag. Interessant genoeg vonden we een omgekeerd 
verband tussen cardiale angst en ernst van de hartziekte. Ernstigere hartziekte was 
gedefinieerd volgens een bepaalde afwijking, te weten (1) een verhoging van het ST 
segment, op het hartfilmpje (STEMI) en (2) een hoog troponine gehalte, een enzym 
in het bloed dat duidt op hartschade. Patiënten met minder ernstige hartziekte bleken 
meer angst te hebben. Hiervoor zijn twee mogelijke verklaringen. Patiënten die angstig 
zijn, zouden eerder hulp kunnen zoeken, waardoor ze ook eerder gediagnostiseerd 
worden met een minder ernstige hartziekte. Ten tweede kan cardiale angst mogelijk 
uitgelokt worden door onzekerheid over de diagnose. Hoewel we moeten erkennen 
dat de correlaties in deze studie klein zijn, kunnen de twee voorgestelde verklaringen 
toch van invloed zijn op de klinische praktijk. Communicatie strategieën om patiënten 
effectiever gerust te stellen zouden voor zowel de subgroep die zich in een situatie van 
onzekerheid over de diagnose bevindt, als voor de subgroep van patiënten die sowieso 
hoger scoren op cardiale angst relevant kunnen zijn. 
Concluderend laten deze resultaten zien dat bij patiënten die opgenomen zijn met 
een hartaanval cardiale angst samenhangt met meer psychische klachten maar 
minder cardiale schade.
(2a) hoe is het beloop en de trajecten van cardiale angst in het jaar na een hartaanval 
en de samenhang met kwaliteit van leven?
Hoofdstuk vier toont de resultaten van een onderzoek in een deel van de patiënten 
die in hoofdstuk 2 werden beschreven en met een hartaanval waren opgenomen. 
Deze subgroep werd gevraagd op meerdere momenten de cardiale angst vragenlijst 
in te vullen: tijdens de opname, en ongeveer na één, drie, zes en twaalf maanden na 
ontslag uit het ziekenhuis. Met behulp van een statische analyse methode die latente 
klasse analyse heet, identificeerden we vier mogelijke beloopstrajecten van cardiale 
angst na een hartaanval: drie groepen hadden gelijkblijvende niveaus van cardiale 
angst met hoge, middelmatige en lage intensiteit van de cardiale angst, en één groep 
scoorde hoog op cardiale angst in het begin, maar in deze groep daalden de klachten 
gedurende de follow-up. 
De groepen die het hoogst scoorden op cardiale angst na één jaar, rapporteerden ook 
de slechtste kwaliteit van leven. Verschillen tussen de groepen zijn vooral interessant 
voor de subgroepen patiënten die veel cardiale angst in het begin rapporteerden, 
omdat deze verschillen aanwijzingen kunnen geven over wie wellicht behandeling 
van cardiale angst verdient en bij wie cardiale angst vanzelf herstelt in de loop van 
de tijd. Patiënten bij wie de angst persisteerde, waren vaker werkeloos, hadden vaker 
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suikerziekte of een eerdere hartaanval gehad, en hadden tijdens de opname meer 
last van symptomen van depressie, algemene angst en vermijding. Jammer genoeg 
was het aantal personen in deze twee subgroepen te klein om te controleren voor 
mogelijke verstorende variabelen. 
Al met al, zijn door deze studie met meerdere meetmomenten van cardiale angst 
in het jaar na een hartaanval, vier mogelijke beloopstrajecten van cardiale angst 
geïdentificeerd. Toekomstig onderzoek zou zich moeten richten op cardiale 
prognose en de effectiviteit van behandelingen op cardiale angst met name in de 
subgroep van patiënten met persisterende cardiale angst.
(2b) (hoe) hangt cardiale angst samen met de cardiale prognose als het gaat om 
nieuwe cardiale gebeurtenissen of overlijden?
In hoofdstuk 5 wordt de voorspellende invloed van cardiale angst op cardiale 
prognose beschreven in dezelfde groep patiënten als waarover in hoofdstuk 4 is 
gerapporteerd. In eerdere soortgelijke onderzoeken werd angst meteen tijdens de 
ziekenhuisopname of na de operatie gemeten 7. Door tijdelijke stress ten gevolge 
van deze opname of operatie kan het angst niveau echter tijdelijk verhoogd zijn, 
terwijl lange termijn uitkomsten vooral beïnvloed worden door klachten die blijven 
bestaan, of pas ontwikkelen gedurende de eerste maanden na een hartaanval zoals 
is aangetoond voor depressieve klachten 18. Bovendien werd in hoofdstuk 4 van dit 
proefschrift aangetoond dat beloopsvormen van cardiale angst met name in de eerste 
drie maanden na het hartaanval bepaald worden. Daarom kozen we ervoor om de 
voorspellende invloed van cardiale angst op cardiale prognose zowel voor angst 
tijdens de opname als na vier maanden erna te bestuderen.
Als maat voor cardiale prognose namen we een gecombineerd eindpunt, te weten het 
optreden van een nieuwe acute ziekenhuisopname voor een coronaire hartziekte of 
overlijden binnen een periode van ongeveer 5 jaar na de start. Dit werd geanalyseerd 
middels Cox-regressie-analyse, waarbij gecorrigeerd werd voor geslacht, leeftijd, 
ernst van de hartziekte (pompkracht van het hart en of er al eerder een hartaanval was 
geweest) en de mate van depressieve klachten, omdat al deze variabelen het mogelijke 
verband zouden kunnen beïnvloeden. De cardiale angst tijdens de ziekenhuisopname 
en die vier maanden erna bleken voorspellend voor het optreden van een gecombineerd 
eindpunt. Aanvullende analyses van de sub schalen van de cardiale angst vragenlijst 
lieten zien dat dit effect vooral werd veroorzaakt door vermijdingsgedrag, met name 
drie maanden na het ontslag. Deze resultaten impliceren dat angst en het daaraan 
gerelateerde gedrag (vooral vermijding van fysieke activiteit) aangepakt moet worden. 
Cognitieve gedragstherapie zou hierbij een goede behandelstrategie kunnen zijn. 
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Concluderend lijkt het dat cardiale angst na een ziekenhuisopname voor een 
hartaanval, en dan met name de angst-gerelateerde vermijding, een belangrijke 
voorspellende factor is voor de cardiale prognose, onafhankelijk van de ernst van 
de hartziekte en depressieve klachten.
In hoofdstuk 6 onderzochten we het verband tussen patiënt-gerapporteerde fysieke 
gezondheid en cardiovasculaire prognose. Patiënten uit het DePreMI cohort vulden de 
vragenlijst Health Complaints Scale (HCS) in op 3 en 12 maanden na het hartaanval. De 
cardiale angst vragenlijst (CAV) was helaas niet afgenomen in dit onderzoek en konden 
we dus niet gebruiken. Omdat in eerder onderzoek in hartpatiënten (Hoyer 2008) 
aangetoond werd dat de CAV meer samenhing met de fysieke dan met de psychische 
kwaliteit van leven, hoopten we dat fysieke gezondheid - in ons geval gemeten met 
de HCS - zou kunnen dienen als surrogaat marker voor cardiale angst. Als maat voor 
cardiale prognose namen we het optreden van een gecombineerd eindpunt binnen 
een periode van ruim 5 jaar na de start: hetzij een nieuwe acute ziekenhuisopname 
voor een cardiovasculaire aandoening, hetzij overlijden. Dit werd geëvalueerd met 
behulp van cox-regressie-analyse, waarbij gecorrigeerd werd voor geslacht, leeftijd, 
opleidingsniveau, ernst van de hartziekte en andere relevante somatische parameters, 
alsmede relevante psychiatrische klachten, in dit geval depressieve symptomen en het 
al dan niet hebben van een gegeneraliseerde angststoornis.
Latente klasse analyse op de HCS liet op beide tijdstippen vijf groepen zien van 
patiënten die respectievelijk (1) geen of weinig, (2) cardiale, (3) energie, (4) slaap en (5) 
gemengde gezondheidsklachten rapporteerden. Met twee meetmomenten resulteerde 
dat in 25 opties (25 latente transitie klassen). In tegenstelling tot wat we hadden 
gehoopt, leek geen deze groepen het begrip cardiale angst te vertegenwoordigen. Toch 
waren de resultaten interessant. 
Op drie maanden na de hartaanval, bleken vooral cardiale klachten belangrijke 
voorspellers, terwijl gemengde gezondheidsklachten en een gebrek aan energie wel 
een trend maar geen statistisch significant verband lieten zien. Wat betreft het beloop 
van de klachten, waren nieuwe en persisterende klachten van het gemengde, cardiale 
en energie-type voorspellend.
Terugkijkend kunnen we stellen dat hoewel we er niet in slaagden een maat voor 
cardiale angst in dit DePreMi cohort te construeren, de onderzoeksresultaten wel 
interessant waren. Fysieke gezondheidsklachten na een hartaanval voorspellen 
de cardiovasculaire prognose onafhankelijk van hartziekte, depressie en angst. 
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Deze klachten na een hartaanval kunnen verdeeld worden in verschillende types 
en beloopsvormen, bestaande uit cardiale, energie, slaap, gemengde en geen tot 
weinig klachten. Het soort gezondheidsklachten en hun beloop zijn mogelijk van 
meerwaarde in het voorspellen van cardiovasculaire prognose. 
(3) wat is het effect van een korte cognitieve gedragstherapie behandeling voor 
patiënten met niet-cardiale-pijn-op-de-borst die verondersteld worden cardiale angst 
te ervaren?
Hoofdstuk 7 gaat over de bevindingen van een 24-weken-durend gerandomiseerd 
gecontroleerd onderzoek naar het effect van cognitieve gedragstherapie in 
vergelijking met de gebruikelijke behandeling in volwassenen die zich op de eerste 
hulp presenteerden met NCPB, 8 of meer punten scoorden op een screenende 
vragenlijst voor depressieve en/of angstige klachten (de HADS)  en vervolgens werden 
gediagnostiseerd met een paniekstoornis en/of depressieve stoornis. CGT bestond 
uit zes individuele sessies. De hoofduitkomstmaat was het globale functioneren zoals 
gemeten met de Clinical Global Inventory (CGI) door een onafhankelijke beoordelaar, 
die niet wist in welke groep de patiënten waren ingedeeld. 
ANCOVA analyses naar de primaire uitkomstmaat in zowel de gehele groep als de 
groep patiënten die de volledige studie afmaakten toonden aan dat CGT na 24 weken 
superieur was aan de gebruikelijke behandeling. De uitkomsten van de secundaire 
maten op angst (HADS-A, STAI-T) en depressieve symptomen (HDRS) kwamen 
hiermee overeen, met uitzondering van de HADS-D, Fear Questionnaire en Stai-State. 
Ook als in de analyses rekening werd gehouden met variabelen die vooraf verschillend 
waren tussen de beide groepen patiënten, bleven deze bevindingen overeind. Ondanks 
dat cardiale angst in deze studie niet expliciet gemeten werd en replicatie van deze 
bevindingen in een groep patiënten met hoge cardiale angst gewenst is, ligt het voor 
de hand dat NCPB patiënten met een paniek en/of depressieve stoornis veel cardiale 
angst ervaren.
Samenvattend liet dit gerandomiseerd gecontroleerd onderzoek in NCPB 
patiënten die gediagnostiseerd zijn met een paniek en/of depressieve stoornis zien 
dat kortdurende cognitieve gedragstherapie het globaal functioneren significant 
verhoogt en depressieve en angstklachten vermindert. 
Hoofdbevinding/Algehele conclusie
De vier onderzoeken in myocardinfarct (MI) patiënten zoals beschreven in 
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hoofdstukken 2-5 van dit proefschrift laten zien dat cardiale angst valide en 
betrouwbaar kan worden gemeten met de door patiënten in te vullen Cardiale 
Angst Vragenlijst, dat patiënten gedurende het jaar na een hartaanval verschillende 
beloopstrajecten van cardiale angst vertonen, én dat meer cardiale angst samenhangt 
met meer algemene angst en depressieve klachten, een slechtere kwaliteit van leven 
één jaar na het hartaanval en een slechtere cardiale prognose tot vijf jaar na het 
hartaanval. Cardiale angst is dus relevant. Of het relevanter is dan algemene angst, 
is in dit proefschrift niet onderzocht. Door het onderzoek in de andere groep MI 
patiënten (hoofdstuk 6) werd duidelijk dat het moeilijk is conclusies te trekken 
over cardiale angst als cardiale angst niet specifiek gemeten wordt. Tenslotte 
toonde het gerandomiseerd gecontroleerde interventie-onderzoek, beschreven in 
hoofdstuk 7 van dit proefschrift, aan dat kortdurende cognitieve gedragstherapie 
in patiënten met Niet-Cardiale Pijn op de Borst (NCPB) die gediagnosticeerd zijn 
met een paniek en/of depressieve stoornis het globaal functioneren significant 
verhoogt en depressieve en angstklachten vermindert. Hoewel in deze laatste studie 
cardiale angst niet expliciet gemeten werd, en replicatie van deze bevindingen in 
een groep patiënten met hoge cardiale angst wenselijk is, ligt het voor de hand 
dat NCPB patiënten met een paniek en/of depressieve stoornis veel cardiale angst 
ondervinden. Als CGT bij hen effectief is, zou je kunnen aannemen dat CGT ook 
behulpzaam kan zijn voor angst mét een cardiale origine, zoals cardiale angst bij 
MI patiënten. Dit zou verder onderzocht moeten worden.
Slot Overwegingen 
Net zoals psychologen en psychiaters zich bij hun patiënten bewust moeten zijn van 
eventuele cardiale aandoeningen en cardiale risicofactoren, behoren cardiologen bij 
hun patiënten cardiale angst te onderkennen en waar nodig te (laten) behandelen.
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tot professor ouderenpsychiatrie in het UMCG, heb ik letterlijk momenten van lief 
en leed met je gedeeld. Los van het feit dat ik ontzettend veel van je heb geleerd op 
onderzoeksgebied, je reactie nooit lang op zich laat wachten en je niet te beroerd was 
vanuit het Groningse naar Nijmegen te komen en anderzijds mij te introduceren in de 
Groningse onderzoeksgroep, versta je de kunst om anderen te motiveren en ondanks 
je eigen drukke werkzaamheden altijd laagdrempelig benaderbaar te blijven. Het is 
fijn met je samen te werken en ik hoop zeker dat er nog nieuwe projecten gaan komen.
Ook ben ik alle overige co-auteurs dankbaar voor hun bijdrage aan de verschillende 
artikelen. Met een aantal heb ik intensiever samengewerkt, en hen wil ik hier expliciet 
noemen. Dank aan cardioloog Gheorghe Pop van het RadboudUMC voor zijn 
medewerking: als betrokken cardioloog was je ondanks je drukte steeds enthousiast 
om de dataverzameling te faciliteren. Heel fijn ook dat je de benodigde cardiologische 
input hebt geleverd! Het zou mooi zijn mede voor de hartpatiënten aan deze 
samenwerking een vervolg te geven. Marjanka Mingels en Femke van Deelen, als 
studenten geneeskunde hebben jullie destijds in het kader van een wetenschappelijke 
stage een groot deel van de data verzameld van de MI patiënten uit het RadboudUMC. 
Martijn Lappenschaar, bedankt dat je als toenmalige datamanager van de afdeling 
psychiatrie hebt meegedacht met de statistiek en ik ook later (toen je naast wiskundige 
ook nog even als arts promoveerde) nog steeds een beroep op je mocht doen. Samen 
met psychiater Neeltje Batelaan van de VU heb ik de kwaliteit van een bestaande 
data set beoordeeld; dankjewel dat ik hiermee ervaring heb kunnen opdoen. Dan de 
onderzoeksgroep uit Groningen met wie ik heb samengewerkt; Marij Zuidersma, 
Annelieke Roest, Klaas Wardenaar. Het was ontzettend leerzaam om met een andere 
vakgroep en dataset te werken, en het proces van onderzoeksvraag opstellen tot artikel 
schrijven met jullie te hebben doorlopen: bedankt en wat mij betreft smaakt het naar 
meer. Marij, ik waardeer je nauwgezetheid en nadruk op logische redeneringen, het 
was inspirerend en ook gezellig om samen met jou in Groningen aan de slag te gaan. 
Annelieke, leuk dat ik in levende lijve kon (en kan) samenwerken met diegene die ik 
al eerder had geciteerd. Klaas, jouw ingewikkelde analyses doe ik echt niet na. 
Dank aan de leden van de manuscriptcommissie, professoren Angela Maas 
(voorzitter), Peter de Jonge, en Adriaan Honig, dat ze ondanks hun drukke agenda’s 
de tijd en moeite hebben willen nemen dit proefschrift te beoordelen. Beste Angela, 
fijn dat jij er bij bent vandaag en ik ben vereerd dat ik nu met jou, Anne en met je 
collega cardioloog Suzette Elias-Smale samenwerk aan onderzoek ten behoeve van 
“jouw” patiënten met microcoronaire dysfunctie. Beste Peter, dank dat je de data 
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van het DePreMI cohort ter beschikking hebt gesteld. Beste Adriaan, dank voor 
het meedenken over wie jouw deskundigheid in de oppositie vandaag zou kunnen 
vervangen.
De huidige en voormalige afdelingsleiding van de afdeling psychiatrie van 
het RadboudUMC (respectievelijk professor Aart Schene & bedrijfsleider 
Nienke Plass-Verhagen, en professoren Jan Buitelaar & Paul Hodiamont en 
bedrijfsleider Martin Bijker) ben ik erkentelijk voor het faciliteren van onderzoekstijd. 
Beste Aart, het is stimulerend om te merken dat het academisch profiel van de 
afdeling zich steeds verder ontwikkelt en je daarin oog hebt voor ieders rol. Beste 
Nienke, fijn dat je als bedrijfsleider zo zichtbaar aanwezig bent en je inhoudelijke 
input waardeert. Dank ook aan alle collega’s (staf en opleidelingen) en medewerkers 
van de afdeling psychiatrie RadboudUMC, voor het waarnemen, de inspirerende 
samenwerking en (uitgesproken en onuitgesproken) belangstellling voor mij en mijn 
(onderzoeks)activiteiten. Speciale dank aan de collega’s met wie ik momenteel nauw 
samenwerk in mijn klinische taken; de collega’s van het Stemming PLUS team en in 
het bijzonder de (voormalige) leden van het ouderenpsychiatrie subteam. En mijn 
kamergenote Pauline Beusekamp: bedankt voor de thee in de vroege ochtend en het 
kunnen verdragen van de stapels (onderzoeks) papieren op mijn bureau. Verder een 
dankjewel aan de co-assistenten en studenten die met hun nieuwsgierigheid ook 
mijn eigen nieuwsgierigheid verder stimuleren.
Voor de lay-out van mijn proefschrift wil ik graag Theo Dobbelsteen bedanken. Wat 
goed dat je bereid was deze tijdrovende taak op je te nemen; het resultaat mag er zijn!
Goede vrienden zijn onbetaalbaar. Evelien Bodar en Inge Boullart zijn vandaag 
mijn paranimfen. Beste Evelien, het is al even geleden dat ik tijdens de vierdaagse 
feesten met jou onder de waalbrug sparde of ik me zou gaan wagen aan een 
promotietraject. Ondertussen heb jij de doctor-titel al even binnen en mocht ik 
samen met Inge jouw paranimf zijn. Daarom, maar vooral vanwege al die jaren 
van vriendschap, gezamenlijke reizen, vele telefoontjes, en het delen van lief en 
leed, ben ik blij dat je nu aan mijn zijde staat! Beste Inge, wij leerden elkaar als 
tweedejaars studenten geneeskunde aan de Universiteit Maastricht kennen toen 
we allebei deelnamen aan het onderzoekstraject geneeskunde. Ik vind het fijn dat 
we nog steeds- na vele (hardloop)avonturen en verwikkelingen verder - goed 
bevriend zijn, en ik ook Ando, Anna en Emma heb leren kennen. Bedankt dat je 
vandaag mijn paranimf bent! Mocht ik tijdens de verdediging last krijgen van cardiale 
angst of andere klachten, weet ik me gesteund door twee top internisten.
Thesis Marleen.indd   203 15-9-2016   10:49:00
Processed on: 15-9-2016
505364-L-bw-vanBeek
204
Chapter 10
Jin, Daisy, Elke, Lucie, Margo, Marieke, Agnes, Isabel; ook al zijn voor de meesten 
de reisafstanden over de jaren heen door verhuizingen groter geworden, ons contact 
is er nog steeds en dat blijft bijzonder! Sevla en Ellen; op naar nog vele etentjes, reizen, 
intervisie momenten (samen met Frank en Gerard) en zo verder.
Van je familie moet je het hebben. Ik ben blij met de schoonfamilie Schellekens die 
ik gratis bij Rogier heb gekregen. Henry, Ans, Gaby en Sjoerd, leuk dat jullie er bij 
zijn vandaag. Sjoerd, dank voor het delen van je kennis en kunde als professioneel 
interaction designer. Dan mijn eigen ouderlijk gezin. Mijn jongere zussen, José en 
Anneke, jullie waren er ook bij toen ik basisarts werd en jullie de officiële toespraak 
mochten houden. Dit keer hebben jullie -ondanks jullie drukke banen- zelf voorgesteld 
de officieuze rol van partynimf op je te willen nemen. Met jullie humor komt dat 
zeker goed! José, super dat je de kaft hebt ontworpen en vormgegeven. Het is wel 
duidelijk dat je samen met Maarten een creatief stel vormt; mooi dat jullie vandaag 
alle drie van de partij zijn. Mijn ouders, Jos en Annie van Beek; lieve papa en mama; 
bedankt voor alle (praktische en morele) steun rondom dit proefschrift en vooral dat 
jullie er voor me zijn. Jullie zijn té gekke ouders! Tot slot, lieve Rogier, het is bewezen: 
jij doet mijn hart sneller kloppen.
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